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                                                          Abstract  
Revival of the ABE fermentation will be enhanced by the ability of bacterial strains to 
utilise cheap, renewable substrates containing a range of fermentable carbohydrates. 
Development of an effective process will, however, depend on a detailed understanding 
of the mechanisms of uptake and metabolism of the available sugars.  The predominant 
mechanism for uptake of sugars and sugar derivatives in the clostridia is the 
phosphoenolpyruvate (PEP) - dependent phosphotransferase system (PTS), which not 
only catalyses the concurrent uptake and phosphorylation of its substrate but also plays  
a central role in regulation of carbohydrate metabolism.  
Complete characterization of the PTS in the solventogenic clostridia will therefore be 
instrumental in developing strategies for constructing effective fermentation strains.  
The Clostridium beijerinckii 8052 genome encodes 43 complete phosphotransferase 
systems, including sixteen belonging to the glucose-glucoside family. Three of the PTSs 
are members of the glucose subgroup in a phylogenetic branch, and might therefore 
transport glucose. Since glucose has been shown to repress utilization of other sugars by 
Clostridium beijerinckii, these systems could also potentially be involved in glucose 
sensing and carbon catabolite repression (CCR).  
The cbei 0751 gene encoding a IICBA PTS permease was amplified by PCR, and 
cloned into Escherichia coli ZSC113, a mutant which cannot take up and phosphorylate 
glucose and mannose. Transformants showed a positive fermentation phenotype for 
glucose and mannose. Extracts showed glucose PTS activity, and cbei 0751 was 
therefore shown to be a functional glucose PTS. The activity was inhibited by mannose 
confirming that the system also recognises mannose as a substrate. The expression of 
this gene appeared to be constitutive although quantitative expression was not 
performed. Similar experiments were used to investigate the function of a second 
system encoded by cbei 4983 (IICB) and cbei 4982 (IIA). Although these genes were 
successfully cloned, their function could not be identified. Since the cbei 4984 gene 
encodes a putative glycoside hydrolase, this suggests that the primary function of this 
PTS may be to transport and phosphorylate a disaccharide, but further experimental 
analysis is required to identify the substrate of this system. Attempts to inactivate the 
two phosphotransferases to examine the effect on the cells were not successful.  
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1. Introduction   
The acetone, butanol, ethanol (ABE) fermentation catalysed by the solventogenic 
clostridia will be enhanced by the ability of bacterial strains to utilise cheap, renewable 
substrates containing a range of fermentable carbohydrates. Development of an 
effective process will, however, depend on a detailed understanding of the mechanisms 
of uptake and metabolism of the available sugars, which also play an important role in 
regulation of carbohydrate metabolism. In general glucose is the dominant sugar which 
represses the metabolism of alternative carbon sources. The clostridial   
phosphoenolpyruvate(PEP) dependent phosphotransferase system (PTS) is a widespread 
mechanism for uptake of substrates, which involves a group translocation in which the  
carbohydrate is phosphorylated as it crosses the membrane. The PTS consists of a 
multi-protein phosphoryl transfer chain that passes phosphate from the PEP to the 
carbohydrate which is phosphorylated as it enters the cell. The PTS also plays an 
important role in bacteria carbon catabolite repression (CCR). The solventogenic 
clostridia exhibit the phenomenon of CCR in which expression of genes concerned with 
sugar uptake and metabolism is repressed by glucose. Understanding the mechanism of 
CCR will be useful in formulating strategies for manipulation of the bacteria to 
maximise the rate of conversion of carbohydrate mixtures to solvent. A range of sugars 
and polymers are important as potential substrates for the ABE fermentation, and so 
uptake and metabolism should be investigated at genetic and biochemical levels.      
Waste materials from different sources containing different fermentable substrates 
including glucose, mannose, sucrose and maltose can potentially be exploited as 
renewable raw materials substrates for the industrial solventogenic process.  
    1.1. Carbohydrates  
Carbohydrates are organic compounds composed of carbon, hydrogen and oxygen        
(in the ratio 1:2:1, CH2O) and are divided into groups such as monosaccharides, 
disaccharides, oligosaccharides and high molecular weight polysaccharides. 
Carbohydrates are considered a very important energy source for humans, animals and 
microorganisms and also are used to store energy in the form of polysaccharides.  
Carbohydrates are important in food science particularly as complex carbohydrates 
found in bread and pasta, or simple carbohydrates such as glucose found in jams or 
desserts (Bockov et al., 1991).  
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1.1.1. Monosaccharides    
The most important natural monosaccharides are simple sugars which most often 
contain five or six carbon atoms carrying hydroxyls and also contain an aldehyde or 
ketone group. Examples are glucose, mannose, galactose, and sorbose. In addition there 
are amino sugars considered as monosaccharides, in which a hydroxyl group is replaced 
by an amino group such as in N-acetylglucosamine, N-acetylgalactosamine, D-
glucosamine, D-mannosamine, D-galactosamine and fucosamine (Robyt, 1998, Macek 
et al., 2011). Also the sugar alcohols mannitol, glucitol and galactitol are considered to 
be monosaccharides (Stoker, 2012, Cummings and Stephen, 2007). Metabolism of these 
sugars is very important in the cell metabolism to release energy (Miljkovic, 2010, 
Hames and Hooper, 2006).  
1.1.2. Disaccharides 
Disaccharides are formed by two units of simple sugar which are linked by a covalent 
glycosidic bond. Sucrose is a common disaccharide composed of glucose and fructose 
joined by an α(1-2) glycosidic bond, and is found in all plants. Another important 
disaccharide is maltose, consisting of two glucose molecules linked by an α(1- 4) 
glycosidic bond.  Maltose occurs as a product of starch degradation by amylase. Lactose 
is the main sugar component in milk and consists of glucose and galactose joined by a 
β(1-4) glycosidic bond. Cellobiose is plant sugar belong to the group of carbohydrates 
called β-glucosides and is composed of two β(1-4) linked glucose residues and is the 
most abundant β-glucoside (Rajvaidya and Markandey, 2005). 
 1.1.3. Oligosaccharides  
Oligosaccharides are composed of several units (from 3-10) of simple sugars joined 
together by covalent glycosidic bonds. They are commonly found in food, mammalian 
tissues, and vegetables such as legumes, wheat, and have various applications in the 
food and medical industry. Examples are trisaccharides like raffinose, tetrasaccharides 
such as stachyose, pentasaccharides like verbascose, and hexasaccharides such as 
ajugose (Hames and Hooper, 2006). 
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1.1.4. Polysaccharides  
Polysaccharides are long chains of monosaccharides which may contain hundreds or 
thousands of units linked together by covalent bonds. Polysaccharides found in nature 
are classified into three groups. Water-binding polysaccharides prevent tissues and cells 
from drying, structural polysaccharides provide a mechanism of stability to an 
organism, and reserve polysaccharides are storage compounds which release simple 
sugars as required. Polysaccharides include starch, glycogen, cellulose, and chitin.      
Starch is a polysaccharide plant storage compound found in the chloroplasts in leaves 
and in seeds, tubers, and fruits. Cereal grains contain approximately 75 % starch 
(Koolman and Röehm, 2005). Starch consists of two polysaccharides, amylopectin and 
amylose. Amylose consists of glucose units linked α(1- 4), it may have a molecular 
weight from thousands to half a million. Amylopectin is a branched polymer, found in 
starches from for example potato, rice, and wheat and often makes up between 70- 80 % 
of the starch content (BeMiller and Whistler, 2009). 
The main storage polysaccharide in animals is glycogen. Glycogen is a highly branched 
polymer composed of glucose chains linked by α(1- 4) bonds, similar to starch, and it's 
function is energy storage by muscle and liver.  
Cellulose is the main component in plant cell walls (Garrett and Grisham, 2010). It is     
a linear polymer of glucose molecules up to 10
4 
units long, and can reach lengths of     
6-8 µm. The glucose residues are joined by β(1-4) glycoside bonds.  
Chitin is a polymer of N-acetylglucosamine linked by β(1-4) bonds. It is the second 
most abundant carbohydrate in the environment after cellulose, being present in the cell 
walls of fungi and in the exoskeletons of insects, crustaceans, and spiders (Young et al., 
2005).   
A full range of carbohydrates is available in different renewable and waste materials 
that could support a solventogenic fermentation process. The ability of the fermenting 
bacteria to utilise these materials should therefore be examined and optimised in order 
to develop efficient industrial processes.  
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1.2. Clostridia and the history of acetone – butanol – ethanol (ABE) fermentation  
The genus Clostridium, was proposed by Prazmowski more than 100 years ago. Many 
bacterial species were assigned to the genus. Andreesen et al., (1989) considered that 
there were 83 species of Clostridium  Some of them are able to degrade polysaccharide 
into monosaccharide (Minton and Clarke, 1989) and some are pathogenic and excrete 
proteinaceous toxins, although they are predominantly anaerobic, some such as            
C. histolyticum, C. durum, C. aerotolerans, C. carnis are moderately aerotolerant  
(Shone and Hambleton, 1989). The acetone-butanol-ethanol fermentation (ABE 
fermentation) is not new but dates back to the beginning of the 20 century (Jones and 
Woods, 1986). In 1862, Louis Pasteur was the first person who observed that 
fermentation by a species of Bacillus named  Bacillus granulobacter was able to 
produce butanol (Dürre, 2008). Acetone fermentation dates back to 1905 (Schardinger, 
1905). Between 1912-1914 during World War I, the process was scaled up considerably 
to produce acetone to support the manufacture of cordite (Jones and Woods, 1986). The 
demand for acetone decreased after the World War I; however, butanol was needed for 
production of lacquers in the automobile industry which was growing in the USA 
(Dürre, 2007, Dürre, 2008). In 1927 solvent production by fermentation in the USA  
reached 50,000 gallons (Gabriel, 1928). In 1936 a new strain, Clostridium saccharo-
acetobutylicum was isolated which fermented molasses refined from sugar cane or sugar 
beet. In 1938 other new strains were named Clostridium saccharobutylacetonicum 
liquefaciens, and these strains have given higher yields of about 30-33 % conversion to 
ABE from 6.5 % (w/v) sugar in the medium. These and other strains, including 
Clostridium beijerinckii were used to produce acetone during World War II (Claassen et 
al., 1999, Woods, 1995, Jones and Keis, 1995). After World War II the commercially 
important ABE fermentation catalysed by clostridia was the second largest biological 
industrial process in the world, before being supplanted by the petrochemical industry 
(Jones and Woods, 1986, Lee et al., 2008a). The molasses price increased, and the 
petroleum industry was able to produce a larger quantity of solvents at lower price. 
Also, the fermentation process was rejected in the USA in the 1950s because starch and 
molasses could be used for animal feed (Morris, 1993). ABE production plants soon 
closed down in some countries, particularly in the western world, although the process 
still continued in the former Soviet Union, the People's Republic of China, South 
Africa, and Egypt (Jones and Woods, 1986). 
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Several factors contributed to the decline of the ABE fermentation (Claassen et al., 
1999). Firstly high cost of materials; the major factor in ABE fermentation is substrate 
cost, and using biomass from food crops or wastes material would significantly lower 
the cost of the ABE fermentation process. Secondly, low final concentration of solvent 
due to high butanol toxicity to the bacteria. Butanol disrupts the cell membrane and 
associated functions such as carbohydrate transport (Evans and Wang, 1988), and it is 
expensive to recover it from a dilute solution. However, since the 1970s oil crisis, 
researchers have focused on other energy alternatives, hence the desire to improve the 
ABE fermentation (Ezeji et al., 2004), by understanding the principles of genetics, 
biochemistry and physiological pathways in the bacteria (Gheshlaghi et al., 2009).    
This renewed interest has been strengthened by a number of factors including the finite 
nature of the supply of oil, environmental concerns relating to burning fossil fuels and  
the fact that butanol can be used as a biofuel. Reintroduction of the fermentation will 
however depend on a number of things including use of cheap, renewable substrates, 
full understanding of genetics and metabolism, and improved butanol tolerance, 
production and recovery from fermentations. 
1.3. Biofuels 
Liquid biofuels are fuels produced from solid biomass and used for energy production 
(Peri and Baldi, 2012). Biofuels have particular importance as transportation fuels 
(Demirbas, 2009). Biomass refers generally to matter including crops, waste residues 
and wood produced by farming and other agricultural processes. Currently, biofuels are 
produced mostly from sugar or starch. However, lignocellulose is an abundant biomass 
composed mainly of cellulose, hemicellulose, and lignin. Cellulose has a high molecular 
weight of hemicellulose, which is composed of pentoses such as arabinose, xylose and 
hexoses (glucose and mannose). Lignin is a polymer of aromatic alcohols and  provides 
rigidity to  the cell wall, and may be converted into biofuels by physical treatment 
followed by microbial metabolism (Brodeur et al., 2011).  Biofuels can contribute to 
reducing carbon dioxide emissions (Ali et al., 2013). In    2008-2011, 13% of vegetable 
oil, 11% of coarse grain and 21% sugarcane global production were used to produce 
fuel (Serra and Zilberman, 2013). In the European Union (EU), production of biofuel 
increased by 395%  from  2005 to 2009. The biggest producers in the EU are Spain, 
Germany, Italy and France because of the economic incentives available (Peri and 
Baldi, 2012). There are variety of potential fuel products such as biodiesel, bioethanol, 
and biobutanol.  
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1.3.1. Biodiesel 
Biodiesel is a fuel for diesel engines. There are different biological sources for biodiesel 
production such as animal fats (beef tallow, poultry oil) or vegetable oil ( sunflower oil, 
soybean oil, peanut oil) and long chain fatty acids (Atabani et al., 2013). Use of 
vegetable oil as a fuel began in 1978 in the United States and in 1981 in South Africa. 
In Europe approximately 2.7 million tones of biodiesel were produced in 2003. 
Petroleum diesel is considered less safe than biodiesel, especially environmentally, and 
burning it is considered more toxic compared with biodiesel (Demirbas, 2009). The 
advantages of biodiesel are reducing engine emissions such as sulfur oxide, unburned 
hydrocarbons and carbon monoxide (Kiakalaieh et al., 2013). There are however some 
problems with biodiesel, for example high viscosity, high nitrogen oxide emission, low 
energy content, and lower power and engine speed, which may damage the diesel 
engine (Balat, 2011, Ramadhas et al., 2004).                                                                           
1.3.2. Bioethanol  
Bioethanol is produced from renewable agriculture products such as sugar cane in 
Brazil and corn in the USA (Mathew et al., 2013). These feedstocks can also be utilised 
for human and animal food, which causes these materials to be subject to price 
fluctuations and then food scarcity, caused by biofuel production. Sugar and starch are 
converted to ethanol by yeast (Hägerdal et al., 2006). There is a lot of interest in 
producing bioethanol from lignocelluose, however, lignocelluose is not easily broken 
down, it requires to be pre-treated chemically or physically or enzymatically in order to 
release the fermentable sugar. Bioethanol used for transport fuel has some advantages. 
Firstly, to increase the impact of ethanol, it can be blended with gasoline and will 
reduce gasoline utilization. Secondly, it  improves the efficiency of an engine cycle, and 
also provides a greenhouse benefit, as it is releases less SO2 and CO emissions than 
gasoline and also diesel fuel (Dodić et al., 2009). As an environmentally friendly 
renewable liquid biofuel (John et al., 2011, Ranalli, 2007), bioethanol is already being 
used on a large scale in some European countries, USA, Canada, China and Brazil  
(Prabhakar and Elder, 2009, Kecebas and Alkan, 2009).    
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1.3.3. Biobutanol  
As previously described butanol  has been produced on an industrial scale from sugar 
and starch by the solventogenic clostridia such as Clostridum beijerinckii and 
Clostridum acetobutylicum under anaerobic conditions (García et al., 2011). Although 
butanol has been mainly used as solvent and as an important industrial chemical, its 
potential as a commercially attractive biofuel for transportation purposes has been 
recognised recently (Lee et al., 2008b). Butanol is a flammable liquid and is colourless, 
and it has a number of advantages as transport fuel which make it more attractive than 
ethanol. For example, it is less miscible with water and is not corrosive, meaning that it 
can be distributed by pipelines. It also has a higher energy content, and can be used 
without any modification in current car engines, at any concentration blend with 
gasoline up to pure butanol (Shapovalov and Ashkinazi, 2008, Dürre, 2007). At the 
present time 350 million gallons per year of butanol production enter the World market, 
and 220 million gallons per year are consumed just by the USA (Shapovalov and 
Ashkinazi, 2008). By 2020 in the biofuel market butanol is predicted to be worth $ 247 
billion and also has the potential to substitute for both ethanol and diesel (Green, 2011). 
1.4. Metabolic production of acetone and butanol  
The revival of the ABE fermentation process will require the use of cheap renewable 
substrates as the raw material, for example agriculture wastes containing complex 
polysaccharides that must be degraded to monosaccharides, disaccharides, and 
oligosaccharides that can be taken up and metabolised by the bacteria. Most clostridia 
are strictly anaerobic bacteria, and two distinct metabolic phases during growth are 
found with the majority of solventogenic species. The first phase is the acidogenic 
phase in which acetate, butyrate, carbon dioxide, and hydrogen are produced as 
metabolic end products (Figure 1.1). Acid formation causes a decrease of the pH of the 
culture medium, and metabolism shifts to solventogenesis (Ballongue et al., 1985). The 
second phase, or solventogenic phase, is accompanied by an increase in pH and some of 
the acetate and butyrate is converted into acetone and butanol. A small amount of 
ethanol is also produced (Ross, 1961, Davies and Stephenson, 1941, Johnson et al., 
1931, Reilly et al., 1920).  
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The ABE fermentation begins in clostridia with the transfer of the carbohydrate 
substrate across the cytoplasmic membrane. Most sugars can be taken up by a specific 
mechanism known the phosphoenolpyruvate (PEP) dependent phosphotransferase 
system (PTS) which both transports and phosphorylates the sugar (see section 1.6)  
(Mitchell et al., 1991, Hutkins and Kashket, 1986). Some strains like C. beijerinckii and 
C. acetobutylicum then utilize the glycolytic route as shown in Figure 1.1. After 
glycolysis, acetyl-CoA, acetoacetyl-CoA and butyryl-CoA are considered to be branch 
points in the metabolic pathway. During the acidogenic phase, acetyl-CoA and butyryl-
CoA are converted to acetate and butyrate, respectively, which results in production of 
one molecule of ATP for each molecule of product formed.  
Four major enzymes, phosphotrans-butyrylase, butyrate kinase, phosphotrans-acetylase,  
acetate kinase, are involved in formation of acids. The highest amount of hydrogen 
production also occurs in the acidogenic phase. After the switch to solvent production 
the activity of these enzymes rapidly decreases (Andersch et al., 1983, Hartmanis and 
Gatenbeck, 1984), associated with a reduction in the cell growth and  metabolic activity 
(Byung and Zeikus, 1985). 
When the cells enter stationary phase to begin to produce solvent, the first enzyme 
required is an acetoacetyl–CoA; acetate/butyrate CoA transferase that converts 
reinternalized acetate and butyrate into acetyl CoA and butyryl CoA. Acetyl CoA is 
then converted into acetaldehyde to produce ethanol or is recycled to acetoacetyl –CoA 
via thiolase. Acetoacetate is converted into acetone by acetoacetate decarboxylase, 
white butyryl CoA is reduced to butyraldehyde and the butanol. These reactions are 
catalysed by AdhE, which is a bifunctional butanol dehydrogenase and butyraldehyde-
CoA dehydrogenase, whereas, butanol dehydrogenase is responsible for the production 
of butanol (Dürre, 2007, Palosaari and Rogers, 1988).  
The synthesis of major solvent-forming enzymes is induced, perhaps partly in response 
in pH. The influence of pH has been recognized in transition from acid to solvent 
production (Monot et al., 1984, Fond et al., 1985). This results in changes in gene 
expression and enzyme synthesis, so that acetate and butyrate are now converted into 
solvents including acetone, butanol and a small amount of ethanol. There is some 
evidence that Spo0A which is a master regulator of stationary phase development in 
Bacillus subtilis (Errington, 1993), plays a role in regulation of the switch from 
acidogenic phase to solvent production in clostridia (Ravagnani et al., 2000). Although 
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control of solvent formation is important, another principal control point in metabolism 
is uptake of metabolisable sugar substrates. Understanding the mechanism and control 
of sugar uptake is vital for optimisation of the ABE fermentation process.  
   
 
 
 
Figure 1.1: Metabolic pathways of acid and solvent formation by clostridia during the fermentation. 
Products of acidogenic phase and solventogenic phase are shown by red and green colours, respectively. 
Enzymes are indicated by boxes (from Garcia et al., 2011).   
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1.5. Transport systems in bacteria  
Understanding of sugar uptake in the clostridia is required for the economic formation 
of butanol. The substrate is an expensive component of the fermentation, therefore the 
sugar uptake process must support the highest productivity and economic production. 
Sugars are transported across the cytoplasmic membrane, and metabolised to generate 
energy. The bacterial cytoplasmic membrane is a selectively permeable structure which 
consists of a phospholipid bilayer which is impervious to carbohydrates, amino acids, 
and other polar or ionic molecules (Saier, 2000). Transport mechanisms which allow 
translocation of these molecules are an integral part of metabolism, but also act as an 
apparatus for sensing in the cell, that allows the bacteria to monitor their extracellular 
environment and communicate with it, they are classified on the basis of the form of 
energy used to support substrate translocation and accumulation (Figure 1.2).  The 
transport mechanisms are generally divided into groups dependent on the source of 
energy input. 
Passive transport, also called facilitated diffusion, is a process which occurs when the 
substrate concentration is high in the medium and lower in the cytoplasm. Molecules 
are transported from the area of high concentration to the area of low concentration until 
equilibrium is achieved (Kell et al., 1981). No energy is coupled to this process, and so 
the concentration of the substrate within the cells will never exceed that of the 
surroundings.    
Bacterial cells usually live in famine conditions in which the concentration of 
metabolisable molecules is low. Therefore, molecules must be usually transported 
against concentration gradients, and energy must be consumed (Nikaido and Saier, 
1992). Mechanisms by which concentration of substrates is achieved are referred to as 
active transport. These transport processes are classified on the basis of their 
dependence on different forms of energy. There are different kinds of active transport. 
Electrochemical ion gradient driven transporters such as uniporters, symporters and 
antiporters, are described as secondary transporters and they derive energy in the form 
of an ion gradient. ABC binding cassette transporters derive energy from hydrolysis of 
ATP. They generally consist of two proteins which form the translocation pore, and two 
peripheral nucleotide-binding domains (ATPases). Among prokaryotes, ABC importers 
may require a periplasmic substrate-binding protein or domain (Rees et al., 2009, 
Davidson et al., 2008, Higgins, 1992). Tripartite ATP-independent periplasmic (TRAP) 
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transporters, have properties related to both secondary transporters and ABC systems, 
since they are dependent on ion gradient but include a periplasmic binding protein.  
A final type of transport process is typified by the PEP dependent phosphotransferase 
system (PTS) (Figure 1.2). Unlike other transport systems, the PTS both transports and 
phosphorylates its substrates. The PTS thus initiates the metabolism of the substrate, 
and its products are readily metabolised further by intracellular enzymes. There are 
some advantages of this type of transport system in the cell. Firstly, these systems are 
responsible for accumulation and conversion of substrate and are considered part of 
metabolism. Secondly, extensive studies of the phosphotransferase system have shown 
that it plays a central role both in sugar uptake and sensing of small molecules in the 
environment (Reizer and Peterkofsky, 1987, Saier, 1985).  
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Figure 1.2: Model of classes of transport system in bacteria, (A) facilitated diffusion, (B) ion-symporter, 
(C) TRAP transporter, (D) ABC type transporter,  (E) phosphotransferase system transporter (Adapted 
from Nikaido and Saier, 1992, Rabus et al., 1999).  
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1.6. The carbohydrate phosphotransferase system (PTS) in bacteria 
As described above this system is the first step in sugar or carbohydrate metabolism, 
and constitutes a process known as group translocation. The PTS was discovered in 
Escherichia coli by Kundig et al., (1964), and is now known to transport many 
carbohydrates such as glucose, maltose, mannose, sucrose, mannitol and fructose, 
(Deutscher et al., 2006a, Postma et al., 1993). The PTS is a complex system found 
widespread in facultative and obligately anaerobic bacteria (Romano and Saier, 1992). 
In addition to achieving both translocation and phosphorylation of its substrates, the 
PTS is known to be involved in regulation of carbohydrate metabolism (Deutscher et 
al., 2006a, Postma et al., 1993). There are some advantages of sugar(s) uptake by the 
PTS. Phosphorylation of the substrate during entry into the cells alters the substrate 
configuration, meaning that the sugar(s) are unable to leave the cells. Also, both uptake 
and metabolism are accomplished by a single metabolic step, meaning less energy input 
(Tangney et al., 2001). The PTS carries phosphate between PEP and the substrate 
through a multiprotein phosphoryl transfer chain.  There are three major components  of 
the  PTS which are  Enzyme I, histidine- phosphorylatable protein HPr  and  Enzyme II  
(respectively EI, HPr  and  EII) (Kotrba et al., 2001) (see Figure 1.3). 
1.6.1. Enzyme I (EI) and HPr   
This first two proteins in the PTS, EI and HPr, are cytoplasmic proteins that participate 
in the phosphorylation of all PTS carbohydrates in a given organism and thus have been 
called the general PTS proteins. They are found in the soluble fraction of cell extracts.   
EI is phosphorylated by PEP in the presence of Mg
2+
 (Weigel et al., 1982).              
Mg
2+
 is required for EI phosphorylation, but is not required to transfer the phosphate 
from EI to the general phosphocarrier protein  HPr (Weigel et al., 1982, Chauvin et al., 
1996). EI consists of approximately 570 amino acids, with a size around 63 kDa 
(Kuang-Yu and Saier, 2002). EI is considered the first step in the phosphotransferase 
system (Postma et al., 1993), and has been purified from many species of bacteria for 
example E.coli (Waygood and Steeves, 1980, Dooijewaard et al., 1979) Streptococcus 
faecalis (Alpert et al., 1985), Mycoplasma (Ullah and Cirillo, 1976) and Salmonella 
typhimurium (Weigel et al., 1982). 
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Figure 1.3: Phosphotransferase system (PTS) of bacteria. The PTS is composed of Enzyme I, HPr, and an 
Enzyme II complex which form a phosphorylation chain reaction that transfers the phosphoryl group 
from PEP to the substrate. The sugar substrate is transported into the cell by EIIC (from Gorke and 
Stulke, 2008).  
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HPr  is the second protein in the PTS, which receives a phosphate from EI, and passes it 
to the EII (Kotrba et al., 2001).  This protein consists of around 90 amino acids with            
a molecular mass of about 10 kDa, and is phosphorylated on a conserved His-15 
(Postma et al., 1993).  In the presence of a variety of carbohydrates, the expression of 
the genes ptsI and ptsH encoding EI and HPr is increased (Tanaka et al., 2008).                           
The ptsI and ptsH genes are usually linked in an operon ptsHI (Postma, 1987). 
1.6.2. Enzyme II (EII)  
EII  is complex and usually consists of three domains or components IIA, IIB and IIC 
(Martin-Verstraete et al., 1990, Reizer et al., 1992). Some systems also have a fourth 
domain IID (Saier Jr and Reizer, 1992). The EII domains may be present on different 
proteins, or they may be fused together in different combinations depending on the 
system. The IIA and IIB domains are hydrophilic. The IIA domain is the receiver of the 
phophoryl group from HPr, and it is then transferred to the IIB domain (Kotrba et al., 
2001). The IIC and IID domains are found in the cell membrane, these domains are 
hydrophobic. The IIC domain has a high  hydrophobicity compared with IID (Mitchell 
and Tangney, 2005). The IIC (and IID) domains consist of 6 - 8 transmembrane helices 
and form a channel across the membrane which is required for translocation of the 
substrate into the cell (Saier Jr and Reizer, 1992, Postma et al., 1993).  In the majority 
of systems the sugars are transported by the IIC domain alone (Postma et al., 1993).        
IIB and IIC domains in many cases are linked together, presumably to facilitate the 
transfer of phosphate from the IIB domain to the substrate as it enters the cell. There is 
no evidence that the IIC (or IID) domains are phosphorylated during this transfer.       
All domains IIA, IIB and IIC are required in EII to complete a functional PTS, although 
the EIIA domain is absent in some systems and has to be provided by an alternative 
system to complete the phosphorylation transfer chain (Reizer et al., 1999).   
Seven PTS families have been identified on the basis of sequence relationships, and 
these families are characteristically involved in transport and phosphorylation of a range 
of identified substrates. 
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(1). The glucose/glucoside(Glc) family translocates a variety of α- and β-glucosides, 
and also includes permeases for glucose, glucosamine and N-acetylglucosamine. In this 
family, several of the PTS permeases lack their own IIA domain and use the glucose 
IIA protein (Nguyen et al., 2006). 
(2). The mannose/fructose/sorbose(Man) family, is the only family in which members 
possess a IID domain, and only in the Man family is the domain IIB phosphorylated on          
a histidine residue rather than a cysteyl residue. The Man family exhibits a wide 
specificity for a range of carbohydrates, for example in  E.coli systems can transport and 
phosphorylate a broad range of sugars including glucose, fructose, mannose, 
glucosamine, N-acetylmannosamine, and N-acetylglucosamine (Plumbridge and Vimr, 
1999).  
(3). The fructose/mannitol (Fru) family is a complex and a large family and includes 
many sequenced fructose and mannitol permeases. Systems belonging to this family 
phosphorylate fructose on the 1-position compared with Man family systems which 
phosphorylate fructose on the 6- position (Nguyen et al., 2006).  
(4). The lactose/diacetylchitobiose/β-glucoside(Lac) family includes many sequenced 
lactose permeases from Gram-positive bacteria, while in Borrelia burgdorferi and 
E.coli systems can transport cellobiose and  β-glucosides (Nguyen et al., 2006).  
(5). The glucitol(Gut) family is a small family consisting of glucitol specific permeases 
that occur in Gram- positive and Gram- negative bacteria. Unusually the IIB domain is 
flanked by two parts of the IIC domain (Nguyen et al., 2006). 
(6). The galactitol(Gat) family, is a very small family including the galactitol permease 
of  E.coli (Nobelmann and Lengeler, 1995).    
(7). Finally the ascorbate(Asc), family is represented by the SgaTBA permease of         
E. coli (Zhang et al., 2003).  
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1.7. Carbon catabolite repression (CCR) 
CCR is an important mechanism responsible for control of bacterial metabolism.           
In 1940, B. subtilis and E. coli were studied by Jacques Monod who demonstrated that, 
these strains showed a preference for selected carbon sources within a mixture of 
different carbohydrates (Monod, 1942). This phenomenon has come to be known as 
carbon catabolite repression (CCR) (Deutscher et al., 2006b). In some bacteria CCR is 
the paradigm regulatory mechanism to achieve both metabolic capacity and catabolic 
balance of the organism and it is found to occur in most bacteria (Deutscher, 2008, 
Görke and Stülke, 2008).  
For most bacteria, glucose is the preferred carbon source which blocks the utilization of 
other substrates, by preventing the synthesis of enzymes for their uptake and 
metabolism.  CCR helps bacteria become adjusted to a physiological condition that does 
not overtax the metabolism of the organism (Brückner and Titgemeyer, 2002). CCR in 
many bacteria is exerted through the PTS (Cases et al., 2007, Deutscher et al., 2006b, 
Postma et al., 1993). CCR has been observed in both Gram-negative and Gram positive 
bacteria, and the PTS is involved in both cases, although the mechanisms have been 
shown to be very different (Deutscher, 2008).  
 1.7.1. CCR in Gram negative bacteria 
The major player in E. coli is the cyclic AMP receptor protein (CRP), sometimes known  
as catabolite activator protein (CAP) which is activated by binding cAMP in the 
absence of a carbon source such as glucose (Fic et al., 2008, Gama-Castro et al., 2008). 
CRP activates transcription in the presence of cAMP at many promoters by binding 
upstream of the promoter (Lawson et al., 2004, Busby and Ebright, 1999).     
cAMP was observed to be linked with catabolite repression and controlled by the 
activity of the enzyme for cAMP synthesis, adenylate cyclase (Epstein et al., 1975). 
cAMP was observed at a high concentration when glucose was absent, therefore 
stimulating CRP binding to the DNA to activate transcription. However, in the presence 
of glucose, cAMP is at a low level, that means no transcriptional activation occurs 
(Lawson et al., 2004, Crasnier-Mednansky et al., 1997). cAMP synthesis by adenylate 
cyclase is stimulated by the phosphorylated form of EIIA
glc
, a glucose-specific 
component of the PTS(Postma et al., 1993). In the presence of glucose, because glucose 
is coming into the cell and being phosphorylated, this results in dephosphorylation of 
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EIIA
glc 
which means it can no longer stimulate adenylate cyclase activity, therefore 
cAMP concentration goes down (Deutscher et al., 2006a, Postma et al., 1993).  
Another important transcription factor besides CRP is  the catabolite repressor activator 
(Cra) protein which plays a key role in E.coli in controlling metabolic pathways 
(Chavarría et al., 2011). The Cra protein was first discovered as the fructose repressor 
of the genes involved in fructose metabolism. It consists of two domains, a DNA-
binding N-terminal domain and a C-terminal domain which binds effectors. Cra is 
regulated by fructose 1-phosphate via stimulating removal of Cra from its DNA binding 
sites,  in the presence of glucose the concentration of fructose 1-phosphate increases 
which interact with Cra to prevent binding to the target promoter (Shimada et al., 2011).  
1.7.2. CCR in Gram positive bacteria 
The catabolite control protein CcpA plays a central role in regulation of metabolic 
pathways in low G-C Gram positive bacteria which are known as firmicutes including 
endospore forming bacteria such as the Clostridia (Singh et al., 2008). The protein  
belongs to the LacI-GalR family of transcriptional regulators (Shimada et al., 2011, 
Deutscher, 2008), and in addition to controlling carbohydrate metabolism is also 
involved in regulation of toxin production and sporulation in some pathogenic species 
(Antunes et al., 2011, Varga et al., 2008, Varga et al., 2004). The CcpA protein binds to 
cis-acting catabolite repression elements (cre) located between the upstream activating 
sequence and the promoter (Martin-Verstraete et al., 1995).  
In firmicutes the PTS protein HPr is the key in the regulation of carbon metabolism 
(Figure 1.4). HPr of these organisms has two phosphorylation sites. In addition to the 
histidine that is phosphorylated by Enzyme I and PEP, the HPr protein can be 
phosphorylated on residue serine-46. There are two main effects of this serine 
phosphorylation. Firstly, it strongly interferes with phosphorylation by EI on His-15, 
resulting in a decrease of PTS dependent transport of carbohydrate. Secondly, CcpA 
forms a complex with (P-Ser-HPr) in the presence of fructose 1,6-bisphosphate (FBP) 
that stimulates binding to cre sites (Deutscher et al., 1995).  
The protein which catalyses phosphorylation of HPr on serine 46 is a HPr 
kinase/phosphorylase (HPrK/P), a sensor enzyme for catabolite repression in low G-C 
Gram positive bacteria (Nessler et al., 2003). The activity of the phosphorylation and 
dephosphorylation reactions is controlled by the concentration of metabolic 
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intermediates. In particular, ATP, FBP and other glycolytic intermediates stimulate the 
kinase activity, on the other hand the phosphorylase activity is inhibited by ATP but 
stimulated by inorganic phosphate (Deutscher and Saier, 1983). Therefore, under 
conditions of high nutrient status (in the presence glucose), when the kinase activity of 
HPrK/P is stimulated, HPr is phosphorylated at Ser46. This results in inhibition of 
carbohydrate transport via the PTS and repression of catabolic genes via the (P-Ser-
HPr)-CcpA-FBP complex. On the other hand, under condition of low nutrient status the 
phosphorylase activity of HPr K/P is favoured, and the effects of glucose are reversed.   
HPrK/P has been observed in a range of low G-C Gram positive bacteria, including         
B. subtilis (Jault et al., 2000, Reizer et al., 1998, Galinier et al., 1998). Enterococcus 
faecalis and C. acetobuylicum (Tangney et al., 2003). It is also present in Mycoplasma 
pneumoniae (Steinhauer et al., 2002), but has not been found in Gram negative bacteria 
such as E. coli. 
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Figure 1.4. Model of catabolite repression in low G-C Gram- positive bacteria. Proposed sensory 
transduction pathway by which exogenous glucose is believed to activate the CcpA transcription factor to 
promote catabolite repression (CCR) by binding to a catabolite responsive element (cre) in the control 
region of a target gene. Proteins primarily involved are (i) the glucose phosphotransferase system 
including EI, HPr and EIIBCA
Glc
, (ii) glycolytic enzymes, (iii) HPr/kinese/ phosphorylese and HPr, and 
(iv) CcpA  (from Lorca et al., 2005).  
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1.8. Sugar uptake by the clostridia 
The transport and metabolism of sugars is a key requirement of clostridia for growth 
and development (Mitchell and Tangney, 2005). As for other anaerobes, the 
predominant mechanism for sugar uptake in these bacteria is the phosphoenolpyruvate 
(PEP) dependent phosphotransferase system (PTS), which characterized by transport 
and metabolism of its sugars as it enters the cell (Mitchell, 1998). It has been 
demonstrated that the PEP dependent PTS plays an important role in the uptake of          
a wide range of sugars in the clostridia.     
As shown in Table 1.1, PTS activity has been recorded for a variety of sugars including 
lactose, fructose, cellobiose, glucitol, sucrose, and glucose (Yu et al., 2007, Mitchell 
and Tangney, 2005). In addition has recently been shown that N- acetylglucosamine is 
phosphorylated by both C. beijerinckii and  C. acetobutylicum (Al Makishah and 
Mitchell, 2013). 
 
Table 1.1. Phosphotransferase activities that have been demonstrated by activity assays in some species of 
clostridia (Mitchell and Tangney, 2005).  
Clostridium                         PTS system carbohydrate  
C. acetobutylicum glucose, lactose, maltose, mannitol, sucrose, cellobiose, fructose 
C. beijerinckii glucose, glucitol, lactose, mannitol, fructose, sucrose 
C. difficile mannitol 
C. pasteurianum glucose, fructose, mannitol, sucrose, glucitol 
C. saccharobutylicum glucose, lactose, galactose 
C. thermocellum fructose, mannitol 
C. perfringens glucose, mannose 
C. butyricum fructose 
C. rubrum fructose 
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The four major solvent producing species, C. beijerinckii, C. acetobutylicum,                 
C. saccharobutylicum, C. saccharoperbutylacelonicum, were distinguished by genetic 
techniques including 16S rRNA sequence and genomic DNA (Keis et al., 2001) and 
these are able to ferment a wide variety of sugars including disaccharides hexoses and  
pentoses. The most detailed studies of the PTS and carbohydrate utilisation have been 
done using C. beijerinckii and C. acetobutylicum. In this context, it should be noted that   
before 1995 the strain C. beijerinckii NCIMB 8052 was classified as C. acetobutylicum 
and this organism was considered to be the same organism as C. acetobutylicum ATCC 
824. Glucose has been shown to repress the metabolism of several alternative substrates 
by clostridia. Several operons in clostridia including the glucitol operon of C. 
beijerinckii (Tangney et al., 1998), the sucrose operon of C. beijerinckii (Reid et al., 
1999), the  lactose operon of C. acetobutylicum (Yu et al., 2007), and the  mannitol 
operon of C. acetobutylicum (Behrens et al., 2001),  have been shown to be repressed 
by glucose. Although the mechanisms have not been completely described, C. 
acetobutylicum extracts were shown to have HPrK/P activity (Tangney et al., 2003), 
and the mechanism is believed to be similar to the CcpA- dependent mechanism shown 
in Figure 1.4.  
Full redevelopment of the ABE fermentation will require a more complete 
characterization of the PTS and its metabolic function in clostridia. The                        
C. acetobutylicum genome encodes 13 complete PTSs. As a result of transcriptomic 
study and experimental analysis, most of their substrates have been identified 
(Servinsky et al., 2010, Tangney and Mitchell, 2007, Yu et al., 2007, Tangney et al., 
2003). Therefore, strategies for strain improvement can be tested.  
Xiao et al., (2011), knocked out glcG which encodes the glucose phosphotransferase 
system in C. acetobutylicum (Tangney and Mitchell, 2007). When the gene was 
knocked out, the glucose metabolic rate did not decrease, however, they did observe      
a less severe CCR of xylose and arabinose metabolism compared to the wild type cells. 
This suggested that the GlcG PTS is in involved in sensing glucose in the medium and it 
might be important for CCR. Therefore, it was demonstrated that it is possible to 
interfere with CCR in the clostridia.    
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1.9. Clostridium beijerinckii 
C. beijerinckii  was first  isolated by Martinus Beijerinck from soil (Durre, 2008)  and 
as a member of the solvent producing group (Lee and Blaschek, 2001), it is able to 
convert a range of carbon sources to acetone, butanol and ethanol (ABE) (Ezeji et al., 
2007). As described earlier C. beijerinckii strains were isolated and used in the ABE 
fermentation process (Jones and Woods, 1986). There are number of factors which 
favour C. beijerinckii as an organism for solvent production. Firstly, it is more tolerant 
to organic acids, for example formic acid and acetic acid (Cho et al., 2012), and also 
solventogenic inhibitors such as hydroxymethylfurfural and furfural (Ezeji et al., 2007), 
compared with other strains such as C. acetobutylicum. Secondly, the genes for solvent 
production are located on the chromosome in C. beijerinckii, unlike C. acetobutylicum 
which carries then on a plasmid, C. beijerinckii is therefore not so likely to show 
degeneration, that is a loss of the ability to make solvent. Thirdly, the genome size of   
C. beijerinckii NCIMB 8052 is around 6.0 Mbp, which is 50 % bigger  than the genome 
of C. acetobutylicum (Wang et al., 2011). This suggests that the bacterium  has greater 
metabolic capacity than C. acetobutylicum and this may be useful with respect to 
exploiting a number of different carbon sources for fermentation.  
There are 43 complete PTSs encoded in the genome. Shi et al., (2010) listed 47, but   
five were incomplete and the system encoded by cbei 3367 was not included.                        
A phylogenetic tree (Figure 1.5), of these systems shows that all seven PTS families are 
represented. Only two systems were characterised experimentally before the genome 
sequence was available. Their IIC domains are encoded by cbei 0336 and 0337 (glucitol 
PTS; Tangney et al., 1998) and by cbei 5012 (sucrose PTS; Reid et al., 1999). Recently 
a third system has been characterized encoded by cbei 4532 and has been shown to 
phosphorylate N- acetylglucosamine and glucose (Al Makishah and Mitchell, 2013). 
Therefore, overall the metabolic capacity of the bacterium associated with the 
phosphotransferase systems which are encoded by the genome is not well understood.  
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Figure 1.5. Phylogenetic tree of IIC domains of PTS of Clostridium beijerinckii. (Courtesy of W.J. 
Mitchell). The tree shows different PTS families and their relationships. C. beijerinckii systems are 
highlighted in colour and belong to * black, glucose family (sucrose subfamily),* black, glucose family 
(glucose subfamily),*green, mannose-fructose-sorbose,*red, galactitol,*boring blue, L-ascorbate,*purple, 
glucitol,*blue, fructose-mannitol, *gold, lactose-diacetylchitobiose-β-glucoside.    
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1.10. The ClosTron 
Clostridium is the second largest bacterial genus and encompasses bacteria of both 
industrial and medical importance which are described as anaerobic Gram positive, and 
rod shaped bacteria (Tangney and Mitchell, 2007). Numerous genome sequences are 
now available, but the ability to exploit the information has been limited by the lack of 
reliable genetic manipulation techniques. A common approach to studying functionality 
of clostridial genes is to clone them into E.coli and try to demonstrate the function.  
This has been done successfully for a β-glucoside PTS in Clostridium longisporum 
(Brown and Thomson, 1998), and has also recently been done for the N- 
acetylglucosamine PTS in C. beijerinckii (Al Makishah and Mitchell, 2013). This 
approach is therefore an important part of this particular project, which is aimed at 
characterization of two additional phosphotransferase systems in C. beijerinckii that 
belong to the glucose family.  However, a few years ago Heap et al., (2007), reported a 
system called the ClosTron which appears to be a reliable system for gene inactivation 
in clostridia as shown in Figure 1.6. This system opens up additional possibilities for 
studying gene function, and it seems to work in a variety of different clostridia such as   
C. acetobutylicum, C. difficile and also C. beijerinckii (Jia et al., 2011, Kuehne et al., 
2011a, Heap et al., 2010). The ClosTron is an intron- based integration system which 
can target the inactivation of a specific gene, leaving behind a selectable antibiotic 
resistance marker to enable isolation of mutants. It has been used successfully for 
isolation of mutants affected in solvent formation by  C. acetobutylicum (Cooksley et 
al., 2012, Wietzke and Bahl, 2012, Heap et al., 2010)  and toxin production in C. 
difficile (Baban et al., 2013, Dingle et al., 2011, Antunes et al., 2011, Heap et al., 
2007).  
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Figure 1.6. Schematic of ClosTron insertion using pMTL007C-E2 (from Kuehne SA and Minton NP, 
2011). The ClosTron plasmid pMTL007C-E2 encompasses a Group II intron containg the ermB gene 
encoding resistance to erythromycin (blue colour is insert). The ermB gene has been inactivated by the 
phage (td) intron (black region). The td intron can self-catalytically splice from mRNA, but the process of 
splicing is orientation dependent. When the ermB is transcribed the td intron is in the incorrect 
orientation, and the ClosTron plasmid does not confer Em resistance on the clostridial cells. The LtrA 
protein (green region) binds to the intron transcript mRNA, and td is allowing to splice out restoring 
functionality to ermB gene. The RNA is then directed towards it is DNA target, and is inserted within it. 
A series of events involving synthesis of cDNA by LtrA, degradation of RNA by nuclease, DNA 
synthesis by DNA polymerase (DNP) and ligation result in insertion of a functional ermB gene  within the 
target. 
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1.11. Aim of the study 
The aim of this project was to characterize potential glucose phosphotransferase 
systems in C. beijerinckii. Glucose is the preferred substrate for clostridia and enters the 
cell via one or more phosphotransferase systems. Any PTSs involved in glucose uptake 
may also be involved in glucose sensing and CCR. Therefore, identifying these systems 
may lead to development of strategies to construct strains showing altered metabolic 
control and fermentation performance.    
The first aim of the study was to use a functional approach to identify the function of 
the cbei 0751 gene. The gene was amplified by PCR, and then cloned and transformed 
into a mutant E.coli ZSC113 unable to phosphorylate glucose. The characteristics of 
selected recombinants were then studied with respect to uptake and phosphorylation of 
glucose. Attempts were also made to knock out the cbei 0751 gene using the ClosTron, 
in order to examine the effect on glucose utilization and CCR. 
The second aim of the project was to analyse the genes cbei 4982/ cbei 4983 which also 
code for a PTS belonging to the glucose subfamily. The experimental approach 
involving PCR, cloning, and transformation was similar to that used for cbei 0751.  
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CHAPTER 2 
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2. Materials and Methods 
 2.1. Bacterial strains used in this study 
C. beijerinckii NCIMB 8052 was the main strain used in this study and was obtained 
from National Collection of Industrial and Marine Bacteria (NCIMB). Stock culture 
was maintained at 4 °C as a spore suspension in distilled water.  Escherichia coli strains 
were used in complementation studies and stored in glycerol containing media at            
-70 °C. Details of E.coli strains are shown in Table 2.1.        
 2.2. Buffers and solutions 
The composition of buffers and solutions used in this study are either described in the  
relevant sections or listed in Appendix V.  
2.3. Growth media composition 
All media were autoclaved at 121 °C for 15 minutes. 
Reinforced Clostridial Medium (RCM) was obtained from Oxoid LTD, England. 
Synthetic Reinforced Clostridial Medium (sRCM) was prepared according to the 
composition of RCM, but did not contain glucose, soluble starch or agar. A carbon 
source was added as necessary.  
Clostridial Basal Medium (CBM) contained per litre: casein hydrolysate, 4 g; FeSO4 
 
7H2O, 10 mg; MgSO4.7H2O, 0.2 g; MnSO4.4H2O, 10 mg; thiamine HCl, 1 mg;            
p-aminobenzoic acid, 1 mg; d- biotin, 20 µg; 10 g sugar.  10 x phosphate solution was 
autoclaved separately from the other medium components [K2HPO4, 0.5 g; KH2PO4, 0.5 
g in 100 ml] at 121 °C for 15 minutes and then the separate solutions were cooled in the 
anaerobic cabinet. Phosphates (10 % v/v) were added to the medium before use.     
Luria-Bertani (LB broth) medium contained per litre: tryptone 10 g; sodium chloride      
5 g; yeast extract 5 g. (Sambrook et al., 2001, Gerhardt et al., 1994).     
When solid media were required, agar technical (Agar No.3) (Oxoid) was added to 
concentration of 12.0 g per 1000 ml.   
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Difco™ MacConkey agar base used for examination of fermentation phenotype 
contained per litre: peptone 17 g; proteose peptone 3 g; sodium chloride 5 g; bile salts 
1.5 g; crystal violet 0.001 g; neutral red 0.03 g; and agar 13.5 g. Carbohydrates were 
added into the medium as required.  
Antibiotics were added to the media as required after cooling to 55 °C (Table 2.2).   
Table 2.1: E. coli strains used in this study  
E.coli strain                                 Genotype    Source  
ZSC 113    gpt-2 mpt-2glk-7strA    Lab collection  
(Curtis and  
Epstein, 1975) 
TOP10F 
  
F-mcrAΔ(mrrhsdRMSmcrBC) Φ80lacZΔM15ΔlacX74 
recA1araD139Δ(araleu)7697gal UgalKrpsL(StrR) end  
A1nupG  
Invitrogen 
TOP10 
  
F-mcrAΔ(mrrhsdRMSmcrBC) Φ80lacZΔM15ΔlacX74 
recA1araD139Δ(araleu)7697gal UgalKrpsL(StrR) end 
A1nupG  
Invitrogen 
JW3381-4  F-, Δ(araD-araB)567, ΔlacZ4787(::rrnB-3),λ-, ΔmalT 
752::kan,rph-1, Δ(rhaD-rhaB)568, hsdR514 
CGSC * 
JW3701-2  F-,Δ(araD-araB)567,ΔlacZ4787(::rrnB-3),λ,rph1,ΔbglG 
754::kan, Δ(rha-DrhaB)568, hsdR514  
CGSC  
JW4199-1  F-,Δ(araD-araB)567,ΔlacZ4787(::rrnB-3),λ-,rph1,Δ 
(rhaD-rhaB) 568, ΔtreB787::kan,hsdR514  
CGSC  
JW0665-1  F-,Δ(araD-araB)567, ΔlacZ4787(::rrnB-3),ΔnagE728:: 
kan, λ-,rph-1, Δ(rhaD-rhaB) 568, hsdR514  
CGSC  
JC10279  srl 301:: Tn10 srlD50 gnt C300 ? metB1 mtl2 gat C300 
gatA50 malAl xyl 7 rpsL 104 sup
 - 
 
Lab collection  
C600RK2  thr1,leuB6(Am), fhuA21, cyn101, lacY1, glnV44(AS), λ-, 
e14-, rfbC1, glpR200(glp
c
), thiE1 
S. Mastrangelo, 
University of  
Nottingham  
* CGSC, Coli Genetic Stock Center 
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Table 2.2: Antibiotics used in this project 
Antibiotic name Abbreviation  Final concentration 
Ampicillin     Amp 50 or 100 µg/ml 
Kanamycin     Kan 30 µg/ml 
Spectinomycin    Spc 750 µg/ml or 250 µg/ml 
Erythromycin    Ery 10 µg/ml 
Cycloserine    Cyl  250 µg/ml 
 
  2.4. Growth of C. beijerinckii NCIMB 8052 
0.8 ml spore stock was heat–shocked for 10 minutes at 80 °C, and then transferred into 
20 ml of Reinforced Clostridial Medium (RCM,Oxoid), and incubated overnight at      
37 °C under N2-H2-CO2 (80:10:10) mixed gas in an  anaerobic cabinet. 2 ml of starter 
culture was transferred to 100 ml Clostridial Basal Medium (CBM) supplemented with 
the required sugar(s) and incubated overnight at 37 °C. Cells were harvested by 
centrifuging for 10 minutes at 4 °C and 4,000 xg using tubes sealed with a rubber 
stopper sub-a-seal. The pellets were resuspended and then washed two times in 
Clostridial Basal Medium (CBM) without a carbon source before being resuspended in 
10 ml of the same medium. The cells were inoculated into 100 ml CBM containing the 
required sugar(s) to an OD600 of 0.05-0.1. The working culture was incubated in the  
anaerobic cabinet at 37 °C.  
A sample of cultures was routinely checked for contamination. Gram stains were used 
to confirm purity of culture. Growth test were also set up using RCM agar medium.       
A loopful of culture was spread around the RCM plate and incubated aerobically at      
37 °C.    
2.5. Preparation of C. beijerinckii NCIMB 8052 spores 
0.8 ml of C. beijerinckii NCIMB 8052 spores was inoculated into 20 ml of RCM and 
incubated overnight. 1 ml of overnight culture was transferred into 500 ml of synthetic 
Reinforced Clostridial Medium (sRCM) and then incubated for two weeks at 37 °C in 
the anaerobic cabinet. The culture was transferred into 250 ml centrifuge bottles and 
cells were harvested by centrifuging for 15 minutes at 12,000 xg and 4 °C. The pellets 
were washed three times in 200 ml sterile dH2O. After the final spin the pellets were 
combined and resuspended in 100 ml sterile dH2O and then stored at 4 °C. The pellets 
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were washed three times in 200 ml sterile dH2O. After the final spin the pellets were 
combined and resuspended in 100 ml sterile dH2O and then stored at 4 °C.  
2.6. Genomic deoxyribonucleic acid (DNA) extraction   
2.6.1. DNA extraction from C. beijerinckii NCIMB 8052 
DNA isolation was carried out using PUREGENE
® 
DNA ISOLATION kit (Gentra®, 
Cat# D-6000A) for Gram-positive bacteria. 
0.8 ml of heat-treated spores was add to 20 ml starter culture and incubated under 
anaerobic conditions at 37 °C overnight. One ml of overnight culture was transferred 
into 100 ml of CBM medium. 5 ml of the cells were harvested by centrifuging for 10 
minutes at 4 °C and 4,000 xg. 3 ml of cell suspension solution was added to the cell 
pellet and gently pipetted up and down. 15 µl of lytic enzyme solution was added to the 
tube and incubated at 37 °C for 30 minutes, then centrifuged at 13,000 rpm for 10 
minutes and the supernatant was removed.  3 ml of cell lysis solution was added to the 
cell pellet and mixed gently, then 15 µl of RNase A solution was add to the cell lysate 
and the sample was mixed by inverting the tube several times and then incubated at      
37 °C for 25-30 minutes. 1 ml of protein precipitation solution was added to the cell 
lysate and vortexed for 20 seconds and centrifuged at 13,000 rpm for 10 minutes. The 
supernatant containing the DNA was added into a clean 15 ml polypropylene tube 
containing 3 ml of 100 % isopropanol and mixed several times, and centrifuged at 
13,000 rpm for 3 minutes, after which the DNA pellet was visible.  3 ml of 70 % (v/v) 
ethanol was added to the pellet and inverted several times to wash the DNA, and 
centrifuged at 13,000 rpm for 1 minute. The tube was drained on clean absorbent paper, 
and allowed to air dry for 15-20 minutes. 500 µl DNA hydration solution was added to 
the tube, and incubated for 1 hour at 65 °C and then overnight at room temperature. 
DNA was stored at -20 °C. 
The DNA concentration was determined by taking 2 µl of DNA and adding 48 µl of 1x 
TE buffer in a sterile PCR tube. The absorbance of DNA was measured at 260 nm in an 
Eppendorf uvette
®
 using a BioPhotometer, with TE buffer as a blank. 
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2.7. Cloning and screening for genes  
2.7.1. Design of primers  
To amplify fragments of DNA, the primers were designed to be around 18-22 bp long to 
make the melting temperature (Tm) in the range from 50–60 °C. The primers were 
synthesised by Eurofins MWG. Melting temperatures were calculated by using the 
equation [4 × (G+C) + 2 × (A+T)] and the PCR annealing temperature calculated       
[Tm – 5].  
The different primers used during polymerase chain reaction (PCR) are listed in      
Table 2.3. The position of annealing relative to the cloned gene are shown in Appendix 
I 
Table 2.3: The primers used in the experiments for gene cloning and screening of clones  
Primer Name  Reference  
 Number  
               Primer Sequence  
Cbei 0751 F*      356     5´-TTATTGAAGATGTTTATGTTGG-3´  
Cbei 0751 R*      357  5´-CCAAAACCTATACCTTTTCC-3´  
Cbei 4984 F*      434  5´-AATGTACATTATACTATATGTG-3´  
Cbei 4983 F*      432  5´-ATCGTATCTGCTAAAAAAGC-3´  
Cbei 4982 R*      433  5´-ATTAGACTTGAATTGCACAC-3´  
          M13F*      371  5´-GTAAAACGACGGCCAGTG-3´  
          M13R*      372  5´-CAGGAAACAGCTATGACC-3´  
 T7promoter       373  5´-TAATACGACTCACTATAGGG-3´  
* F, forward primer; * R, reverse primer 
  
2.8. Polymerase Chain Reaction (PCR) for gene cloning  
Reactions for the amplification were carried out in a mix containing 10 µl of 5x PCR 
buffer, 1 µl of DNA template, 1 µl of each primer (forward and reverse), 36.5 µl of 
deionised water and 0.5 µl of DNA polymerase, added  after 4.5 minutes to give the  
final volume 50 µl. Easy-A
® 
High-Fidelity PCR Cloning Enzyme (Stratagene), was 
used for cloning of cbei 0751 (section 2.10.1), cloning of cbei 4983/ cbei 4982 (section 
2.10.2), and also cloning of the cbei 4984/ cbei 4983/ cbei 4982 (section 2.10.3), 
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Pfu DNA polymerase (Fermentas) was also used in cloning of the cbei 4983 / cbei 4982 
genes with a pJET1.2 cloning kit (section 2.10.2). Samples were amplified on the 
following cycle; 30 times a cycle of denaturation step at 95 °C for 1 minute, annealing  
temperature  for 1 minute, and elongation step at 72 °C for 3 minutes. Then after 30 
cycles of the reaction, a final elongation was performed for 10 minutes at 72 °C, and the 
reaction kept at 4 °C. 
2.9. DNA Gel Electrophoresis  
 Samples of DNA were routinely examined using agarose gel electrophoresis. Bioline 
Agarose gel powder was dissolved to a concentration of 1.0 % (w/v) in 1 x TAE buffer 
using a microwave, and after cooling 1 µl of 10 mg/ml ethidium bromide was added to 
100 ml of gel, and poured into a 10 cm x 7.5 cm or 11 cm x 10 cm gel container sealed 
with autoclave tape at the edges. A comb was inserted into the gel to form sample wells. 
After the gel had set, the comb and tape were removed, and the gel was immersed in 1 x 
TEA buffer (diluted from a 50x stock).  2 µl of 6x loading dye (Fermentas) were mixed 
with 5 µl of PCR product, and electrophoresis was carried out at 80 volts for 1 to 2 
hours, before viewing the bands on a UV-light box. 5 µl of hyperladder I (Bioline) was 
used as molecular size marker.  
 2.10. Cloning Reactions 
2.10.1. Cloning of cbei 0751 
A TOPO TA Cloning® Kit was used to perform the cloning of gene cbei 0751.    
Cloning reaction was set up which included 3 µl of fresh PCR product, 1 µl of salt 
solution, 1 µl of water and 1 µl of pCR
®
 2.1-TOPO
®
  vector (Appendix IV) giving          
a final volume of 6 µl. These were mixed gently and incubated for 15 minutes at 25 °C 
(room temperature). 2 µl of the cloning reaction were added to a vial of E.coli TOP10F 
competent cells. This was mixed gently and then incubated on ice for 15 minutes, the 
cells were then heat-shocked by placing them for 30 seconds at 42 °C in a water bath 
and then immediately placed on ice for two minutes.  250 µl of LB broth was added to 
the tube and then the cells were incubated for 1 hour at 37 °C with shaking horizontally.    
50 µl of transformed cells were spread on LB plates with 100 µg/ml ampicillin, the 
plates were then incubated overnight at 37 °C. 
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2.10.2. Cloning of cbei 4983 and cbei 4982 
The genes cbei 4983 and cbei 4982 were cloned using a StrataClone PCR cloning kit. 
Strata (Agilent) vector (Appendix IV). The cloning reaction was set up which included      
2 µl of fresh PCR product, 3 µl of StrataClone Cloning Buffer, 1 µl of pSC-A- 
amp/kanVector see (Appendix IV), in a final volume of 6 µl. These were mixed gently 
and incubated for 5 minutes at 25 °C (room temperature) and then kept on ice. 1 µl of 
the cloning reaction was added to a vial of thawed E.coli TOP10 competent cells 
(Invitrogen). This was mixed gently and then treated as described in section 2.10.1.  
Alternatively the cbei 4983 and cbei 4982 genes were cloned using a pJET1.2 cloning 
kit (Fermentas). 1 µl of fresh PCR product, 10 µl of 2X Reaction Buffer, 1 µl of 
pJET1.2/blunt Cloning Vector, (see Appendix IV), 7 µl water and 1 µl of T4 DNA 
ligase were mixed in a final volume of 20 µl.  These were incubated for 5 minutes at 25 
°C (room temperature) and kept on ice.  2.5 µl of the cloning reaction were added to a 
vial of E.coli TOP10 cells (Invitrogen). The mixture was mixed gently and then 
incubated on ice for 15 minutes. The remaining steps were carried out as described 
above in section 2.10.1.  
2.10.3. Cloning of cbei 4984/ cbei 4983/ cbei 4982  
The StrataClone PCR cloning kit was also used for cloning of the three genes,            
cbei 4984/ cbei 4983/ cbei 4982. Cloning reaction was set up which included 2 µl of 
fresh PCR product, 3 µl of StrataClone Cloning Buffer, 1µl of StrataClone Vector Mix 
amp/kan, see (Appendix IV) in a final volume of 6 µl. The procedure was carried out as 
described above in section 2.10.2.  
 2.11. Screening and Analysis of Clones 
2.11.1. Screen for presence of cloned genes   
Initial screening was for the presence of the gene using cloning primers. Single colonies 
were picked and streaked on a LB plate containing 100 µg/ml ampicillin and incubated 
overnight at 37 °C. Samples were then inoculated into 20 µl of sterile deionised water.  
These samples were heated at 100 °C in a heating block for 10 minutes, and plunged 
into ice for 3 minutes. The tubes were then centrifuged for 2 minutes at 13000 rpm, and 
1 µl of the supernatant was used as the DNA template for PCR reaction.  
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The PCR reaction contained, 25 µl of BioMix (Bioline), 1 µl of each primer and the 
volume was made up to 50 µl with distilled water, the PCR cycles were done as 
described in section 2.8.     
2.11.2. Determination of orientation of DNA inserts by PCR  
Screening for gene orientation used a combination of primers directed against sequences 
in the cloned fragment and the vector to determine the orientation of DNA inserts 
within recombinant clones. Primer combinations depended on the cloned genes and the 
vector used, as described for individual experiments. The PCR reaction was set up and 
was run as described in section 2.11.1.  
2.12. Preparation of plasmids by miniprep procedure  
Plasmids were purified using the Fermentas GeneJET
TM
 Plasmid Miniprep Kit #K0502.  
Cells were inoculated into 10 ml of LB broth containing 100 µg/ml ampicillin, and the 
culture was incubated at 37 °C with vigorous shaking overnight. 4.5 ml of bacterial 
culture was collected in an Eppendorf tube by centrifuging at 13,000 rpm for 5 minutes 
(1.5 ml each time, three times) and supernatant was removed. The pellet was completely 
resuspended in 250 µl of the resuspension solution by vortexing. 250 µl of the lysis 
solution was add to the Eppendorf tube and mixed thoroughly by inverting the tube 4-6 
times until the solution was clear.  350 µl of the neutralization solution was added to the 
tube and mixed immediately and thoroughly by inverting the tube several times. The 
clear solution was separated by centrifuging at 13,000 rpm for 5 minutes, and the 
supernatant transferred to the supplied GeneJET
TM
 spin column by pipetting and 
centrifuged for 1 minute. 500 µl of the wash solution (diluted with ethanol) was added 
to the column
 
and centrifuged for 60 seconds (twice).  The flow- through was discarded 
and the column was centrifuged for an additional 1 minute to remove residual wash 
solution. The GeneJET
TM
 spin column was finally transferred into a fresh Eppendorf 
tube and 50 µl elution buffer was added to the center of it, and incubated for 2 minutes 
at room temperature, and then centrifuged at 13,000 rpm for 2 minutes.  The purified 
plasmid DNA was stored at -20 °C. 
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2. 12.1. Large-scale plasmid purification  
Plasmids were purified using the QIAGEN plasmid Midi kit.  A colony was transferred 
to 10 ml LB Broth with 50 µg/ml ampicillin and incubated overnight with shaking at    
37 °C. 1 ml taken from overnight culture was transferred to a 250 ml flask containing 
100 ml LB Broth with ampicillin at the same concentration and incubated with shaking 
at 37 °C overnight. 50 ml was transferred to a sterile polypropylene tube and 
centrifuged at 4000 xg for 20 minutes at 4°C, and the supernatant was removed.  4 ml of 
buffer P1 containing RNase was added to the pellet and mixed by pipetting up and 
down until no cell clumps remained.  4 ml of buffer P2 was added to the tube and mixed 
by inverting the tube 4-6 times, then incubated at room temperature for 5 minutes.  4 ml 
of chilled buffer P3 was then added to the tube and mixed immediately by inverting the 
tube several times and this was centrifuged at 4000 xg at 4 °C for 20 minutes. 4 ml of 
buffer QBT was added to the supernatant (cleared lysate) and loaded onto a purification 
column (QIAGEN-TIP) which was allowed to empty by gravity flow.  20 ml of buffer 
QC was used to wash the QIAGEN-TIP, then 5 ml of buffer QF was used to elute the 
DNA. 5 ml of room-temperature isopropanol was added to the eluted sample to 
precipitate the DNA and centrifuged at 4000 xg at 4 °C for 20 minutes. 3 ml of room- 
temperature 70 % ethanol was added to wash the DNA pellet, and centrifuged at       
4000 xg for 20 minutes at 4 °C. 50 µl of water was added to dissolve the DNA pellet 
and then mixed by pipetting up and down. The sample was stored at -20 °C.                      
Samples of plasmid DNA were sent for sequencing analysis by Beckman Coulter 
Genomics. Inserts were sequenced on both strands, starting from primer directed against 
the vector close to the point of insertion. After completion of the first sequence run, new 
primers were designed to allow extension of the sequence, until the entire insert has 
been sequenced.  
 The different primers used during sequencing analysis are listed in Table 2.4.       
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Table 2.4: List of primers used in analysis sequencing. The positions for annealing are shown in 
Appendix I  
       Primer Name   Reference 
Number 
          Primer Sequence  
  Cbei 0751 F*    510 5´-ACAATGCTTGATACGTATGG-3´  
  Cbei 0751 R*   511  5´-TATGCAATGCTGCTGTACC-3´  
  Cbei 4982 F*    450 5´-GAAGGTATTGCAGTAATTCC-3´  
  Cbei 4983 R* 281   455 5´-AAAGCTGCAATACCTTTCTC-3´  
  Cbei 4983 F*   508 5´-TTCTTTACAAGTCTTGGTGG-3´  
  Cbei 4983 R* 181   509  5´-ACAAATATCCAGTGAGAACC-3´  
* F, forward primer; * R, reverse primer 
  
2.13. Preparation and transformation of chemically competent cells of E.coli  
A colony of E.coli from a LB plate without ampicillin was inoculated into 10 ml of LB 
broth.  This culture was incubated at 37 °C overnight with shaking.  1 ml of overnight 
culture was added to 100 ml LB Broth and incubated for about 3 hours with shaking at 
37 °C until OD600 was between 0.4 and 0.6. 50 ml of culture was then transferred 
aseptically to a polypropylene tube.  This tube was stored on ice for 10 minutes, and the 
cells were recovered by centrifugation at 4000 xg at 4 °C for 10 minutes. The 
supernatant was discarded and final traces of medium were removed from the pellet by 
inverting the tube for 1 minute.  The pellet was resuspended in 10 ml of ice-cold 0.1 M 
CaCl2 and stored on ice for 2-3 minutes and then centrifuged for 10 minutes at 4°C at 
4000 xg. The supernatant was removed, and the pellet dried by inverting. The pellet was 
then resuspended finally in 2 ml of ice-cold 0.1 M CaCl2 and stored on ice. 2 µl of 
plasmid was added to 200 µl of the cells, and the tubes were mixed several times before 
being stored on ice for 30 minutes.  They were then transferred to a water bath for 90 
seconds at 42 °C, and plunged back on ice for 2 minutes. 800 µl of LB medium was 
added to the tubes and the mixture was incubated for one hour at 37 °C.  50 and 100 µl 
was spread out onto LB plates containing 100 µg/ml ampicillin and then incubated 
overnight at 37 °C. Transformed colonies were picked off using toothpicks and scored 
in a grid like pattern onto petri dishes containing MacConkey agar with the required 
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carbohydrate in the presence or absence of ampicillin, and incubated for 48 hours at    
37 °C.  
Fermentation phenotype was compared with the phenotype of untransformed cells on 
MacConkey agar with or without antibiotic as required.   
2.14. Characterization of recombinant E.coli cells containing gene cbei 0751  
2.14.1. Utilization of glucose, mannose and N-acetylglucosamine in growing 
cultures  
A sample of E.coli ZSC113 cells was transferred into 10 ml of LB broth with 50 µg/ml 
ampicillin and incubated overnight with shaking at 37 °C. 1 ml taken from an overnight 
culture was transferred to a 250 ml conical flask containing 100 ml of LB Broth with 
50µg/ml ampicillin and 25mM (glucose, mannose and N-acetylglucosamine) and   
incubated at 37 ºC. Growth was measured by following OD600. Culture samples (0.5 ml) 
were taken every hour, transferred to an Eppendorf tube, and then centrifuged at 13,000 
rpm for 10 minutes. The supernatants were removed and transferred to fresh tubes and 
stored at -20 ºC for the measurement of sugar concentration, by high performance liquid 
chromatography (HPLC). The columns used were a Dionex Carbopac PA-1 Guard 
column, 4 x 50 mm and Dionex Carbopac PA-100 column, 4 x 250 mm, and the 
detection was by a pulsed amperometric detector (PAD). Separation was achieved by 
high performance anion exchange (HPAE). At high pH (14), sugars are partially 
ionised, and therefore, are separated by anion exchange. Detection was by a pulsed 
amperometric detector (PAD). Sugars were detected by measuring the electrical current 
generated by oxidation at the surface of the electrode. Sample was prepared in 1.5 glass 
vials, 60 µl of cellobiose was added to 300 µl of diluted sample (1:200) and mixed well. 
A glass vial of fresh calibration standard was putted in position 1 of the instrument and 
then the samples were load into the tray in sequence. The set detector (PAD) was set up 
as follows; pulse duration; T1= 2        T2= 2         T3= 5          Range= 2.       Display 
direction = +    Response time = 0.3 secs.       E1= +0.1V     E2= +0.7V         E3= -0.1v     
Range= 2.  
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2.14.2. Glucose uptake by whole cells 
A single colony of E.coli ZSC113 was transferred to 10 ml of LB broth with 50 µg/ml 
ampicillin, and incubated overnight at 37 °C with shaking. 2 ml taken from the 
overnight culture were transferred to a 250 ml flask containing 100 ml of LB Broth with  
ampicillin and 25 mM glucose. This culture was shaken at 37 °C for 3- 4 hours, until the 
OD600 was 0.6 - 0.8. 100 ml was transferred to 50 ml a polypropylene tube, and 
centrifuged at 4000 xg for 10 minutes at 4 °C. The cells were washed with 50 mM 
potassium phosphate buffer pH 7.0, and subsequently resuspended in 10 ml of the same 
buffer and stored on ice. 20 µl cells in 50 mM potassium phosphate buffer pH 7, were 
incubated for 3 minutes at 37 ºC, and then radiolabelled sugar [
14
C glucose (9.5 mM; 1 
mCi/mmole)] was added to the tube to give final concentration of 0.2 mM. The total 
volume was 1000 µl. 150 µl samples were removed, filtered through a glass fibre disc 
(Whatman GF/F paper) and washed twice with 5 ml of potassium phosphate buffer, and 
then discs were dried under a heat lamp. Discs were transferred into 5 ml leak-proof 
scintillation tubes and 4 ml of scintillation ultima gold F (PerkinElmer) was added. The 
radioactivity was measured using a Liquid Scintillation Analyzer (Packard, 1900CA). 
All experiments included sample blanks consisting of a 0.2 mM solution of [
14
C]- 
glucose in phosphate buffer which was treated as for the experimental samples. Small 
volumes (20 µl) of the blank solution were spotted directly on glass fiber discs, dried 
and counted, to allow for conversion of radioactive counts to nmoles of sugar 
phosphate.  
2.15. Preparation of cell extracts  
10 ml of LB broth containing 50 µg/ml ampicillin were inoculated with E.coli ZSC113   
and incubated overnight with shaking at 37 ºC. The entire overnight culture was 
transferred to a 1000 ml flask containing 500 ml LB Broth with 50 µg/ml ampicillin and 
25 mM glucose. The culture was incubated overnight at 37 ºC with shaking, and then 
the cells were harvested by centrifugation at 12,000 xg at 4 ºC for 10 minutes. The 
supernatant was removed and the cells were washed twice with 50 mM potassium 
phosphate buffer pH 7.0. The pellets were resuspended and combined, and centrifuged 
again. The supernatant was removed and the pellet was weighed and stored at -20 ºC 
until used. The pellet was thawed and suspended (4 ml/g) in 50 mM potassium 
phosphate buffer pH 7 containing 5 mM MgCl2 and 1 mM DTT. The cells were 
disrupted by two passages through a French pressure cell press at 20,000 Ibf in
-2
 
(138MPa). The cell debris was removed  by centrifugation at 12,000 x g at  4 ºC for  10 
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minutes, and the cell extract (supernatant) was aliquoted  and then flash frozen in liquid 
nitrogen then stored at  -70 ºC. 
2.15.1. Assay of sugar phosphorylation in cell- free extracts 
Glucose phosphorylation with PEP or without PEP was assayed by precipitation of 
labelled sugar phosphate in barium bromide solution (BaBr2) as described by Mitchell 
et al, (1991). The assay mixture contained 2 mM DTT, 12 mM KF, 5 mM MgCl2, cell 
extract, 50 mM potassium phosphate buffer, 1 mM PEP and 0.2 mM 
14
C-glucose. The 
sample was incubated at 37 ºC in a water bath for 3 minutes, before the 
14
C-glucose was 
added.  Samples (0.15 ml) were taken into 2 ml of 1 % BaBr2   in 80 % (vol/vol) ethanol. 
The precipitates were removed by filtration through a glass fibre disc (Whatman GF/F 
paper) and then washed once with 5 ml of 80 % (vol/vol) ethanol. The filters were dried 
under a heat lamp and treated as described in section 2.14.2. 
2.16. Dialysis of cell extracts  
Samples of extracts were dialyzed by using a Dialysis cassette Slide- A-Lyzer (3 ml, 
molecular weight cut off 3,500), from Thermo Scientific (Cat# 66330).  Up to 1.5 ml of 
extract was dialysed against 1 liter of 50 mM potassium phosphate buffer pH 7, 
overnight at 4 ºC. 
2.17. Restriction digests  
Restriction digests were carried out in Eppendorf tubes. Digests contained 2 µl of           
1 µg/µl DNA, 1 µl of each required FastDigest enzyme (Fermentas), 2 µl of 10x 
FastDigest buffer, and were made up to 20 µl with nuclease-free water. The mixture 
was vortexed briefly and then incubated for 30 minutes, at 37 °C in a heating block. The 
10x FastDigest green buffer was used as loading buffer in gel electrophoresis. The 
mixture was loaded in the gel and electrophoresed for 1 hour at 80 V, and results were 
analysed by viewing under UV illumination.    
2.17.1. Gel extraction     
GeneJET Gel Extraction Kit, # K0691 (Fermentas), was used to purify fragments of 
DNA from the gel. A gel slice containing the DNA was cut out using a sterile scalpel 
and then transferred into a pre-weighed 1.5 ml Eppendorf tube. After adding the gel 
slice the tube was weighed again, and the difference in weight was recorded. 1 volume 
of binding buffer was added to the gel slice (e.g. 200 µl of binding buffer was added for 
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every 200 mg of agarose gel). The gel mixture was incubated at 60 °C for 10 minutes in 
a heating block, with the tube inverted every 2 minutes to facilitate the melting process. 
When the gel was completely dissolved, the gel solution was transferred to a GeneJET 
purification column and then centrifuged for 1 minute at 13,000 rpm. The liquid was 
discarded. 700 µl of washing buffer was added into the GeneJET purification column 
and centrifuged at 13,000 rpm for 1 minute, the solution was removed and the column 
was put back into the same tube. To remove the residual washing buffer the empty 
purification column was centrifuged for 1 minute at 13,000 rpm. The column was then 
transferred into a sterile 1.5 microcentrifuge tube and 30 µl of elution buffer was added 
to the centre and centrifuged for 1 minute at 13,000 rpm. The eluted DNA was stored at 
-20 °C.  
2.17.2. Ligation of DNA fragments 
Fragments of linear DNA were joined together using a Rapid DNA Ligation Kit      
(Fermentas, K# 1422). In a 1.5 ml sterile Eppendorf tube, 11 µl of nuclease-free water, 
4 µl of 5 x rapid ligation buffer, 1 µl of T4 DNA ligase, and 3 µl of DNA was added 
with 1 µl vector (3:1 ratio of amount of DNA). The total volume was 20 µl. The ligation 
mixture was vortexed for a few seconds and incubated for 5 minutes at room 
temperature and then stored at 4 °C. 5 µl of the mixture was transformed into E.coli 
TOP10 competent cells as described previously in section 2.1. The cells were isolated 
after transformation on LB plates containing 50 µg/ml ampicillin, and then screened by 
PCR to confirm the presence of the cloned fragments.   
2.18. Ribonucleic acid (RNA) extraction    
Spores of  C. beijerinckii NCIMB 8052  were heated  at 80 °C  for 10 minutes and then 
added to 20 ml RCM starter culture and incubated under anaerobic conditions at 37 °C 
overnight. 1 ml of overnight culture was transferred into 100 ml of CBM with             
1% (wt/vol) sugar(s) as required and incubated overnight under the same conditions.      
1 ml of overnight culture was then transferred to fresh 100 ml of the same medium and 
incubated until OD600 was between 0.5-0.7.  
750 µl of culture sample and 750 µl of RNA stabilization solution (Qiagen) were mixed 
for 2-3 seconds and stored at room temperature for 7 minutes. The cells were then 
harvested by centrifuging at 10,000 rpm for 10 minutes, the supernatant was removed 
and the pellets quickly plunged into liquid nitrogen and stored at – 70 °C.  
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The RNA purification was carried out using an RNeasy® mini Kit (Qiagen).  According 
to the manufacturer's instructions, 10 µl β- mercaptoethanol (β-ME) was added to 1 ml 
of RLT buffer, add 44 ml of 96 % ethanol was added to 11 ml of RPE buffer.  
Lysozyme buffer was prepared as TE buffer containing 3 mg/ml lysozyme. The pellet 
was thawed on ice and 300 µl of lysozyme buffer was added and the pellet was 
resuspended by pipetting, then the mixture was incubated at room temperature for 12 
minutes with vortexing every two minutes. 700 µl of RLT Buffer containing                  
β-mercaptoethanol was added to the Eppendorf tube and vortexed.  500 µl of 96 % 
ethanol was then added and mixed by pipetting. The mixture was transferred to an 
RNeasy Mini spin column and centrifuged for 15s at 10,000 rpm. 700 µl of RW1 Buffer 
was added to the column and centrifuged for 15s at 10,000 rpm. The column was then 
removed into a 2 ml collection tube. 500 µl of RPE Buffer was added and centrifuged at 
10,000 rpm for 15s, followed by another 500 µl of RPE Buffer with centrifugation at 
10,000 rpm for 2 minutes. The spin column was then removed into a new Eppendorf 
tube, and finally 50 µl of RNase-free water was added into the column and then 
centrifuged at 10,000 rpm for 1 minute to collect the RNA. The Eppendorf tube 
containing the RNA was immediately placed in liquid nitrogen and then stored at           
-70 °C. 
To estimate the RNA concentration, a sample of the RNA was diluted 2 : 48 in 1x TE 
buffer in a sterile PCR tube. Absorbance was measured at 260 nm in an Eppendorf 
uvette
®
 using a BioPhotometer, with TE buffer as the blank.                                                                              
2.19. Agarose gel electrophoresis of RNA 
 Total RNA samples were examined using agarose gel electrophoresis. Agarose was 
dissolved to concentration of 1 % (w/v) in 1 x MOPS (morpholinopropanesulfonic acid) 
buffer. 10 ml of 10x MOPS stock buffer (200 mM MOPS, 50 mM sodium acetate, and 
10 mM EDTA at pH 7.0,) were added to 80 ml distilled water. 1 g agarose was 
dissolved by heating in a microwave oven, and after cooling 10 ml of formaldehyde was 
added to the mixture and poured into the gel container. 5 µl of  purified RNA was 
mixed with 10 µl of the RNA loading buffer, consisting of 10 % (v/v) of 10 x MOPS 
buffer,   16 % (v/v) formaldehyde, 50 % (v/v) formamide, 0.1 mg/ml ethidium bromide, 
and 0.01 % (w/v) bromophenol blue, and then denatured for 10 minutes at 70 °C, and 
placed on ice for 3 minutes. The RNA samples were vortexed before loading into the 
gel, which was electrophoresed for 30 minutes at 100 volts in 1x MOPS.   
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2.20. Slot-blot hybridization 
2.20.1. DEPC treatment  
All solutions used in hybridization procedures were treated with DEPC to remove any 
RNase. 1000 μl of DEPC was added to 1000 ml of distilled water and then the mixture 
was stirred for 60 minutes at room temperature, followed by autoclaving the solution to 
remove any remaining DEPC.  
2.20.2. Labeling of DNA probes  
DNA probes were labelled using digoxinenin-11-dUTP (Roche Diagnostics GmbH, 
Germany). Primers were designed for amplification of 200-400 bp DNA, see Appendix 
I, and are shown in Table 2.5.  PCR reaction for DIG-labelled DNA probes used 20 µl 
of deionized water, 25 µl of 2x BioMix
 
buffer (Bioline), 2 µl of digoxinenin-11-dUTP,    
1 µl forward primer, 1 µl reverse primer, and 1 µl of DNA template. The PCR reaction 
was as described above in section 2.8, and the samples were run on a 1 %  agarose  gel 
for 90 minutes at 80 V. Labelling of the probes was confirmed by preparing serial 1:5 
dilutions, and 1 µl of each dilution was applied onto a nylon membrane as a dot. The 
membrane was placed in an ultraviolet cross- linker for 1 minute to fix the DNA, and 
then was transferred to 10 ml blocking buffer and incubated for 1 hour at room 
temperature. 1µl of Anti-Dig (Anti-Digoxigenin-AP Fab fragments) (Roche Diagnostics 
GmbH, Germany) was added to the blocking buffer and the membrane was incubated 
for 30 minutes under the same conditions. The membrane was then washed 4 times for 
10 minutes with DIG-1 buffer and finally the nylon was immersed in DIG-4 buffer for   
5 minutes.  
For detection, the nylon membrane was placed between two acetate sheets and 800 µl of 
CDP-star chemiluminescent substrate solution (Sigma) was poured between them, and 
any bubbles were removed. An X-ray film (Lumi-Film Chemiluminescent Detection 
Film) was placed on the top and incubated for 60 minutes in the dark, and then the  X-
ray film was washed with developing solution (GBX developer- replenisher/ Sigma) for 
1 minute and fixing solution (GBX  fixer- replenisher/ Sigma) for 1 minute, finally 
rinsing in water and  drying at 25 °C.       
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Table 2.5:  Primers used for preparation of hybridization probes 
  Primer Name Reference                          
Number     
                 Primer Sequence 
Cbei0751dig F*        510           5´-ACAATGCTTGATACGTATGG -3´ 
Cbei0751dig R*        511       5´-TATGCAATGCTGCTGTACC-3´ 
Cbei4984dig F*        446       5´-TGAAAGATACCCTGAATTGG-3´ 
Cbei4984dig R*        447       5´-AAAACTCTGCCATAAGAACG-3´ 
Cbei4983dig F*        448              5´-TCTATGATATACGGTCTAGC-3´ 
Cbei4983dig R*         449       5´- ATTCCATATAATGCTGGTGC -3´ 
Cbei4982dig F*        450       5´-GAAGGTATTGCAGTAATTCC-3´ 
Cbei4982dig R*        451                 5´-TATCTCAGCTCCAGTTTGC-3´ 
* F, forward primer; * R, reverse primer 
  
2.20.3. Slot Blotting  
 The purified RNA was diluted to 50 ng/µl with nuclease-free water. The samples were 
incubated for 10 minutes at 70 °C and immediately placed on ice for three minutes, the 
blotting stack consisted of three pieces of Whatman 3 MM paper, and a nylon 
membrane which was immersed in 20 x SSC for five minutes with the orientation 
marked. After the stack was assembled on the vacuum manifold (Schleicher & Schuell) 
traces of   20x SSC were removed from the wells by vacuum and 10 µl of RNA samples 
were loaded in the wells. After 20 minutes under vacuum, the nylon membrane was 
removed and UV cross-linked two times as described in section 2.20.2.  
 2.20.4. Hybridisation of RNA 
A hybridisation bottle and mesh were treated with RNA-zap, then rinsed with DEPC 
treated water. 10 ml of hybridisation buffer was poured into the bottle and incubated for 
30 minutes at 58 °C. 1.5 µl of DIG-labelled probe PCR product was diluted in 18.5 µl 
nuclease-free water and heated at 95 °C for 10 minutes and then placed on ice for 5 
minutes and poured into the hybridisation bottle. The bottle was incubated overnight at 
58 °C.  
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2.20.5. Washing, blocking and detection 
  After hybridisation, the nylon membrane was washed three times with 2X SSC high 
salt concentration buffer and once with 0.2X SSC low salt concentration buffer for 15 
minutes. After washing the nylon was rinsed by immersing in DIG-1 buffer, transferred 
to 10 ml blocking buffer, then treated as described in section 2.20.2.  
 2.21. Reverse transcriptase (RT) PCR  
Trace genomic DNA was removed from RNA samples using the Bioline RNA isolation 
kit. 5 µg of RNA was mixed thoroughly with 5 µl of 10x DNasel reaction buffer, 5µl of 
DNasel, and DEPC-treated water to make up the volume to 100 µl, and the mixture was 
then incubated for 10 minutes at 37 °C. The reaction was stopped by adding 1 µl of 0.5 
M EDTA and heating for 10 minutes at 75°C.  
cDNA (complementary DNA) strands were synthesized from RNA and amplified in a 
PCR tube using the Bioline cDNA kit. This reaction consisted of two stages. The first 
stage was synthesis of cDNA using RNA as template, nucleotide primers and reverse 
transcriptase (RT) enzyme to synthesize a complementary DNA strand. The second 
stage was copying and amplification of the cDNA product. 1 µg (10 µl) of DNasel- 
treated RNA was added to 1 µl of random hexamer primer and 1 µl of 10 mM dNTPs,  
mixed together then incubated for 10 minutes at 65 °C, and then placed on ice for           
2 minutes. 4 µl of 5x reverse transcriptase buffer, 1 µl of RNase inhibitor,  0.25 µl of 
reverse transcriptase and 2.75 µl of DEPC water were added to the mixture and then 
incubated at 42 °C for 30 minutes, heated for 15 minutes at 70 °C, and immediately 
placed at 4 °C.  The PCR reaction for cDNA, used 21 µl of deionized water, 25 µl of 
BioMix
 
(Bioline), 1µl forward primer (Cbei0751dig), 1µl reverse primer (Cbei0751dig), 
and 2 µl of cDNA product. The PCR reaction was as described above in section 2.8. 
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2.22. Gene knockout using the ClosTron    
DNA sequences required for targeting genes cbei 0751 and cbei 4983 were designed 
using the algorithm available on the ClosTron website at the University of Nottingham 
http://www.clostron.com. Integration vectors were then ordered from DNA 2.0. The 
plasmids obtained from DNA 2.0, were extracted from a Whatman GFC filters by 
placing then on a sterile surface, adding 100 µl of 100 mM Tris–HCl, pH 7.5 and 
incubating for 2 minutes, at room temperature. The bottom of a small tube was 
punctured, the filter was placed in the tube and it was placed in a 1.5 ml tube, and 
centrifuged for 1 minute. Approximately 90 µl buffer containing 2 µg plasmid DNA, 
was expected to be recovered.   
2.22.1. Bacterial strain used in gene knockout 
E. coli strain C600RK2 was recovered from storage at -70 °C, and was inoculated onto 
an LB plate without antibiotic and incubated overnight at 37 °C to grow the cells.  
 2.22.2. Transformation of E. coli 
A single colony of E. coli strain C600RK2 from the LB plate without antibiotic was 
inoculated into 5 ml of LB broth and incubated overnight at 37 °C. 1 ml of overnight 
culture was transferred into a flask containing 100 ml LB broth and incubated for 
approximately 3 hours until the OD600 reached 0.6. Competent cells were prepared and 
transformed as described previously, in section 2.13.   
2.22.3. Conjugation  
A colony of E .coli C600RK2 carrying plasmid was inoculated into 5 ml of LB broth 
with 250 µg/ml spectinomycin and incubated overnight at 37 °C on a shaking incubator. 
1 ml of overnight culture was transferred into each of three 1.5 ml Eppendorf tubes and 
centrifuged for two minutes at 13.000 rpm at room temperature, and the supernatants 
were completely discarded. 1 ml of phosphate buffer saline (PBS) was added to each 
tube to wash the pellet, the supernatant was poured off and the pellet was transferred to 
the anaerobic cabinet for conjugation.  0.8 ml of C. beijerinckii spores had been heated 
at 80 °C for 10 minutes and then transferred into 10 ml 2X YTG broth medium without 
any antibiotic and incubated overnight at 37 °C in the anaerobic cabinet. 1 ml of 
overnight culture was added to fresh 10 ml 2x YTG medium and ten fold (v/v) serial 
dilutions were prepared and incubated overnight in the same conditions. 
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  The culture which was closest to the required state (OD600 = 0.6) was used for 
conjugation. The conjugation was initiated by adding 200 µl of C. beijerinckii culture to 
an E .coli cell pellet and gently resuspending by pipetting up and down several times. 
Ten 20 µl samples of mixture were transferred onto 2X YTG plates (three plates) 
without antibiotic and incubated at 37 °C under anaerobic conditions for 8-24 hours. All 
the cells from the plates were recovered using an inoculation loop and resuspended in 1 
ml of PBS solution. The mixture of cells was spread onto CBM plates containing 750 
µg/ml spectinomycin (selective for clostridia) and 250 µg/ml cycloserine (to kill E. coli 
cells) and incubated anaerobically at 37 °C until colonies appeared.  
2.22.4. Purification of transconjugants  
 Colonies from the conjugation selection plates were picked and re-streaked on fresh 
plates of the same type and incubated at 37 °C until growth appeared on the plates. 
Several colonies were then restreaked onto CBM plates containing 10 µg/ml 
erythromycin four times to purify a transconjugant clone.  
2.22.5. DNA isolation from putative mutants  
DNA isolation was carried out using a PUREGENE
® 
Bacteria kit (Qiagen). 
A single colony from a selective plate was transferred to a 15 ml tube with 10 ml 2X 
YTG medium containing 10 µg/ml erythromycin, and incubated at 37 °C under 
anaerobic conditions for 2 - 4 days. 1 ml of the cell culture was transferred into a sterile 
Eppendorf tube and centrifuged at 13,000 rpm for 5 second and the supernatant was 
removed carefully by pipetting. 300 µl of cell suspension solution was added into the 
tube and mixed gently by pipetting up and down. 5 µl of lysozyme buffer (10 mg/ml 
lysozyme in 10 mM Tris-Cl, pH 8.0) was added immediately, mixed by inverting the 
tube 25 times and incubated at 37 °C for 30 minutes. The mixture was centrifuged for 
one minute at 13,000 rpm, and then the supernatant was discarded by pipetting. 300 µl 
of cell lysis solution was added into the tube and mixed by pipetting. 1.5 µl of RNase A 
solution was added into the mixture and mixed by inverting 25 times and incubated at 
37 °C for 60 minutes then immediately placed on ice for one  minute to cool the sample. 
100 µl of protein precipitation solution was added to the tube and vortexed for 20 
seconds at high speed, and then the tube was centrifuged at 13,000 rpm for three 
minutes and the supernatant was transferred into a new 1.5 ml tube. 300 µl of 
isopropanol was added and mixed by inverting gently 50 times, and then after 
centrifugation for one minute at 13,000 rpm, the supernatant was removed and the tube 
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was inverted on a clean piece of absorbent paper. 300 µl of 70 % ethanol was added and 
the tube was inverted ten times to wash the DNA pellet, and centrifuged at 13,000 rpm 
for one minute at room temperature. The supernatant was carefully discarded, and the 
tube was drained on absorbent paper for 20 minutes. 100 µl of DNA hydration solution 
was added and vortexed for 5 seconds, then incubated for 1 h at 65 °C to dissolve the 
DNA. The DNA was incubated overnight at room temperature with gentle shaking, and 
the sample was centrifuged briefly and then transferred into a new sterile Eppendorf 
tube and stored at -20 °C. 
 2.22.6. Screening of DNA by PCR 
 PCR was used to screen for the presence of the intron within the target gene. The PCR 
reaction was carried out as follows: 21 µl of sterile nuclease-free water was added to    
25 µl of BioMix (Bioline), 1 µl each of flanking primers or EBS primer plus one 
flanking primer, and 2 µl of DNA isolated from putative mutants as a template. Primers 
and their position of annealing are shown in Table 2.6 and Appendix I. The PCR was 
carried out as described previously in section 2.11.1, and the products were analysed by 
electrophoresis at 80 V for 60 minutes in a 1% agarose gel in TAE buffer as described 
in section 2.9.   
Table 2.6: List of primers used for analysis of putative mutants  
 Primer Name  Reference                              
Number     
Primer Sequence  
    Cbei-glcG- F*    435 5´-GTTAATGCATATGTTAGGTGTTGGCGTA 
     GGTAT-3´  
    Cbei-glcG- R*     436 5´-ATAGCCCGATGCTCCAGTTTGTTTTAACA 
     AAC-3´ 
   Cbei-glcX-  F*     437 5´-GTGGTACAAAATTTGTCCCAATGGTTTCT 
     ATTATCG-3´ 
    Cbei-glcX- R*    438 5´-CATAGCCAAAGCTGCCCCTGGCAA-3´ 
       EBS     452 5´-CGAAATTAGAAACTTGCGTTCAGTAAA 
     C-3´  
  * F, forward; * R, reverse  
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2.23. Bioinformatics analysis 
Protein sequences were obtained using the BLAST programs at  National Center for 
Biotechnology Information (Altschul et al., 1997). Multiple alignment of Protein 
sequences was performed using ClustalW2 of the European Bioinformatics Institute 
(Chenna et al., 2003), and  phylogenetic trees were drawn using TreeView (Page, 1996). 
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                     RESULTS  
 
 
FUNCTIONAL OF ANALYSIS OF THE GENE CBEI 0751  
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3. Results 
3.1. Characterisation of potential glucose PTS genes in C. beijerinckii   
As described in the introduction, the whole genome of C. beijerinckii NCIMB 8052 has 
been sequenced and it has been found that C. beijerinckii has forty three complete 
phosphotransferase systems (Shi et al., 2010). Seven are members of glucose subfamily, 
and three are within the phylogenetic branch which is associated with glucose uptake 
systems. These three permeases are encoded by; cbei 0751 which encodes a PTS with 
three domains IIA, IIB and IIC together; cbei 4983 which encodes two domains IIB,IIC  
and cbei 4982 which encodes a separate IIA domain; and cbei 4532 which encodes two 
domains IIBC, and cbei 4533 which encodes a IIA domain.   
As a preliminary experiment to precede analysis of the potential functions of the 
glucose subfamily phosphotransferase systems, the ability of C. beijerinckii NCIMB 
8052 to take up and grow on different sugars was examined. C. beijerinckii was grown 
on CBM plates supplemented with a number of different carbohydrates. As shown in 
Table 3.1, the bacterium was capable of growth on glucose, mannose, maltose, sucrose 
and trehalose, all of which are known to be carbon sources which are transported by 
phosphotransferase systems of glucose-glucoside family.  
 
Table 3.1. Growth of C. beijerinckii on CBM plates containing; glucose, mannose, maltose, sucrose, 
trehalose or no carbon source. Plates were incubated for 24 hours at 37 ºC. 
Carbon source  Growth/ No Growth 
Glucose              + 
Mannose              + 
Maltose              + 
Sucrose              + 
Trehalose              + 
No carbon source              - 
 
The sequences of the proteins were obtained from the C. beijerinckii   genome data base 
(http://genome.jgi-psf.org/clobe/clobe.home.html).  A BLAST analysis was carried out 
to identify the position of the IIC domain in each protein. This information was used to 
extract the IIC domain region from the protein and these regions were aligned using 
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ClustalW2 and analysed in the form of a phylogenetic tree along and with IIC domains 
from characterised phosphotransferases in other bacteria.   
As shown in the phylogenetic tree (Figure 3.1), the IIC domains encoded by cbei 0751 
and cbei 4983 are in a similar place. The cbei 4532 IIC domain is clearly different and 
related to N-acetylglucosamine systems from other bacteria. This C. beijerinckii PTS 
has been shown to transport both N-acetylglucosamine and glucose (Al Makishah and 
Mitchell, 2013). The cbei 0751 domain occupies a position in between maltose and 
glucose systems, while the cbei 4983 domain is closely related to the EcoMalX  
(Frömmel et al., 2013). The identity between the IIC domains of the Cbei 0751 protein 
and Cbei 4983 protein is 45.3 %.    
Table 3.2 also shows the relationship between IIC domains included in the phylogenetic 
tree (Figure 3.1). As was expected, the Cbei 4532 protein domain is the most closely 
related to N-acetylglucosamine systems of other bacteria. The Cbei 0751 domain is the 
most closely related to glucose systems of other bacteria. The Cbei 4983 domain is the 
most closely related to three systems which are (A), BgIP, the β-glucoside  specific PTS 
of Staphylococcus mutans  (Cote et al., 2000),   (B), EcoMalX the maltose specific PTS 
of E. coli  (Reidl and Boos, 1991),  and (C), PttB a  trehalose specific PTS of S. mutans  
(Webb et al., 2007).  
The cbei 0751 gene which encodes a complete PTS (IICBA domains) is upstream of a 
gene encoding a transcriptional antiterminator. Genes encoding the glucose  PTS of C. 
acetobutylicum (Tangney and Mitchell, 2007) and  B.subtilis (Stülke et al., 1997), are 
also associated with an antiterminator. An antiterminator is a protein that binds to 
mRNA and is involved in regulation of gene expression, and it is therefore likely that 
expression of the cbei 0751 gene may be antiterminator dependent. The cbei 4983 gene 
encoding the IICB domains of a PTS is upstream of a gene encoding a IIA domain, and 
downstream of a gene encoding a glycoside hydrolase as shown in Figure 3.2. This 
arrangement strongly suggests the substrate of the PTS should be a disaccharide, since 
the phosphorylated product of the PTS is probably hydrolysed by the hydrolase enzyme.    
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Figure 3.1: Phylogenetic tree of IIC domain including the relationship of glucose-glucoside family PTS 
systems.  A Phylogenetic  tree was constructed from the amino acid of different strains included E. coli 
glucose (EcoGlc) (WP_000317748), B.subtilis glucose (BsuGlc) (NP_389272), Staphylococcus carnosus 
glucose (ScaGlcA) (YP_002634092), S.carnosus glucose (ScaGlcB) (YP_002634093), B.subtilis 
glucosamine (BsuGam) (NP_388117), C.acetobutylicum glucose(CacGlc) (NP_347209), E.coli 
maltose(EcoMalX) (P19642), Enterococcus faecalis maltose(EfaMal) (NP_814695), S.mutant 
glucose/maltose(SmuGlc/Mal) (NP_722340), S. mutants β-glucoside (SmuBglP) (NP_721375), S.mutants 
sucroseA(SmuScrA) (NP_722158), S.mutants putative trehaloseB (SmuPttB) (NP_722334), Streptomyces 
coelicolor N-acetylglucosamine (ScoNag) (NP_627133), Ralstonia eutrophus N -acetylglucosamine    
(ReuNagE) (YP_724831), Streptomyces olivaceoviridis N-acetylglucosamine (SoliNag)(CAD29623),      
E. coli N-acetylglucosamine (EcoNag)(NP_415205), C. acetobutylicum N-acetylglucosamine (CacNag) 
(NP_347981), B.subtilis N-acetylglucosamine (BsuNag) (NP_388651). All member are of the glucose 
subfamily, and they have been characterized as glucose (Glc), glucoseamine (Gam), maltose (Mal),         
N-acetylglucosamine (Nag), and β-glucoside phosphotransferase, Cbei 0751, is a  glucose PTS. Cbei 
4532 is N-acetylglucosamine PTS, Cbei 4983 might be a maltose PTS. 0.1,  amino acid substitutions per 
sequence site. 
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Figure 3.2: The organization of genes, cbei 0751 and  cbei 4983,  cbei 0752 encodes a putative              
anti-terminator protein, and cbei 4984 encodes a putative glycoside hydrolase.  
     
Table  3.2: BLAST homology results for the deduced amino acid sequences of the IIC domain of glucose, 
β-glucoside, maltose and  N-acetylglucosamine PTSs and glucose subfamily PTSs of C. beijerinckii.     
 
          Species/system     Cbei 0751 
 
       Cbei  4983   Cbei 4532 
   % 
Identity  
 
     % 
Similarity  
  
     %  
Identity  
 
    % 
Similarity  
 
   % 
Identity  
 
   % 
Similarity  
  
E.coli Glc      40      57      38      55      39      58 
B.subtilis Glc      47      64      43      62      35      53 
Staphylococcus carnosus 
GlcA 
     45      64      42      62      41      57 
S. carnosus GlcB      44      62      41      60      39      54 
B.subtilis Gam      45      60      40      56      38      58 
C. acetobutylicum  Glc      40      55      34      50      35      52 
Streptomyces coelicolor 
Nag 
     40      54      31      50      41      58 
Ralstonia  eutrophus 
NagE 
     45      59      37      56      46      62 
Streptomyce  
solivaceoviridis   Nag 
     38      55      35      54      43      61 
E.coli Nag      40      54      33      48      42      59 
C. acetobutylicum  Nag       40      53      38      51      42      59 
B.subtilisNag      39      53      34      49      45      62 
E.coli MalX      42      61      43      62      32      49 
Enterococcus  faecalis  
Mal 
     35      50      33      51      33      44 
S. mutants  Glc/Mal      34      50      33      51      30      45 
S. mutants BgIP      26      42      45      51      25      42 
S. mutants ScrA      41      51      33      48      25      40 
S. mutants PttB      28      45      37      63      27      41 
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3.2. Cloning and characterization of gene cbei 0751    
3.2.1. Amplification of gene cbei 0751 by PCR  
 As demonstrated in the previous section, the protein encoded by gene cbei 0751 was 
identified as the most likely glucose phosphotransferase system in the organism. This 
protein encodes a PTS protein with three domains IIA, IIB and IIC together therefore 
encodes the entire phosphotransferase system. Therefore, the aim was to investigate 
whether the encoded protein could function as a glucose PTS. The cbei 0751 gene was 
amplified by PCR as described in Materials and Methods section 2.8. The size of 
obtained product was between 2000 and 2500 bp, in agreement with   the expected size 
of 2364 bp, as shown in Figure 3.3. The amplified DNA was then cloned in             
pCR
®
 2.1-TOPO
®
 vector and transformed into E.coli and plated onto LB agar 
containing ampicillin.   
 
             
 
Figure 3.3: PCR amplification of gene cbei 0751; lane M, Hyperladder I used as a marker; lane 1, 
amplified product from PCR reaction using the forward primer 356 and the reverse primer 357. 
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3.2.2. Screening and analysis of clones 
40 colonies were picked off and transferred onto fresh LB agar plates and incubated 
under the same conditions. These were given reference numbers, and incubated 
overnight at 37 ºC. Colonies were then screened to identify the gene insert within the 
vector (Figure 3.4).  Only two colonies (numbered ME15 and ME20) were found to 
contain the gene insert with the same size as the cloned PCR fragment. The gene had 
been successfully cloned into the pCR
®
 2.1-TOPO
®
 vector, although the number of 
recombinants recovered was small.  
                       
Figure 3.4: Screening of transformants by PCR. The presence of cbei 0751 was determined using the 
forward primer 356 and the reverse primer 357; lane M, Hyperladder I; lane 1, sample ME15; lane 2, 
sample ME20.  
3.2.3. Determination of orientation of DNA inserts by PCR 
In the next stage to determine the insert orientation, a new PCR was carried out, using 
different combinations of primers directed against the vector and the insert.  The cloned 
DNA could be inserted in 5´- 3´ or 3´- 5´ orientation with respect to the lac promoter on 
the vector. The 5´- 3´ orientation would be in the suitable direction for expression by the 
lac promoter within the pCR
®
 2.1-TOPO
®
 vector. If the combination of the M13 reverse 
primer and the reverse cloning primer 357 gives a product, that indicates the insert is 
under the control of the lac promoter.  However, the primer combination of the M13 
reverse and forward cloning primer 356 should not give a PCR product if the insert is 
under control of the lac promoter (Figure 3.5(i)). Likewise, the combination of the T7 
promoter primer 373 and the primer 357 should not give a product if the insert is under 
the control of lac promoter, but the combination of the T7 promoter primer and the 
primer 356 will give a product if the insert is under the control of the lac promoter 
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(Figure 3.5(i)). On the other hand, different products will be obtained if the insert is in 
the opposite orientation, under control of the T7 promoter (Figure 3.5(ii)).  
 The results of the analysis are shown in Figures 3.6 and 3.7. According to the results, 
the inserts were cloned in opposite orientation in the two vectors. Thus, ME15 gave 
product with the M13 reverse primer and forward primer 356, and no amplification with 
M13 reverse primer and reverse primer 357; the cloned gene was therefore in the 3´- 5´ 
orientation (Figure 3.6).  ME20 did not give product with the M13 reverse primer and 
forward primer 356, but gave product with the M13 reverse primer and reverse primer 
357, so the orientation was 5´- 3´ and under the control of lac promoter as shown 
(Figure 3.6). As expected, ME15 did not give product with forward primer 356 and T7 
promoter primer, but gave product with reverse primer 357 and T7 promoter primer 
(Figure 3.7).  ME20 gave product with forward primer 356 and T7 promoter primer, but 
did not give product with reverse primer 357 and T7 promoter primer. The results 
clearly indicated that the orientation of the insert in the two plasmids was different 
(Figure 3.7). 
One gene was potentially expressed under control of lac promoter and the other one was 
under the control of the T7 promoter. Therefore, it was expected that ME20 will be 
expressed in E. coli because it is under the lac promoter whereas the other gene may not 
be expressesd because it is in the opposite orientation.  
                    
                     
Figure 3.5: The annealing of primers 356,357 and M13 reverse (372), and the T7 promoter primer (373)    
with recombinant pCR
®
 2.1-TOPO
®
 vector, plac, promoter of the lac operon,  blue colour, vector 
sequence. 
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Figure 3.6: Determination of orientation of clones by PCR; lane M, Hyperladder I; lane 1, ME15 with 
M13 reverse primer and primer 356; lane 2, ME20 with M13 reverse primer and primer 356; lane 3, 
ME15 with M13 reverse primer and primer 357; lane 4, ME20 with M13 reverse primer and primer 357.  
 
           
Figure 3.7: Determination of orientation of clones by PCR; lane M, Hyperladder I; lane 1,  ME15 with 
primer 356 and T7 promoter primer 373; lane 2,  ME20 with primer 356 and T7 promoter primer 373;  
lane 3, ME15 with primer 357 and T7 promoter primer 373; lane 4, ME20 with primer 357 and T7 
promoter primer 373. 
3.2.4. Preparation of plasmids                                                        
 The next step was to introduce the plasmids (ME15 and ME20) into E. coli mutant 
ZSC113 which lacks transport and phosphorylation of glucose or mannose, in order to 
determine whether the fermentation phenotype of the mutant would be complemented.  
Plasmids were purified using the Fermentas GeneJET
TM
 Plasmid Miniprep Kit. 
Recombinant plasmid was prepared from ME15 and ME20 grown in LB Broth 
containing 100 µg/ml ampicillin, and then incubated overnight at 37 °C with vigorous 
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shaking at 180 rpm. Successful plasmid isolation was confirmed by agarose gel 
electrophoresis as shown in Figure 3.8. 
                               
Figure 3.8: Isolation of plasmids ME15 and ME20 from E.coli TOP-10F; lane M, Hyperladder I;         
lane 1, plasmid ME15; lane 2, plasmid ME20. 
3.2.5. Fermentation phenotype tests  
The purified plasmids were next transformed into mutant E. coli ZSC113 as described 
in Materials and Methods. The transformants were isolated on LB plates containing 100 
µg/ml ampicillin. Colonies were then transferred onto MacConkey agar plates with 1% 
glucose or 1% mannose as the fermentable carbon source. The transformed cells 
showed a positive fermentation phenotype for both sugars, thus showing the ability to 
ferment glucose and mannose (Figures 3.9 and 3.10). Also the positive phenotype was 
found for both plasmids independent of the orientation of the cloned gene, which 
indicates that the gene is expressed whether or not it is under the control of the lac 
promoter. This suggests that, there is a functional promoter which is driving the 
expression of pME15 in which the insert is in the opposite orientation. On the other 
hand, E.coli ZSC113 was unable to ferment glucose and mannose. The presence of the 
plasmids in the transformed cells was demonstrated by PCR using primers 356 and 357 
(data not shown). The results therefore showed that gene cbei 0751 encoded a 
phosphotransferase system which was capable of uptake of both glucose and mannose. 
 The ability of the PTS encoded by cbei 0751 to transport N- acetylglucosamine was 
also tested by transforming into an E.coli nagE mutant lacking NAG PTS activity and 
screening on MacConkey agar plate supplemented with 0.5% N- acetylglucosamine. 
The results shown in Figure 3.11, demonstrated that the transformed cells were unable 
to ferment the N- acetylglucosamine substrate. 
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Figure 3.9: Fermentation of glucose by E.coli ZSC113 containing plasmids pME15 and pME20 on 
MacConkey agar.  
 
 
                                                  
Figure 3.10: Fermentation of mannose by E.coli ZSC113 containing plasmids pME15 and pME20 on 
MacConkey agar.  
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Figure 3.11: Fermentation of NAG by E.coli JW0665-1 mutant containing plasmid pME20 on 
MacConkey agar contained 0.5 % N- acetylglucosamine.  
3.2.6. Large scale preparation of plasmid 
Plasmids were purified using the QIAGEN plasmid Midi kit as described in Materials 
and Methods, section 2.12.1. An agarose gel electrophoresis was run to check the 
presence of the plasmid from ME15 and ME20 (Figure 3.12). Samples of these 
plasmids were sent for sequencing to Beckman Coulter Genomics. The sequence was 
obtained as a result of two reactions working along the genes. The results indicated that 
the complete sequence was 100% correct, when compared with the sequence from the 
genomic database (http://genome.jgi-psf.org/clobe/clobe.home.html), which confirmed 
the structure and orientation of the recombinants. Further characterization with respect 
to glucose uptake and phosphorylation was carried out.   
                                     
Figure 3.12: Plasmid purification of ME15, ME20 using the Qiagen midi kit; lane M, Hyperladder I; lane 
15, plasmid ME15;  lane 20,  plasmid ME20.                              
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3.3. Characterization of recombinant E.coli cells containing gene cbei 0751  
The successful complementation of E.coli ZSC113 for fermentation of glucose and 
mannose, suggested that recombinant cells should now had the ability to take up and 
phosphorylate these sugars. Therefore, this ability was measured in various ways. 
Firstly, utilization of glucose and mannose was examined in LB broth. Secondly, 
glucose uptake and phosphorylation by whole cells and cell extracts was investigated.    
3.3.1. Utilization of glucose and mannose in growing cultures   
The strains were examined for the ability to take up and utilise glucose and mannose 
when growing in cultures. Strains ZSC113/pME15 and ZSC113/pME20, and the 
untransformed mutant ZSC113, were grown in LB broth containing 25 mM glucose and 
mannose, and 100 µg /ml ampicillin in the case of the recombinant strains only. The 
growth was measured by reading optical density at 600 nm, and supernatant samples 
were collected for sugar analysis.  Both recombinant strains were able to utilise glucose 
and mannose, as shown in Figures 3.13 and 3.14 (glucose) and in Figures 3.16 and 3.17 
(mannose), whereas the mutant E.coli ZSC113 showed very poor ability to remove the 
sugar from the growth medium (Figures 3.15 and 3.18 for glucose and mannose 
respectively). Therefore the utilization of glucose and mannose was evident only in 
ZSC113/pME15, ZSC113/pME20, and was absent in the untransformed mutant.   
The strain JW0665-1/pME20 was also investigated for the ability to uptake and utilise 
NAG in LB broth under the same conditions. The results showed that the recombinant 
strain could not utilise NAG (Figure 3.19), had been demonstrated previously for 
untransformed JW0665-1 strain   (Al Makishah and Mitchell, 2013).          
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Figure 3.13: Growth and glucose utilization by strain ZSC113/pME15 in LB broth. Results from average 
value of independent duplicate cultures are shown. The initial glucose concentration was 25 mM and 
indicated by (♦), optical density of cells by (□). Error bars (standard deviation (SD)) are hidden by the 
symbols. 
                          
Figure 3.14: Growth and glucose utilization by strain ZSC113/pME20 in LB broth. Results from average 
value of independent duplicate cultures are shown. The initial glucose concentration was 25 mM and 
indicated by (♦), optical density of cells by (□). Error bars (SD) are hidden by the symbols. 
              
Figure 3.15: Growth and glucose utilization by strain E.coli ZSC113 in LB broth. Results from average 
value of independent duplicate cultures are shown. The initial glucose concentration was 25 mM and 
indicated by (♦), optical density of cells by (□). Error bars (SD) are hidden by the symbols. 
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Figure 3.16: Growth and mannose utilization by strain ZSC113/pME15 in culture. Results from average 
value of independent duplicate culture are shown. The initial mannose concentration was 25 mM and 
indicated by (♦), optical density of cells by (□). Error bars (SD) are hidden by the symbols. 
                   
Figure 3.17: Growth and mannose utilization by strain ZSC113/pME20 in culture. Results from average 
value of   independent duplicate culture are shown. The initial mannose concentration was 25 mM and 
indicated by (♦), optical density of cells by (□). Error bars (SD) are hidden by the symbols. 
                     
Figure 3.18: Growth and mannose utilization by strain E.coli ZSC113. Results from average value of 
independent duplicate culture are shown. The initial mannose concentration was 25 mM and indicated by 
(♦), optical density of cells by (□). Error bars (SD) are hidden by the symbols. 
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Figure 3.19: Growth and N- acetylglucosamine utilization by strain JW0665-1/pME20. Results from 
average value of independent duplicate cultures are shown. The initial N-acetylglucosamine  
concentration was 25 mM and indicated by (♦), optical density of cells by (□). Error bars (SD) are hidden 
by the symbols. 
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3.3.2. Glucose uptake by whole cells 
Accumulation of glucose by whole cells was measured by following uptake of 
radiolabelled sugar 
14
C- glucose. That strains ZSC113/pME15 and ZSC113/pME20 
were able to accumulate glucose at a significant rate indicating that a transport system 
for glucose was active, as shown in Figure 3.20.  On the other hand, mutant E.coli 
ZSC113 did not appear to be able to transport glucose during the experiment (Figure 
3.21). Therefore, the result clearly shows that the recombinant strains are able to take up 
glucose but this activity is not seen in mutant E.coli ZSC113. Therefore, the results are 
in agreement with the results of the culture studies and the fermentation studies, which 
indicate that the cbei 0751 gene has given the E.coli strain the ability to take up glucose.                                                             
 
                                  
 
Figure 3.20: Uptake of glucose by whole cells of strains ZSC113/pME15 (a) and ZSC113/ pME20 (b). 
Results from average value of independent triplicate assays are shown, and error bars indicate standard 
deviation of the means. 
 
 
Figure 3.21: Uptake of glucose by whole cells of strain E.coli ZSC113. Results from average value of   
independent triplicate assays are shown, and error bars indicate standard deviation of the means. 
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3.3.3. Assay of glucose phosphorylation by cell extracts 
As a final step in characterization of recombinant cells carrying the cbei 0751 gene, 
glucose PTS activity was assayed directly by following the rate of phosphorylation by 
cell free extracts. Cell extracts were prepared from strains ZSC113/pME15, 
ZSC113/pME20 and ZSC113 growing in LB broth. PTS activity is expected to be 
dependent on PEP.  However, in initial assays the rate of sugar phosphorylation by the 
ZSC113/pME15 and ZSC113/pME20 extracts was similar in the presence or absence of 
PEP. The extracts were therefore dialysed to remove any PEP or other metabolites 
which might be present and interfering with the assay.  
Following dialysis, the sugar phosphorylation assays were repeated. For both 
ZSC113/pME15 and ZSC113/pME20 extracts glucose was phosphorylated at a rapid 
rate in the presence of PEP. However, in the absence of PEP, the phosphorylation rate 
was considerably lower (Figure 3.22). Therefore, the results provide evidence for 
glucose PTS activity in both extracts.  
 
                                     (a)                                                            (b)                
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 Figure 3.22: Phosphorylation of glucose by extracts of strains ZSC113/pME15(a) and ZSC113/     
pME20 (b) with PEP, and without PEP as a control. Error bars (SD) are hidden by the symbols.  
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On the other hand, cell extract prepared from E.coli ZSC113 showed no activity with or 
without PEP even without being dialysed (Figure 3.23). 
 
    
Figure 3.23: Glucose phosphorylation by extract of strains E.coli ZSC113 in the presence and absence of 
PEP. Error bars (SD) are hidden by the symbols. 
Experiments investigating fermentation of glucose and mannose on MacConkey agar,  
and utilization of glucose and mannose in LB broth, provided evidence that the gene     
cbei 0751 encodes a glucose phosphotransferase system which also recognises mannose 
as a substrate. Given the apparent dual substrate specificity of the system, it was clearly 
of interest to examine whether mannose could inhibit phosphorylation of glucose. 
Therefore, experiments were set up in order to look at the inhibition of glucose 
phosphorylation by mannose and other glucose analogues.    
3.3.4. Inhibition of glucose phosphorylation by other sugars 
Glucose phosphorylation by cell extracts was examined in the presence of  other related 
sugars in order to identify which sugar(s) might be recognised as substrates of the 
glucose PTS. The analysis showed that in extracts of ZSC113/pME20 glucose 
phosphorylation was inhibited by mannose (Figure 3.24). The glucose analogues methyl 
α –glucoside, (α MG) and 2-deoxyglucose also caused a strong inhibition of glucose 
phosphorylation, but inhibition by 3-O-methyl glucose was much less severe as shown 
in Figure 3.25. Glucose phosphorylation was most strongly inhibited by mannose, 
which is consistent with previous observations showing that the cloned cbei 0751 
complemented strain E.coli ZSC113 for fermentation of both glucose and mannose, and 
confirming that mannose is a substrate of the PTS encoded by the cbei 0751 gene.    
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Figure 3.24: Effect of mannose on glucose phosphorylation by cell extract of strain ZSC113/ pME20. The 
results average of two experiments. The glucose concentration was 0.2 mM and the inhibitor at the 
concentration of 10 mM. Error bars (SD) are hidden by the symbols.   
 
 
 
 
 
 
 
 
 
                                       
Since cbei 0751 is clearly a glucose PTS and gene arrangement next to an antiterminator 
is similar to the glucose PTS (glcG) in C. acetobutylicum, it is proposed that the cbei 
0751 gene should be named glcG.    
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Figure 3.25:  Effect of glucose analogues on glucose phosphorylation by cell extract of strain 
ZSC113/pME20.The results average of two experiments. The glucose concentration was 0.2 
mM and the inhibitor at the concentration of 10 mM. Error bars (SD) are hidden by the symbols.     
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3.4. Analysis of expression of cbei 0751 in C. beijerinckii  
3.4.1. RNA isolation 
According to the previous experiments the cbei 0751 PTS is a glucose uptake system.   
It was therefore of interest to determine whether the system is induced by glucose.  
RNA was isolated from C. beijerinckii NCIMB 8052 cells that were grown in CBM 
containing different carbon sources; glucose, sucrose, galactose, N- acetyglucosamine, 
mannose and  maltose. RNA samples were examined by agarose gel electrophoresis, 
and results indicate the RNA was of good quality as shown in Figure 3.26.  
  
                     
Figure 3.26: Total RNA isolation from C. beijerinckii. Cultures were grown on CBM containing: lane 1, 
glucose; lane 2, sucrose; lane 3, galactose; lane 4, N- acetylglucosamine; lane 5, mannose; lane 6, 
maltose. RNA samples were run on denaturing agarose gel containing ethidium bromide.  
3.4.2. Preparation of hybridization probe 
 
A hybridization probe was prepared by digoxigenin-labelling of PCR amplified product 
using C. beijerinckii NCIMB 8052 DNA as the template, and primers directed agents 
internal regions of the gene, as mentioned previously in Materials and Methods in 
section 2.20.2. In agarose gel electrophoresis, the unlabelled control reaction gave a 
product of a size in agreement with the expected size of 350 bp.  
The DIG-labelled product had a higher molecular mass, which suggesting successful 
incorporation of DIG (Figure 3.27).     
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Figure 3.27: PCR amplified hybridization probe for cbei 0751. Lane M, Hyperladder I;  lane 1, gene       
cbei 0751 DIG- labelled PCR product; lane 2, control, unlabelled PCR  product.   
 
The probe was examined directly on a nylon membrane by dot blot as shown in Figure 
3.28. Detection of the probe from undiluted sample to the fifth dilution, confirmed that 
it was suitable for hybridization analysis.   
 
   
 
Figure 3.28: Dot blot of DIG- labelled section of the gene cbei 0751. The sample was serially diluted 
x5(from left to right) and samples were processed and detected with CDP-star as described in Materials 
and Methods.  
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3.4.3. Expression of the cbei 0751 gene during growth on several carbon sources   
 
The DIG-labeled PCR amplified DNA product (DNA probe) was used in slot blot 
hybridization with RNA samples extracted from C. beijerinckii cultures grown on 
glucose, sucrose, galactose, N- acetylglucosamine, mannose and maltose. The results 
are shown in Figure 3.29. As can be seen, hybridization was observed following growth 
on all substrates tested. The strongest hybridization signal was obtained from RNA 
prepared from cells grown on galactose, and surprisingly the weakest signal was from 
cells grown on glucose. Therefore, while the slot blot hybridization does not provide     
a quantitative analysis of gene expression, there is clearly no evidence for induction of 
cbei 0751expression by glucose.   
 
 
Figure 3.29: Slot blotting and hybridization of RNA samples for monitoring gene cbei 0751 expression. 
RNA samples were isolated from cells grown on different carbon sources; glucose, sucrose, galactose, N- 
acetylglucosamine, mannose and maltose.   
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3.4.4. DNaseI treatment 
To remove any trace amount of DNA present in RNA samples, New England Biolabs 
protocol was used as described in the Materials and Methods section 2.21. Following 
the treatment RNA samples were reanalysed by agarose gel electrophoresis. The result 
shown in Figure 3.30 indicated that the RNA was still intact. A PCR reaction was 
carried out using the cbei 0751dig forward primer and cbei 0751dig reverse primer as 
described in the Materials and Methods.  As can be seen in Figure 3.31, the RNA before 
treatment gave product indicating that DNA was present, but after treatment there was 
no PCR product indicating DNA had successfully been removed.  
      
Figure 3.30: Some RNA samples after treatment to remove any trace of DNA present. Samples were run 
on denaturing agarose gel containing ethidium bromide. 
 .                             
Figure 3.31: PCR amplification of RNA isolated from cells grown on glucose; lane M. Hyperladder I; 
lane 1, RNA after treatment with DNase; lane 2, RNA before treatment with DNase; lane 3, PCR 
amplification with genomic DNA as control. 
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3.4.5. Analysis of gene expression by reverse transcriptase (RT)-PCR 
To re-examine the expression of the gene cbei 0751 in different growth conditions,          
a reverse transcriptase (RT)-PCR analysis was carried out. In this procedure, reverse 
transcriptase is used to create a complementary DNA (cDNA). The RT-PCR reaction 
consists of two steps. The first one is reverse transcription of RNA which can be 
performed using a primer that anneals to the RNA template to create a complementary 
DNA (cDNA) by using the reverse transcriptase (RT) enzyme, hence, this reaction is 
termed the RT reaction. The second step is then amplification of the cDNA by PCR. 
The results were analysed on an agarose gel shown in Figure 3.32. In each case a band 
of the expected size was obtained when reverse transcriptase had been included to 
generate the cDNA. On the other hand in the control samples when the reverse 
transcriptase step was eliminated, there is no product. This shows clearly that there was 
no DNA present in the samples and it confirms that the expression of the gene had taken 
place in samples extracted from cells grown on different carbon sources.   
 
                             
 
Figure 3.32: Reverse transcriptase (RT)-PCR of C. beijerinckii RNA isolated following growth on 
different carbon sources. lane M, Hyperladder  I; lane 1, cDNA of glucose; lane 3, cDNA of sucrose; lane 
5, cDNA of galactose; lane7, cDNA of N- acetylglucosamine; lane 9,  cDNA of mannose; lane11, cDNA 
of maltose. Lanes, 2, 4, 6, 8, 10 and 12, were a control for each sample respectively in which the RT-step 
was eliminated. 
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 3.5. Gene Knockout using the ClosTron 
To assess the importance of the glcG gene in C. beijerinckii, one experimental approach 
would be to inactivate it and examine the effect on cellular behaviour. The plasmid used 
in C. beijerinckii is pMTL007S-E2 as shown in Figure 3.33(a) (Heap et al., 2010).  
Three critical features are present in the plasmid. First, the intron which contains the  
ermB gene (encoding resistance to erythromycin) which is inactive due to the insertion 
of an intron from the phage td as shown in Figure 1.6. Second, the specR gene encoding 
resistance to spectinomycin. Third a gene encoding for LtrA, the protein which 
catalyses the incorporation of the retargeted intron into the target gene. By incorporating 
a specific short sequence in the intron, it can be targeted to a particular gene and transfer 
to the target is accompanied by activation of erythromycin resistance which allows for 
selection of stable mutants. The activation is due to the splicing out of the phage (td) 
intron during transfer of the ermB- containing intron to the target site.  
Following insertion of the target intron and selection for erythromycin resistance, 
different combinations of primers directed against either chromosomal DNA or the 
intron can be used in PCR to establish whether mutants have been correctly constructed. 
In the wild type the combination of forward primer 435 and reverse primer 436 should 
give product of 368 bp. However, for a mutant the primer combination of EBS primer   
(which is specific to the intron sequence and present within the insert) and 435 forward 
primer should give a PCR product of 490 bp, but the combination of EBS primer and 
the 436 reverse primer should not give a product. After putative clones were isolated 
and purified several times on CBM plates supplemented with 10 µg/ml erythromycin, 
DNA was extracted and the various PCR amplification were carried out.  The results of 
the analysis are shown in Figure 3.34. The only products which were obtained from the 
combination of the forward primer and reverse primer as describe above these not 
expected for mutant so, this indicated that the DNA was still from a wile type 
bacterium, on the other hand the product which was expected from mutant which the 
reverse primer and EBS primer did not give product for any of the mutant.  
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Figure 3.33: (a) Plasmid pMTL007S-E2 (from Muhammad Ehsaan, Nottingham University); (b) PCR 
used to screen for intron insertion in gene glcG. The specified insertion into glcG was at nucleotide 1347 
on the sense strand.  = ClosTron target, - - PCR product using the forward primer 435 and the reverse 
primer 436 with wild type, - - PCR reaction using the forward primer 435 and the EBS primer and also 
used reverse primer 436 and EPS primer with mutant. Only one of these reactions will give product 
depending on the orientation of the intron insertion.    
   (a) 
      (b) 
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Figure 3.34: Mutant screening by PCR used to screen for intron insertion in gene glcG. lane M, 
Hyperladder; lane 1, sample 2 with forward primer 435 and reverse primer 436; lane 2,  sample 2 with 
forward  primer 435 and EBS primer; lane 3, sample 2 with reverse  primer  436 and EBS primer; lane 4, 
sample 4 with forward primer 435 and reverse primer 346;  lane 5, sample 4 with forward primer 435 and 
EBS primer; lane 6, sample 4 with reverse primer 436 and EBS primer;  lane 7, sample 6 with forward 
primer 435 and reverse primer 436; lane 8, sample 6 with forward primer 435 and EBS primer; lane 9, 
sample 6 with reverse primer 436 and EBS primer; lane10, wild type with forward primer 356 and   
reverse primer 357; these are the cloning primers as a control, and the expected size of 2364 bp, the 
numbers on the gel are reference numbers for the samples (individual colonies). 
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3.6. Cloning of the genes cbei 4983 and cbei 4982  
3.6.1. Amplification of genes cbei 4983 and cbei 4982 by PCR 
In the previous section the gene cbei 0751 was successfully cloned and it was shown it 
at codes for a glucose PTS which also recognises mannose as a substrate. This leaves 
the question of what is the function of the other system coded for by the genes cbei 
4983 and cbei 4982. This system is in a phylogenetic position that suggests that it may 
be a system for a disaccharide uptake, and the fact that the genes are located next to a 
gene encoding for a hydrolase also suggests that a disaccharide may be the substrate. 
The genes cbei 4983 and cbei 4982 were amplified by PCR using 432 forward primer 
and 433 reverse primer, and Easy-A
® 
High-Fidelity PCR Cloning Enzyme (Stratagene). 
As described in Materials and Methods in section 2.8, the product obtained was just 
lower than 2500 bp, in agreement with a product expected to be 2263 bp, as shown in 
Figure 3.35. Therefore, the PCR- generated DNA fragment encodes the entire PTS; the 
gene cbei 4983 encodes the two PTS domains IIB and IIC, and the cbei 4982 gene 
encodes a separate PTS IIA domain. These genes could be cloned in the StrataClone 
PCR Cloning Vector and transformed into E.coli TOP10.  
 
               
Figure 3.35: PCR amplification of genes cbei 4983 and cbei 4982; lane M, Hyperladder I; lane 1 and    
lane 2, amplified products from PCR reaction using the forward primer 432 and the reverse primer 433.  
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3.6.2. Screening and analysis of clones 
 The PCR amplified product was inserted into the StrataClone PCR Cloning Vector (see 
Appendix IV) from the StrataClone PCR Cloning Kit, and then transformed into E.coli 
TOP10 competent cells. Transformed cells were plated onto LB plates containing 100 
µg/ml ampicillin and incubated at 37 ºC overnight. 56 colonies were picked off onto 
fresh LB plates containing the same amount of ampicillin and incubated again at 37 ºC 
overnight. These isolates were then screened for the presence of the cloned genes. 38 of 
the 56 clones showed the presence of the genes (as shown in Figure 3.36), since they 
had an amplified PCR product of the expected size of around 2263 bp. This indicated 
that the cbei 4983 and cbei 4982 genes had been successfully inserted into the 
StrataClone PCR Cloning Vector.  
    
      
                             
Figure 3.36: Screening of transformants for the presence of genes cbei 4983 and cbei 4982 by PCR using 
the cloning primers (forward primer 432 with the reverse primer 433). The numbers on the gel are 
reference numbers for the samples (individual colonies) and the expected size of the insert to be 2263 bp.                                                                                                                                                                                                                                                                                                                                    
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3.6.3. Determination of orientation of DNA inserts by PCR  
The orientation of the inserted genes cbei 4983 and cbei 4982 in the StrataClone PCR 
Cloning Vector was determined by PCR was described in section 2.8, using a 
combination of a primer directed against the vector (see Appendix IV), and a primer 
directed against the insert. If the primer combination of M13 reverse primer and the 
reverse primer 433 gives a product, the insert is under the control of lac promoter. 
However, the primer combination of M13 reverse and the forward primer 432 should 
not give product if the insert is under control of the lac promoter (Figure 3.37(i)). On 
the other hand, the combination of the T7 promoter primer and the forward primer 432 
will give a product if the insert is under the control of lac promoter, but the combination 
of the T7 promoter primer and the reverse primer 433 should not give a product if the 
insert is under control of the lac promoter (Figure 3.37(ii)). The results of the analysis 
are shown in Figures 3.38-3.41. Of the 38 colonies which had the gene insert, only one 
colony (number 25) gave a  product with M13 reverse primer and 433 reverse primer 
(Figure 3.38), and also gave product with T7 promoter  primer  and 432 forward  prime 
(Figure 3.40). However, this isolate did not give product with M13 reverse primer and 
432 forward primer (Figure 3.39), nor with T7 promoter primer and 433 reverse primer 
(Figure 3.41). The other 37 colonies gave product with M13 reverse primer and 432 
forward primer (Figure 3.39), and most, but not all, of these also gave a product with T7 
promoter primer and 433 reverse primer (Figure 3.41). It was therefore concluded that 
one clone (number 25) contained the insert under the control of the lac promoter, and 
the others contained the insert under the control of the T7 promoter.  
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Figure 3.37: The annealing of primers 432,433 and M13 reverse (372), and the T7 promoter primer (373) 
with recombinant StrataClone PCR cloning vector. plac, promoter of the lac operon,  blue colour, 
vector sequence.  
 
                           
Figure 3.38: Screening of transformants for the orientation of genes cbei 4983 and cbei 4982 by PCR 
using the M13 reverse primer with 433 reverse primer. Only sample 25 gave product with the M13 
reverse primer and 433 reverse primer.  
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Figure 3.39: Screening of transformants for the orientation of genes cbei 4983 and cbei 4982 by PCR 
using the M13 reverse primer with 432 forward primer. Sample 25 did not give product with M13 reverse 
primer and 432 forward primer. The numbers on the gel are reference numbers for the samples (individual 
colonies) and the expected size of the insert to be 2263bp.   
 
                                                                                                                               
                                                                                                                                                                                                                                                    
Figure 3.40: Screening of transformants for the orientation of genes cbei 4983 and cbei 4982 by PCR 
using T7 promoter primer with 432 forward primer. All samples did not give product except sample 25 
give product with T7 promoter primer and 432 forward primer. And the expected size of the insert to be 
2263bp. 
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Figure 3.41: Screening of transformants for the orientation of genes cbei 4983 and cbei 4982 by PCR 
using T7 promoter primer with 433 reverse primer. Sample 25 did not give product with T7 promoter  
primer with 433 reverse primer. The numbers on the gel are reference numbers for the samples 
(individual colonies) and the expected size of the insert to be 2263bp. 
3.6.4. Preparation of Plasmids   
 Plasmids were prepared from recombinants carrying the cbei 4983 and cbei 4982 genes  
using the Fermentas GeneJET
TM
 Plasmid Miniprep Kit. The samples chosen were 
pME25, because it was in preferred orientation with the insert under the control of the 
lac promoter, and pME26 selected at random as a sample that had the insert in the 
opposite orientation. Successful plasmid isolation was confirmed by gel electrophoresis 
as shown in Figure 3.42.   
                                    
Figure 3.42: Isolation of plasmids pME25 and pME26 from E.coli TOP-10; lane M, Hyperladder I;         
lane 1, pME25; lane 2, pME26.  
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3.6.5. Transformation of chemically competent cells of E. coli  
The purified pME 25 and pME26 were transformed into mutant E. coli ZSC113 which 
is unable to phosphorylate glucose or mannose (see section 3.2.5), and the colonies 
were transferred onto MacConkey agar plates containing 100 µg/ml ampicillin and 1 % 
glucose or 1 % mannose. The results were that pME25 and pME26 did not have any 
effect on glucose fermentation as shown in Figure 3.43, and they also had no effect on 
mannose metabolism (not shown). The cells had a negative fermentation phenotype as 
shown by pale yellow colonies, which indicated that the plasmids did not provide the 
ability to ferment glucose and mannose. 
                          pME 25                                                      pME 26 
 
Figure 3.43: Fermentation of glucose on MacConkey agar by E. coli ZSC113 containing plasmid pME25 
or pME26 showing the inability to ferment glucose, all samples on the plates from clones pME25 and 
pME26. 
pME25 was transformed into other E. coli mutants including JW3381- 4 which is 
unable to metabolise maltose, JW3701-2 unable to ferment cellobiose and JW4199- 1 
unable to phosphorylate trehalose. The transformants were screened on MacConkey 
agar containing 30 µg/ml kanamycin and 100 µg/ml ampicillin and also 1 % maltose,      
1 % cellobiose or 0.1 % trehalose. The trehalose concentration was lower because it was 
found that strain JW4199-1 gave a positive fermentation phenotype when the 
concentration of trehalose was 1 %. After incubation at 37 °C for up to 48 h, the strains 
containing pME25 demonstrated a negative fermentation phenotype for maltose, and 
trehalose as shown in Figures 3.44 and 3.45, and also cellobiose (not shown). The nagE 
mutant JW0665-1 was able to ferment maltose, but not trehalose under the condition 
tested. The nagE mutant was used as a control because it is resistant to kanamycin.  
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Figure 3.44: Fermentation of maltose on MacConkey agar by mutant JW3381- 4 containing pME25 
showing the inability to ferment maltose. The nagE mutant JW0665-1 was able to ferment maltose under 
these conditions.  
                                      
 
Figure 3.45: Fermentation of trehalose on MacConkey agar by E. coli JW4199- 1 containing pME25 
showing the inability to ferment trehalose.    
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3.6.6. Large scale preparation of plasmid 
The pME25 and pME26 plasmids were purified in a higher yield, using the QIAGEN 
plasmid Midi kit, as described previously in section 2.12.1, and agarose gel 
electrophoresis was used to check the presence of the plasmids. The plasmids were then 
sent for sequencing to Beckman Coulter Genomics.    
 The sequence of the insert in pME26 was found to be correct, and it confirmed that it 
was in the orientation with the cbei 4983/cbei 4982 genes under control of the T7 
promoter. For pME25 the insert was in the opposite orientation. However, although the 
sequence of the genes was correct in the reverse direction, the upstream region in the 
vector was correct only until the Kpn I site as shown in Figure 3.46. The sequence then 
had no relationship to the vector sequence. In the forward direction from the M13 
reverse primer, the sequence had no relationship at all to the vector or the cloned genes. 
Both of the unknown sequences showed a relationship to a transposable element. 
Therefore it appeared possible that some sort of DNA transfer may have taken place 
perhaps from the genome of the host cell into the plasmid, and this would obviously 
affect expression of the cloned genes.   
                       
 
Figure 3.46: StrataClone PCR cloning vector pSC-A-amp/kan. 
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3.6.7. Screening and analysis of clones in the vector pJET 1.2/blunt  
The clones of genes cbei 4983/ cbei 4982 that were obtained by the previous methods, 
were predominantly in the wrong orientation so would not be expected to be expressed. 
The one clone that was apparently under the control of the lac promoter was found not 
to contain the correct DNA sequence. Therefore, an alternative strategy was to try to 
clone the genes in a different vector. The genes cbei 4983 and cbei 4982 were amplified 
by PCR using 432 forward primer and 433 reverse primer, and Pfu DNA polymerase 
(Fermentas). The blunt-ended PCR product was inserted into the pJET 1.2/blunt 
Cloning Vector (see Appendix IV). The transformation of E.coli TOP10 resulted in a 
number of colonies on LB agar plates in the presence of ampicillin. 50 colonies were 
picked off and transferred onto new LB agar plates containing ampicillin and incubated 
at 37 ºC overnight. To show the gene insert within the clones a screening was carried 
out. Figure 3.47, shows some of the results of the screening. 12 of the 50 colonies 
contained a gene insert of between 2000 bp- 2500 bp, but other colonies did not have 
the gene insert. The gene had been successfully cloned in some but not all of the 
colonies. 
                              
 
Figure 3.47: Screening of transformants for the presence of genes cbei 4983 and cbei 4982 by PCR using 
the forward primer 432 and the reverse  primer 433;  lane M, Hyperladder I as a marker; lane 1, DNA 
fragment as a control; lane 2,  sample  13;  lane 3, sample 14;  lane 4, sample 15;  lane 5, sample 16.  
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3.6.8. Determination of orientation of DNA inserts by PCR 
The next stage was to determine the insert orientation. A new PCR was carried out, 
using different combinations of primers against the insert and the vector. The primer 
combination of the T7 promoter primer and the reverse primer 433 should give a 
product that indicates the insert is under the control of the T7 promoter while the 
combination of the T7 promoter primer and the forward primer 432 should not gave 
product if the insert is under the control of T7 promoter primer (Figure 3.48(i)). 
The combination of the T7 promoter primer and the reverse  primer 433 should not give 
product if the  insert is under the control of the lac  promoter, however  the primer                                                                                                                                                                                         
combination of the T7 promoter primer and the forward primer 432 should give product 
if the  insert is under the control of the lac promoter  (Figure 3.48(ii)). 
 
              
         
Figure 3.48: The annealing of primers 432, 433 and the T7 promoter primer (373) with recombinant pJET 
1.2/blunt Cloning Vector, plac, promoter of the lac operon,  blue colour, vector sequence.  
 
The results of the analysis are shown in Figure 3.49.  4 of 12 colonies gave product with 
reverse primer 433 and T7 promoter primer, but they did not give product with forward 
primer 432 and T7 promoter primer. Therefore, the orientation of all cloned genes was 
under the control of the T7 promoter. 
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Figure 3.49: Determination of orientation of clones by PCR; lane M, Hyperladder I; lane1, sample 13 
with forward primer 432 and T7 promoter primer; lane 2, sample 14 with forward primer 432 and T7 
promote primer; lane 3, sample 15 with forward primer 432 and T7 promoter primer; lane 4, sample 16 
with forward primer 432 and T7 promoter primer; lane 5, sample 13 with reverse primer 433 and T7 
promoter primer; lane 6, sample 14 with reverse primer 433 and T7 promoter primer; lane 7, sample 15 
with reverse primer 433 and T7 promoter primer; lane 8, sample 16 with reverse primer 433 and T7 
promoter primer.  The numbers on the gel are reference numbers for the samples (individual colonies). 
At this stage, plasmids were tested for complementation of strain ZSC113 for 
fermentation of glucose and mannose, but they were not tested for the complementation 
of mutants unable to ferment maltose or trehalose. No complementation was observed 
as expected because there did not appear to be a promoter to drive expression of the 
genes. That meant it was decided to consider a different option and this was to transfer 
the genes into a different vector in which they would be expressed. But first, the 
sequence of the cloned genes was determined.    
3.6.9. Large scale preparation of plasmid 
Plasmid pME14 containing genes cbei 4983 and cbei 4982 was purified using the 
QIAGEN plasmid Midi kit as described in Materials and Methods in section 2.12.1. A 
sample of the plasmid was sent for sequencing to Beckman Coulter Genomics 
(Appendix I). The sequence was found to be correct, therefore, it was decided to try to 
move the cloned genes from the pJET 1.2/blunt Cloning Vector to the  pUC18 vector, in 
which they would be under the control of the lac promoter, before carrying out any 
further fermentation tests.    
  
  
92 
 
3.6.10. Recombination of the cbei 4983 and cbei 4982 genes  
 As shown in the previous section the genes cbei 4983 and cbei 4982 were successfully 
cloned in the pJET 1.2 blunt vector. Following verification of the sequence of the 
cloned genes, the vector containing the cbei 4983 and cbei 4982 genes was restriction 
digested as described in Materials and Methods in section 2.17. The vector pME14 
carrying the cbei 4983 and cbei 4982 genes was double–digested with XbaI and BglII. It 
was also digested with XbaI and BglII individually to show that both enzymes were 
functioning. As shown in Figure 3.50, digestion with XbaI  produced a linear fragment, 
whereas digestion with BglII gave two fragments, one of them representing the plasmid 
(2900 bp) and the other one representing the insert (2300 bp). Finally double–digestion 
with XbaI and BglII gave fragments of the same size as shown in Figure 3.50. These 
results are consistent with the restriction map of pJET 1.2 blunt vector (Appendix IV). 
The DNA fragment carrying cbei 4983 and cbei 4982 was then purified (Figure 3.51), 
as described in 2.17.2.    
 
                          
 
Figure 3.50: Restriction digestion of pME14. pME14 was digested using XbaI and BglII; lane M, 
Hyperladder I; lane 1, undigested pME14 containing cbei 4983 and cbei 4982; lane 2, pME14 digested 
with XbaI; lane 3, pME14 digested with BglII; lane 4, pME14 digested with both enzymes XbaI and 
BglII.   
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Figure 3.51: Purification of XbaI and BglII fragment containing gene cbei 4983 and cbei 4982.  
  
The vector pUC18 was digested, by enzymes XbaI and BamHI as shown in Figure 3.52. 
The double-digested plasmid (approximately 2700 bp) was purified as shown in Figure  
3.53, and the purified plasmid was ligated to the purified fragment carrying cbei 4983 
and cbei 4982. The XbaI ends of pUC18 and the DNA fragment will ligate together and 
the BamHI terminus of pUC18 will ligate with the BglII terminus of the DNA fragment 
because they have the same sticky end. Therefore, the fragment can only be inserted 
into pUC18 in one specific orientation (see Figure 3.54). 
                                      
Figure 3.52: Restriction digestion of pUC18; lane M, Hyperladder I, lane 1, undigested   plasmid; lane 2, 
after restriction by XbaI; lane 3, after restriction by BamHI; lane 4, after restriction by XbaI and BamHI. 
                            
    Figure 3.53: Purification of pUC18 digested with XbaI and BamHI. 
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Figure 3.54: Restriction digestion strategy for cloning of cbei 4983 and cbei 4982 in pUC18. 
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Following ligation as described in Materials and Methods section 2.17.2, the mixture 
was transformed into E.coli TOP10 as described in Materials and Methods, and plated 
on LB supplemented with 100 µg /ml ampicillin and 40 µg /ml X-gal for blue-white 
screening (without ITPG). The plate had white and blue colonies, the white were 
transferred and grown on new plates with the same amount of antibiotic. The isolates 
were tested by PCR to check whether they contained the DNA insert. No positive 
results were obtained. The ligation and transformation were repeated several times but 
the results were still negative. It is not clear why this procedure was unsuccessful.   
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3.7. Cloning of the genes cbei 4984, cbei 4983 and cbei 4982   
3.7.1. PCR reaction for genes cbei 4984 /cbei 4983/cbei 4982  
The previous experiments were designed to provide any evidence for the function of the 
PTS encoded by the genes cbei 4983 and cbei 4982. One obvious limitation of the 
approach is that the genes only code for the PTS, so that since the PTS will produce a 
phosphorylated substrate the transformed E.coli cells will have to have the enzyme 
necessary for metabolism of that sugar phosphate. Because the gene immediately 
adjacent to these genes seems to code for a hydrolase enzyme, it was decided effectively 
to begin again and to try to clone all three genes instead of only the PTS genes. Genes 
cbei 4984, cbei 4983 and cbei 4982 were amplified together in a PCR reaction. The 
primer combination used was 434 forward primer and 433 reverse primer, and the size 
of product obtained was around 4000 bp (expected size to be 3738 bp) as shown in 
Figure 3.55 (a), For comparison, the amplified product containing only genes cbei 4983 
and cbei 4982 was between 2000 bp and 2500 bp in agreement with a product expected 
to be 2263 bp as shown in Figure 3.55 (a). The arrangement of genes is shown in Figure 
3.55 (b). 
                               
Figure 3.55 (a): PCR amplification of genes cbei 4984, cbei 4983 and cbei 4982; lane M, Hyperladder I;    
lane 1, amplified product from PCR reaction using the forward primer 434 and the reverse primer 433; 
lane 2, amplified product from PCR reaction using the forward primer 432 and the reverse primer 433; 
lane 3, amplified product from PCR reaction using the forward primer 434 and the reverse primer 433; 
lane 4, amplified product  from PCR reaction using the forward primer 432 and the reverse primer 433.   
               
     Figure 3.55(b): Arrangement of genes encoding phosphotransferase system in C. beijerinckii.   
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3.7.2. Transformation, screening and analysis of clones 
Unlike when cloning the two genes cbei 4983 and cbei 4982, when three genes cbei 
4984, cbei 4983 and cbei 4982 are cloned they will have an upstream promoter 
concerned with expression of the genes. Therefore, in principle it is not necessary to 
isolate clones in which the insert is under control of the lac promoter. The next step was 
to insert the PCR- amplified product into the StrataClone Vector, transform into 
StrataClone SoloPack competent cells, and spread onto LB plates containing 100 µg/ml 
ampicillin, as described in section 2.10.2. 44 colonies were picked off and after plating 
on LB containing ampicillin were incubated overnight at 37 °C. To show the gene insert 
within the vector, a screening was done (Figure 3.56). 35 of the 44 colonies contained 
the gene insert, as shown by a product of around 4000 bp. The genes had apparently 
been successfully cloned in these samples. 
                  
 
                      
Figure 3.56: Screening of transformants for the presence of genes cbei 4984, cbei 4983 and cbei 4982 by 
PCR using the forward primer 434 with the reverse primer 433.  The numbers on the gel are reference 
numbers for the samples (individual colonies) and the expected size of the insert to be 3738 bp. 
 
  
98 
 
3.7.3. Determination of orientation of DNA inserts by PCR  
The strategy for determination of the orientation of the cloned DNA inserts was similar 
to that used earlier for genes cbei 4983 and cbei 4982 in the StrataClone Vector. In the 
StrataClone Vector, the genes are placed under the control of the lac or T7 promoter. 
Therefore, PCR was used to determine the insert orientation by using different 
combinations of primers directed against the vector and the insert. The primer 
combination of the reverse primer 433 with M13 forward primer 371, should give 
product if the insert is under the control of the T7 promoter. The primer combination of 
the forward primer 434 with M13 forward primer 371 should not a give product if the 
insert is under control of the T7 promoter primer. On the other hand, the primer 
combination of the reverse primer 433 with M13 reverse primer 372 should give a 
product if the insert is under the control of the lac promoter. However, the primer 
combination of forward primer 434 with M13 reverse primer 372 should not give a 
product if the insert is under control of the lac promoter. 
 35 colonies containing the gene insert were screened. Seven of the thirty five colonies 
gave a product with M13 forward primer 371 and reverse primer 433, but did not give 
product with M13 forward primer 371 and forward primer 434 as shown in Figure 3.57.  
22 colonies gave a product with M13 forward primer 371 and forward primer 434, but 
did not give product with M13 forward primer 371 and reverse primer 433 as shown in 
Figure 3.58.  Four of these  22 colonies were used  to confirm that the  genes were 
inserted under control of the  lac promoter, and  gave a product with M13 reverse 
primer 372  and reverse primer 433 (Figure 3.59), but did not give product with M13 
reverse primer 372 and forward primer 434 (not shown). Six of the thirty five colonies 
did not give product at all in any of the PCR amplifications.  
            
Figure 3.57: Screening of transformants for the orientation of genes cbei 4984/ cbei 4983/ cbei 4982 by 
PCR using M13 forward primer 371 with 433 reverse primer. The numbers on the gel are reference 
numbers for the samples (individual colonies) and the expected size of the insert to be 3738 bp.  
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Figure 3.58: Screening of transformants for the orientation of genes cbei 4984/ cbei 4983/ cbei 4982 by 
PCR using M13 forward primer 371 with 434 forward primer. The numbers on the gel are reference 
numbers for the samples (individual colonies) and the expected size of of the insert to be 3738 bp.                                                                                                                                                                                                                                                                                                                                      
                                
Figure 3.59: Screening of transformants for the orientation of genes cbei 4984/ cbei 4983 / cbei 4982 by    
PCR using M13 reverse primer 372 with 433 reverse primer. The numbers on the gel are reference 
numbers for the samples (individual colonies). 
3.7.4. Preparation of plasmid and DNA sequencing 
As a result of the analysis (Figure 3.59), three transformants (pME1, pME3, pME11) 
were selected for plasmid preparation and sequencing. The pME1 sample did not 
provide any sequence data, and pME3 showed two errors within in the sequence. 
Therefore, only pME11 which had the correct sequence, was used in the following 
fermentation tests.                                                                                                                                               
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3.7.5. Transformation and phenotype screening  
The plasmid pME11 was transferred into different E.coli mutants including JW3381- 4, 
JW3701-2, and JW4199-1, which are unable to metabolise maltose, cellobiose, and 
trehalose as demonstrated in section 3.6.5. The transformants were screened on 
MacConkey agar containing 30 µg/ml kanamycin and 100 µg/ml ampicillin and 
supplemented with 0.1 % trehalose, 1 % maltose, or 1 % cellobiose, and incubated at 
37°C for up to 48h.The strains containing pME11 demonstrated a negative fermentation 
phenotype for cellobiose and maltose as shown in Figures 3.60 and 3.61 and also 
trehalose (not shown), indicating that pME11 apparently does not encode for uptake and 
metabolism of trehalose, maltose or cellobiose. As in the previous set of experiments, 
the nagE mutant JW0665-1 was shown to be able to ferment maltose as a control 
(Figure 3.61), but not cellobiose.  
pME11 was also transformed into a mutant E.coli JC10279 deficient in maltose 
transport (see section 2.1), and then the colonies were transferred onto MacConkey agar 
supplemented with 1 % maltose to examine the phenotype. Transformants grew as small 
colonies that gave a positive fermentation phenotype (not shown), but on further 
restreaking the cells showed a negative result, indicating that these samples were again  
unable to ferment maltose.  
                                 
Figure 3.60: Fermentation of cellobiose on MacConkey agar by E. coli JW3701-2 containing pME11. The 
recombinant strain is unable to ferment cellobiose.  
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Figure 3.61: Fermentation of maltose on Macconkey agar by mutant JW3381- 4 containing pME11. The 
recombinant strain is unable to ferment maltose. E.coli strain JW0665-1(nagE), however was able to 
ferment maltose. 
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3.8. Gene Knockout using the ClosTron  
As was done for gene cbei 0751 an attempt was made to create a knockout mutant of the 
cbei 4983 gene to examined the effect on growth of C. beijerinckii could be determined, 
as described in section 3.5, site for insertion was selected based on the analysis of  
ClosTron website http://www.clostron.com. The required plasmid was ordered from 
DNA 2.0, the plasmid was treated as described previously and transformed into E.coli 
strain and then conjugated into C. beijerinckii. In the wild type the combination of 
forward primer 437 and reverse primer 438 should give product of 368 bp. However, 
for a mutant the primer combination of EBS primer and 437 forward primer should give 
a PCR product of 490 bp, but the combination of EBS primer and the 438 reverse 
primer should not give a product. After putative clones were isolated and purified 
several times on CBM plates supplemented with 10 µg/ml erythromycin, DNA was 
extracted and the various PCR amplifications were carried out. The results were as was 
found in the previous case with the cbei 0751 gene. The only products which were 
obtained were from the combination of the forward primer 437 and reverse primer 438. 
It was therefore clear that nothing was inserted in between as shown in Figure 3.62. 
             
Figure 3.62: Mutant screening by PCR used to screen for intron insertion in gene cbei 4983; lane M, 
Hyperladder as a marker; lane 1, sample 1 with forward primer 437 and reverse primer 438; lane 2,  
sample 1 with forward  primer 437 and EBS primer; lane 3, sample 1 with reverse  primer  438 and EBS 
primer; lane 4, sample 5 with forward primer 437 and reverse primer 438; lane 5, sample 5 with forward 
primer 437 and EBS primer, lane 6, sample 5 with reverse primer 438 and EBS primer; lane 7, sample 7 
with forward primer 437 and reverse primer 438; lane 8, sample 7 with forward primer 437 and EBS 
primer; lane 9, sample 7 with reverse primer 438 and EBS primer; lane 10, wild type with forward primer 
356 and reverse primer 357 those are the cloning primers as a control, and the expected size to be 2364 
bp, the numbers on the gel are reference numbers for the samples (individual colonies).  
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4. Discussion  
Biofuels are attracting interest as a kind of fuel at present due to the economic 
advantages and environmental concerns. Also they are renewable energy sources (Paul, 
2009). Butanol is a potentially important biofuel of the future. It has been produced by 
fermentation in the past, but by the early 1960's the solvent fermentation began to 
decline in USA and UK, because the ABE fermentation processes could not compete 
economically compared to the petrochemical industry (Jones and Woods, 1986, Gibbs, 
1983). Price increases of substrates such as molasses, wheat and maize after the second 
World War, low production of solvent in the fermentation, and solvent toxicity for 
clostridia especially from butanol, were factors that played a major role in the decline of 
the ABE fermentation (Hastings, 1971). In South Africa and the former USSR, ABE 
fermentation plants operated until 1982, and in China the production of butanol by 
fermentation was 350,000 tons/year until 2004 (Durre, 2008). Reintroduction of the 
ABE fermentation will depend on a number of factors including use of cheap, 
renewable material, and improved butanol tolerance, production and recovery from the 
solvent fermentations. 
The market price of fermentable organic material is one of the major considerations in 
the economics of fermentative biofuel (Gapes, 2000). Lignocellulose is available from 
many sources such as forestry and agriculture including fruit, grains, oil seeds, and 
vegetables (Howard et al., 2004). Other waste material products consist of many 
carbohydrates that can be used as a carbon source to produce huge quantities of 
chemicals acetone and butanol by fermentation (Durre 2008, Durre 2007). Resources 
are dependent on the area of the world (Kim and Dale, 2005), which will dictate the 
availability of substrates for use in biofuels production. After hydrolysis, sugars 
including mono- and disaccharides are released form lignocellulose biomass or other 
waste material, and it is these molecules which are fermented by bacteria.    
In fact, it has been demonstrated that C. beijerinckii has the ability to use a range of 
carbon sources such as glucose, mannose, maltose, sucrose, which could be present in 
the majority of waste materials (Tangney and Mitchell, 2005), to produce the solvents 
acetone, butanol and ethanol  (Ezeji and Blaschek, 2007). 
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The first step of sugar metabolism is the transport of the sugar across the cytoplasmic 
membrane (Mitchell, 1996). Sugar transport systems in bacteria operate by a variety of 
mechanisms. However, the dominant system in obligate anaerobes is the     
phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS), which is 
characterized by transport and metabolism of its substrate as it enters the cell (Mitchell, 
1998). The advantage of substrate transport by the phosphotransferase system is that 
phosphorylation of the sugar during entry into the cells alters the substrate 
configuration, so that the sugar is unable to leave the cells and also both transport and 
metabolism are accomplished by a single metabolic step (Tangney et al., 2001).  
Most of the clostridial species including C. beijerinckii and C. acetobutylicum depend 
greatly on the PTS for uptake and metabolism of different carbon sources such as 
glucose, which is the preferred carbon source. Bacteria prefer to utilise one carbon 
source over another, a phenomenon called carbon catabolite repression (CCR), the 
mechanism of which is discussed in section 1.7. The PTS phosphocarrier protein HPr is 
considered to be a key element of catabolite repression in low G-C Gram- positive 
bacteria (Tangney et al., 2003). In the solventogenic clostridia preferential metabolism 
of glucose over several alternative carbon sources has been observed (Mitchell, 1996, 
Mitchell et al., 1995). Full redevelopment of the ABE fermentation will require a more 
complete characterization of the PTS and its metabolic function in clostridia.        
In the genome sequence, 43 complete PTS have been identified by sequence homology 
in Clostridium beijerinckii NCIMB 8052. Of these, three PTSs have been characterised. 
One has been shown to be a sucrose system (Reid et al., 1999), a second one has been 
shown to be a glucitol system (Tangney et al., 1998) and the third one has been shown 
to be a N- acetylglucosamine system which also transports glucose (Al Makishah and 
Mitchell, 2013).  
 Bacteria which are developed for making biofuel by fermentation will ideally be able to 
take up sugars as fast as possible and in an unregulated way. Because glucose is 
generally a preferred sugar which represses metabolism of other substrates, it is 
necessary to understand how the cells respond to glucose (Alpert et al., 1985).  
Therefore, identifying which systems are involved in glucose uptake is important 
because they are the systems which are likely to be involved in sensing glucose in the 
environment and causing catabolite repression. 
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4.1. The PTS system encoded by gene cbei 0751  
In the first part of this project, the gene cbei 0751 was amplified from genomic DNA of 
C. beijerinckii NCIMB 8052. The gene cbei 0751 encodes a PTS with three domains 
IIA, IIB and IIC together, therefore it is encodes a complete PTS which should be 
functional in E. coli. The PCR product was ligated into the pCR
®
 2.1-TOPO
®
 vector 
and transformed into E. coli. Two (ME15 and ME20) of forty colonies were found to 
have the insert. The colonies were screened by PCR to determined the orientation of the 
insert and plasmids pME15 and pME20 were found to contain cbei 0751 under the 
control of T7 promoter and lac promoter respectively. These plasmids were isolated and 
transformed into E. coli ZSC113 to investigate the fermentation phenotype on 
MacConkey agar containing either glucose or mannose. The transformants 
demonstrated a positive fermentation phenotype for both sugars. Although the gene cbei 
0751 in pME15 was in an orientation under control of the T7 promoter, it appeared that 
it was also expressed. The T7 promoter in E. coli is supposed to be silent, because it is 
recognised by T7 RNA polymerase but not by E. coli RNA polymerase. E. coli ZSC113 
does not contain the T7 RNA polymerase. It could be that there is a low level of 
transcription activity from the T7 promoter but a more likely explanation for expression 
of the gene is that it was cloned with about 210 bp of upstream DNA, which may 
contain a promoter or a DNA sequence that is recognised as a promoter in E. coli. This 
is not unique, because in many cases in the laboratory cloned genes have been 
predominantly isolated in the orientation that appears to be unfavourable for expression. 
DNA base composition of clostridia is around 70 % A-T, and  E. coli promoters are 
highly A-T rich, so any segment of clostridial DNA just might act like a promoter as       
far as the E. coli RNA polymerase is concerned. A low level of expression from a             
non-natural promoter might be compatible with growth and survival, allowing clones 
with unfavourable orientation to be readily isolated.  
After the initial demonstration of complementation of glucose and mannose 
fermentation, additional experiments were carried out which demonstrated that the 
fermentation phenotype was in fact due to activity donated to E. coli ZSC113 by the 
cbei 0751 gene. Firstly, glucose and mannose were shown to be utilised in broth culture 
by pME15 and pME20 but not by E. coli ZSC113. Therefore, the recombinants but not 
the mutant were able to take up the sugars from the growth medium. Secondly, uptake 
of radiolabelled glucose was demonstrated by the recombinants but not the E. coli 
ZSC113 mutant. Thirdly, extracts made from the recombinants, but not E. coli ZSC113, 
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showed PEP- dependent phosphorylation of glucose that indicated the presence of a 
PTS. Glucose phosphorylation was strongly inhibited by mannose, suggesting that both 
sugars are phosphorylated by the same PTS. Therefore, it can be concluded that the PTS 
encoded by cbei 0751 can transport and phosphorylate both sugars glucose and 
mannose. An attempt was made to demonstrate competitive inhibition of glucose 
phosphorylation by mannose, by altering the concentrations of glucose and mannose in 
a series of experiments. Although different reaction rates were observed as expected the 
data did not allow for a definitive conclusion.  
Inhibition of glucose phosphorylation by a number of other analogues was studied as 
shown in Figure 3.25. The activity was inhibited by 2-deoxyglucose and methyl           
α–glucoside (α MG), but not well by 3-O-methyl glucose. When these results were 
compared with experiments carried out previously using crude extract of C. beijerinckii 
(Mitchell et al., 1991), the pattern was similar with the exception of the effect of methyl 
α–glucoside. The difference between the experiments in this study and the earlier 
experiments is that in extracts of C. beijerinckii there could have been two, or more 
PTSs contributing to glucose phosphorylation activity (Mitchell et al., 1991), with the 
result that the total activity was not inhibited strongly by α MG. The N- 
acetylglucosamine system also transports glucose (Al Makishah and Mitchell, 2013), 
and some members of the mannose family might also transport glucose because it is 
well known that systems in the mannose family often have the ability to transport 
glucose as a substrate. The mannose system of E. coli has been shown to transport 
glucose (Tchieu et al., 2001), and the glucose system of E. coli is able to transport 
mannose (Saffen et al., 1987, Erni and Zanolari, 1986). Staphylococcus carnosus 
contains two related glucose phosphotransferase systems which are inhibited by 
different analogues (Knezevic et al., 2000). Therefore, phosphotransferases show 
different specificity with different combinations of sugars being recognised as 
substrates.     
 In the recombinant strains, the components of the PTS from different organisms must 
interact with one and other to make up the complete system. That is E. coli proteins 
must interact with clostridial proteins.  The point of the connection is not entirely clear 
because the mutation in E.coli ZSC113 is not well defined by modern standards.  
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This interaction is likely to be at the level of HPr transferring phosphate to IIA. 
However, it could also be at the level of interaction between proteins within the enzyme 
II complex. Interaction between the components of the C. beijerinckii PTS and the PTS 
in C. pasteurianum, B.subtilis and E.coli has been demonstrated previously (Mitchell et 
al., 1991). Also more recently the complementation of an E.coli N- acetylglucosamine 
PTS mutant by genes from C. beijerinckii also showed that interaction could occur 
between proteins from the two species (Al Makishah and Mitchell, 2013).   
As part of this project experiments were carried out to examine the expression of the 
cbei 0751 gene in cultures grown on different carbon sources. The carbon sources tested 
were glucose, sucrose, galactose, N-acetyglucosamine, mannose and maltose. As shown 
in slot blot hybridization (Figure 3.26), expression of the gene appears to occur under 
all growth conditions tested. The limitation of the hybridization approach is that it is not 
fully quantitative but the results did indicate the gene was expressed constitutively to 
some extent. The initial experiments were followed up by using RT-PCR after removing 
DNA contamination from the RNA samples, and again the expression was seen under 
all conditions as shown in Figure 3.32, but this experiment did not include a control 
gene for RT-PCR. Wang et al., (2011), showed that the cbei 0751 gene is not the most 
highly expressed gene encoding a PTS of the glucose family in a typical C. beijerinckii 
fermentation growing on glucose; the most highly expressed gene was in fact cbei 4532 
which encodes the N- acetyglucosamine PTS (Al Makishah and Mitchell, 2013). They 
found that the cbei 0751 gene was expressed at a lower level, which did not change 
much over the course of the fermentation. Therefore, a more detailed study of the 
expression of cbei 0751 under different condition would add to understanding of the 
importance of the gene.  
Regulation of expression of cbei 0751 is assumed to be a function of the antiterminator 
coded for by cbei 0752. Inspection of the sequence of the putative antiterminator protein 
shows that it contains the conserved histidines which may be phosphorylated to control 
its activity. Therefore, it would be expected that gene cbei 0751 may be induced by the 
substrate of the PTS it codes for as a result of effects on the phosphorylation of the 
antiterminator protein. The association of the glucose PTS gene with an antiterminator 
is similar to the gentic organization in C. acetobutylicum (Tangney and Mitchell, 2007), 
and B.subtilis (Stülke et al., 1997). In C. acetobutylicum (Tangney and Mitchell, 2007), 
a difference is that the gene encoding the antiterminator is situated upstream of the PTS 
gene whereas in C.beijerinckii it is downstream of the PTS gene.  
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Servinsky et al., (2010) carried out a transcription analysis using C. acetobutylicum 
grown on eleven different carbohydrates. Expression of the glucose PTS was regulated 
at transcriptional level, with a strong signal during growth on maltose, starch and 
glucose but lower expression for other substrate. In B.subtilis, antiterminator is 
association with ptsG, ptsH and ptsI which encode for HPr and EI (Stülke et al., 1997). 
The expression of these genes has been shown to be under the control of the 
antiterminator. In contrast, to the clostridia and B.subtilis, in E.coli there is no 
antiterminator involved in regulation of expression of the glucose PTS. The glucose 
PTS is constitutively expressed although there is a difference in expression of the ptsG 
gene in E. coli dependent on the growth conditions (Postma et al., 1993). The precise 
role of the antiterminator coded by cbei 0752 remains to be established by further 
experiments. 
In most clostridia, glucose is the preferred carbon source and its presence inhibits 
transport and phosphorylation of many other carbohydrates. This is an important aspect 
of cell physiology because it has implications for metabolism of sugars in a 
fermentation. One way to identify the importance of a gene is to inactivate it and then 
look at the effect on cell behaviour. As already discussed, there are several potential 
systems for glucose uptake in C. beijerinckii, so that knock out of one particular system 
might not have much effect on glucose utilization and sensing, because other systems 
can take over. However, it has been shown by Xiao et al., (2011), that inactivation of 
glcG (the C. acetobutylicum gene that is equivalent to cbei 0751) did reduce catabolite 
repression but at the same time it had no effect on the rate of glucose metabolism. 
Therefore that study demonstrated that is was possible to see an effect on catabolite 
repression by inactivation of one particular gene.    
In this study, attempts were made to knock out cbei 0751 using the ClosTron 
technology, developed at the University of Nottingham (Heap et al., 2010, Heap et al., 
2007). Although putative mutants were isolated on plates containing erythromycin 
further characterisation showed that the glcG gene had not been disrupted. Several 
attempts were made to obtain a glcG mutant, but without any success.  One explanation 
is that the intron has inserted into a different site in the chromosome, which could have 
been proved by Southern blotting. In this laboratory attempts to use the ClosTron to 
mutate the nagE gene were also unsuccessful. Also at the University of Cape Town 
several attempts have been made to isolate mutants of genes involved in nitrogen 
metabolism, but no mutants were obtained (S. Reid, personal communication). The 
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ClosTron may not be as efficient in C. beijerinckii compared with C. acetobutylicum 
and C. difficile. 
 4.2. The PTS system encoded by genes cbei 4983 and cbei 4982  
The second part of the project concerned the phosphotransferase system encoded by the 
cbei 4983 and cbei 4982 genes. Unlike the PTS encoded by cbei 0751, which is a single 
protein containing the  IIA, IIB and IIC domains together, two genes are required  
because cbei 4983 encodes a protein with the IIB and IIC domains and cbei 4982 
encodes a separate protein with the IIA domain. Therefore, both the proteins are needed 
to constitute an intact PTS. The first attempt at cloning used StrataClone Vector with 
the PCR product generated using 432 forward primer and 433 reverse primer. When the 
cloning was done it was expected that 50 % of clones would be in the favourable 
orientation that is under control of the lac promoter in the vector. But all except one of 
the clones were found to have the genes inserted under the control of the T7 promoter. 
The one exception was pME25 containing cbei 4983/ cbei 4982, under the control of the 
lac promoter. This plasmid was isolated and used to transform E. coli ZSC113 which is 
unable to metabolise glucose and mannose, but the negative phenotype was not 
complemented. The plasmid was also transformed into the mutants JW3381-4 which is 
unable to metabolise maltose, JW3701-2 which is unable to ferment cellobiose and 
JW4199-1 which is unable to phosphorylate trehalose. The transformants were streaked 
onto LB plates and transferred onto MacConkey agar. The transformants demonstrated  
a negative phenotype on the MacConkey agar containing maltose, cellobiose and 
trehalose respectively, which indicated that the cloned genes did not complement the 
mutation. Leter testing of the plasmid found that the gene sequence was in fact correct, 
the plasmid contained an unexpected DNA sequence upstream of the cloned genes. 
Therefore, this provides a possible explanation for why no activity was observed in the 
transformants.        
Unlike cbei 0751, these genes cbei 4983 and cbei 4982 will require a vector promoter 
for expression, because the genes are downstream of cbei 4984 which codes for a 
putative hydrolase enzyme and that gene appears to be part of an operon with cbei 4983 
and cbei 4982. Therefore, since no clones were obtained in the required orientation a 
different approach was adopted.   
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The cbei 4983 and cbei 4982 genes were then cloned in a different vector pJET1.2 
blunt. As for the previous cloning, all clones isolated were found again to contain the 
insert in the unfavourable orientation, under the control of the T7 promoter. One 
plasmid pME14 was selected and sequenced and shown to carry the correct genes.  
This plasmid was transformed into E. coli ZSC113 but had no effect on glucose or 
mannose fermentation. However, the genes may simply not be expressed due to lack of 
an active promoter in the plasmid. It was therefore, decided to transfer the genes to the 
vector pUC18, in a way that would place them under control of the lac promoter by 
unidirectional cloning. Although white colonies were isolated on LB plates 
supplemented with X-gal, suggesting that they contained recombinant plasmid, PCR 
screening did not show the presence of the expected insert. The reasons why this 
approach did not succeed are not known.  
The phylogenetic tree including the IIC domain of cbei 4983 strongly suggested that the 
system may be a maltose PTS. A problem in proving this function may be that E. coli 
does not generally metabolise maltose by a PTS. Instead maltose metabolism in E. coli 
consists of uptake by an ATP dependent transport system, and then metabolism by two 
principal enzymes amylomaltase (MalQ) and maltodextrin phosphorylase (MalP) 
(Schwartz, 1987, Freundieb and Boos, 1986, Reyes et al., 1986), As a result, E. coli 
does not have an enzyme able to hydrolyse maltose 6- phosphate. This is important 
because this is the product of the phosphotransferase system and cells would have to 
metabolise it to give a positive fermentation phenotype on MacConkey agar. Therefore, 
if the genes cbei 4983/ cbei 4982 are expressed in E. coli so that cells can take up and 
phosphorylate maltose it may be that the cells will not be able to metabolise the maltose 
6-phosphate which is generated. E. coli does in fact have a maltose PTS called MalX, 
but this is a minor system that is only synthesised under certain conditions and under 
normal conditions does not play a role in maltose metabolism. MalX has been suggested 
to transport maltose without modifying the substrate, so that a maltose 6-phosphate 
hydrolase is not required to metabolise the sugar (Reidl and Boos, 1991).   
One mutant used in this study is mutated in malT, which is the gene that encodes the 
activator of the maltose regulon and so the cells should not have any activity associated 
with uptake and metabolism of maltose. The other mutant E. coli JC10279 has a 
mutation called malA which affect the region containing the malQ and malP genes.  
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As for maltose, complementation of metabolism of cellobiose and trehalose may be a 
problem in E. coli. The mutant used to screen for cellobiose fermentation was mutated 
in bglG which codes for an antiterminator. The mutation therefore affected expression 
of the β-glucoside specific PTS. The cellobiose PTS in E.coli is cryptic, and is induced 
by chitobiose (Soto-Gil and Zyskind, 1989), so E.coli cannot grow on cellobiose under 
normal circumstances. Similar to maltose, E.coli would require an enzyme able to 
hydrolyse the product of a cellobiose (or β-glucoside) PTS. Earlier study of a β-
glucoside PTS from C. longisporum (Brown and Thomson, 1998), used a strain LP100 
which had a constitutive bglA gene encoding phospho-β-glucosidase. This strain was 
not available for the present study.   
The metabolism of trehalose in E.coli involves accumulation by a PTS followed by 
hydrolysis of trehalose 6-phosphate. The mutant JW4199-1 lacks trehalose PTS activity, 
and could be potentially complemented by a cloned PTS. However, E.coli also has a 
protein call trehalase which is present in the periplasm and which can hydrolyse 
trehalose to glucose. This enzyme is probably the reason why the mutant fermented   
trehalose when it was added to the medium at a concentration of 1 %. This fermentation 
did not occur when the trehalose concentration was decreased to 0.1 % presumably 
because this is below the concentration required for trehalase activity. At this 
concentration, the affinity of a cloned trehalose PTS must be fairly high to take up the 
substrate even when it is present at low concentration. Most phosphotransferases do 
have a high affinity for their substrates, but the properties of the PTS encoded by cbei 
4983 /cbei 4982 are unknown. 
The final strategy of the project attempted to clone the PTS-encoding genes together 
with the gene encoding the putative hydrolase enzyme, that is the three genes cbei 
4984/cbei 4983/cbei 4982. A clone was successfully isolated and verified by 
sequencing, with the genes under the control of the lac promoter. However, when tested 
for complementation of E. coli mutants no positive fermentation was observed for 
maltose, cellobiose or trehalose. However, it was not actually demonstrated in the 
experiments that the genes were expressed.  
In summary, none of the approaches used allowed for identification of the function of 
the PTS encoded by cbei 4983 /cbei 4982. Therefore in future a different strategy 
should be taken. B.subtilis has a maltose PTS and an associated glucoside 6-phosphatase 
providing the mechanism for metabolising maltose 6-phosphate (Schönert et al., 2006). 
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This suggests that a future study may be better to concentrate on cloning in B. subtilis 
because there is better chance that the bacterium will be able to metabolise a product of 
the phosphotransferase system successfully. Also B.subtilis accumulates cellobiose and 
trehalose by phosphotransferase systems (Tobisch et al., 1997, Schock and Dahl, 1996), 
so that these sugars will also be metabolised following accumulation by a PTS.  
A totally different approach would be to try to identify the function of the hydrolase 
enzyme encoded by cbei 4984 since this would potentially identify the product of the 
PTS encoded by cbei 4983/ cbei 4982. Therefore, the hydrolase gene could be cloned 
and expressed in E.coli. In the later part of the project an attempt was made to clone the 
hydrolase gene but this attempt was unsuccessful in the time available. C. 
acetobutylicum has got two genes encoding proteins which show a high relationship 
(identity of about 50 %) to the product of cbei 4984 (Thompson et al., 2004). One of 
them MalH has been shown to hydrolyse maltose 6-phosphate and also a range of other 
glucoside phosphates. The other one PagL only showed the ability to hydrolyse             
p-nitrophenyl-α-D-glucopyranoside 6-phosphate (pNPαGlc6- phosphate), and it did not 
hydrolyse other glucoside phosphates. The PTSs associated with the malH gene and 
with the pagL gene show about 35 % indentity to the PTS coded by cbei 4983, and so it 
is possible that cbei 4983 has a similar substrate. However, it should be noted that the 
phylogenetic tree in Figure 1.5 shows a better candidate for a maltose PTS in C. 
beijerinckii which is the one with a IIC domain encoded by cbei 4705. This PTS is 
closely related to maltose PTSs of other bacteria, including B.subtilis and C. 
acetobutylicum.  
Another totally different approach to looking at function of a gene is to knock it out and 
examine the effects. As for cbei 0751, in this study attempts were made to inactivate the 
cbei 4983 gene using the ClosTron, but these were also unsuccessful. As discussed for 
cbei 0751, the limitation of this approach is that there are 43 different PTSs in C. 
beijerinckii and if one is knocked out another one may still be able to take up the 
substrate.  
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 4.3. Final conclusion 
Understanding of sugar uptake in clostridia is a very important part of optimising 
fermentation.  Very few transport systems in clostridia have been fully characterised. In 
C. beijerinckii three systems have previously been characterised encoded by cbei 
4532/cbei 4533, cbei 0336/cbei 0337 and cbei 5012.  In this study it was shown the cbei 
0751 encodes a glucose/mannose phosphotransferase system, therefore it has been 
demonstrated that there are at least two glucose phosphotransferase systems in C. 
beijerinckii, encoded by cbei 0751 and cbei 4532/ cbei 4533. Both of these systems 
could potentially contribute to catabolite repression. Ability to knock out these genes 
and examination of the behaviour of mutant strains, may be useful in understanding 
their contribution. Even if these systems are more fully characterised there are many 
other systems which still have to be characterised, and therefore a great deal of work has 
to be done in order to fully understand the area of sugar uptake. In part of this study, 
experiments were done to look it the function of the cbei 4983/ cbei 4982 system. 
However at the present time is not possible to identify what the substrate of this system 
is. 
A full characterisation of sugar uptake in C. beijerinckii will be extremely useful in 
designing strains which will be capable of metabolising different substrates. This will 
improve the economics of the ABE fermentation based on use of different substrates.   
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5. Appendices   
  
   Appendix I. Gene sequences  
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Clostridium beijerinckii NCIMB 8052 (cbei 0751)  
 
TGCCCGCGATAATATTTTATGAAAACATTGACATGCAGTTATAGATATGCTAGAGTGAAAAATATGATAT 
AGTATGTGACTGGTAGGTAGGCATTAACTATACATAAATATTTATTGAAGATGTTTATGTTGGTTAATGT 
TTTTTTGCACAAAAAAGGCATAATAAAGCATTAATAATGTGCAAAAATAATCCTATGAAGGAGAAGAATT 
ATGAAAGACAAAGTTTTTGGCGTTTTGCAACGTGTAGGAAGATCTTTTATGCTTCCAATTGCTATTTTAC 
CAGTAGCAGGTTTATTTTTAGGTATAGGTGAGTCATTCACTAATAAAACAATGCTTGATACGTATGGAAT 
TACAGGTTTAATTGGACCTGGCACATTTGTCAATGCACTTCTTTCAGTAATGAATGATGCAGGAAATATT 
GTGTTTGAAAATTTGCCTTTAATATTTGCAATAGGGGTTGCAATAGGCATGTCTAAGAAAGAAAGAGAAG 
TTGCAGCGTTAGCAGCAGGAATTGCATTTCTTATAATGCATGCATCAATTGGTGCCATGATTAAAATTCA 
TGGTGGAACAGAAGCTCTTTTAAGTGGCGCATCAACTGAAGTACTTGGTATAATTTCATTACAAATGGGT 
GTTTTCGGTGGGATTATCGTAGGGCTTGGTACAGCAGCATTGCATAATAGGTATTATAAAATTGAATTAC 
CACAAGTATTATCGTTTTTTGGTGGAACTAGATTTGTTCCTATTATATGTTCAATTGTCTATTTAATAGT 
TGGAATTTTAATGTTTTATATTTGGCCTCCAGTTCAAGGTGCTATTTACAAAGTTGGAAATATAGTGCTT 
GCATCAAGTTATGCAGGAACGTGGGTTTATGGTTTGATGGAACGGCTACTAATACCGTTTGGGCTTCATC 
ACGTATTTTATTTACCATTCTGGCAAACAGCAGTTGGAGGTACAGCTCAAGTAGGAGACAAAGTTATTGA 
AGGTGCTCAAAATATTTTTTTTGCAGAACTAGGAACGCCAGGAATAACACACTTTAGTGTTTCTGCAACA 
AGATTTATGTCGGGTAAATTTCCGCTTATGATATTTGGCTTGCCAGGAGCAGCACTAGCAATGTATAAAT 
GTGCTAAGCCAGAAAAGAGAAAAGCAGTAGGTGGATTATTACTATCAGCAGCATTAACGTCAATGCTCAC 
TGGTATAACAGAACCAATTGAATTCACATTTCTATTTGTAGCACCAGTATTATATGGAATTCACTGTGTG 
CTTGCTGGACTTGCTTATATGTTAATGCATATGTTAGGTGTTGGCGTAGGTATGACCTTCTCAGGTGGAT 
TTATTGATTTATTCTTATTTGGTATTTTACAAGGAAATGCTAAAACAAGCTGGATACTGATTGTTATTGT 
AGGAATCGTATATTTTGTAGTATACTATTTATTATTCACCTTCTTAATTAAGAAGCTTGATTTAAAGACT 
CCAGGTCGTGAAGATTCTGGTGAAGTTAAGCTTTATACTAGAAGTGATTTAGAAGCAAAGAAAAATGATC 
AAAATGAAAACGCAGACGAACTTTCGGCCATGATATGCAGAGGTCTCGGAGGAAAGAACAATATTTCTGA 
TGTTGATTGCTGTGTAACTAGATTGCGTTGTACTGTACATAACTCTGAATTGGTGAATGAAGGTTTGTTA 
AAACAAACTGGAGCATCGGGCATATTTCACAAAGGCGTAGGCGTCCAAATAATGTATGGGCCAAGAGTAA 
CTGTTATAAAATCAAATTTAGAAGATTACTTAGTTACAGCACCAGATAAAGAAGATACTGGTTATGCAAT 
AATAAAAAAAGAATCAGAGAAAGATACTGAAAAAGGTATTGAAAAAAAGGTTCAAGGAAAAGTTATAAGT 
ACAGTGATTTTAAATAGTCCATTGACAGGTGAAGCAAAAGATTTATCCGAAGTACCAGATGAAGTATTTG 
CGAGCAGGATAATGGGAGATGGAGCTGTGGTTGTCCCAAGCGATGGAAATGTTATAGCTCCGGCAGATGG 
AGTAATAAGTTTTGTATTCCCATCAAAACATGCATTGGGATTAACAACAACTGATGGACTTGAATTACTT 
ATTCATATAGGAATAGATACAGTAAAGCTTGATAAAAAAGCCTTTGAAACTTATGTGGAAGAGGGAGATA 
AAGTACAAGCTGGAGATAAAATATTAAGCTTTGACTTAGAATTTATAAAAAATAATGCACCATCTATTGC 
ATCACCATGCATATGCACTGCATTGAATAGCAATCAAAAGGTGCGTCTATTAAAAACTGGAGATATAAAA 
GCCGGAGAAGCTTTAATTGCAGTTGATGCATTTGAATAATATATAAGGGATGAGGAGGCATAAAATGTTT 
AGAGTGATAAAAGCACTAAATCATAATGGTGTACTCGCTATAAATATGGATAACTATAAAGAGTATATCT 
TGCTCGGAAAAGGTATAGGTTTTGGTAAAAAGGTCAATGAACGTATTGAAGCTCCAGAAAATGCACATAT 
ATATCTCTTGCAGCAAGAAACTGAAAGAG 
  
Figure 5.1: Sequence of the cbei 0751gene and annealing positions of primers used in this project. The 
sequence of the strand of the positive chromosome is shown. 
    Amplification primers for cloning of gene cbei 0751 
    Primers for Dig-labelling of hybridization probe for gene cbei 0751 
    Primers, 435 forward primer and 436 reverse primer (glcG) for gene knockout for cbei 0751 
 
 
 
 
 
356fwdprimer 
510Digfwd primer 
511Digrev primer 
357rev primer 
436glcGrev primer 
435glcGfwd primer 
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Clostridium beijerinckii NCIMB 8052 (cbei 4984/ cbei 4983/cbei 4982)  
AATGTACATTATACTATATGTGAAAAAATTTTCTAAAGCTGTTTAAACCCTTCTCTTATTGATAATATCA  
CATTATACTAAAAGTATCATGAATGGTACCACATGAAAGAGTGTTAAAATTTCTATGACAAGGGATTAAT 
AATACCTTGTACAGTAGATATATAAGGGGATGTTTTAGATGAAAAAATTCAATGTATCATTAGTTGGTGG 
AGGTAGTACATGGACTCCAGGACTTCTCGCAAGTTTATGTAAATTAAAGGACAGGTTTCCTATAAATAGA 
TTGATTTTATTCGATATAGATAAAGAACGTCAAGAAACAATTGCAAATTATGCAAAAGTATTGTTTAATG 
AAAGATACCCTGAATTGGATTTTAGATACACTACAAAGGTTGAAGAAGCTTATATAGATGTTGACTTTGT 
AATTATGCAAATGAGAACCGGTGGTTATAAGATGAGGGAAAAGGATGAAAAAATTCCTTTAAGCTTAGGC 
GTAATAGGGCAAGAAACCTGTGGTGCTGGAGGATTTGCGTATGGTCTTAGATCTATAAAAGACATGATTA 
AAACAATAAAGGATATAAGAAAGTATTCTAAAGATGCTTGGATATTAAATTATACAAATCCAGCTGCTAT 
AGTGGCAGAGGCATTAAGAAGAGAATTTCCAGAAGATAAGAGAGTTTTAAATATATGTGATCAACCAGTT 
AATTTATTACGTTCTTATGGCAGAGTTTTGGGAAAAGATTCGAAAAACTTTGAACCAGTTTATTTTGGAT 
TAAATCATTTTGGATGGTTTACTAATTTATATGATGAAAATGGAAACGATTTGGTTCCAGAACTTAGAAA 
AGTAATAAAAGAAAGGGGATTTATTCCTGTAGATGCAGAGCAAAGAGATAAATCATGGTTAGATACTTAT 
GCAATGGTACAGGATATGGTTAATGATTTCCCAGAATATCTTCCAAATACTTATTTACAATATTATTATT 
ATCCTGATTATAAAGTTAGTCATTTAAATCCAGATTATACAAGAGCAAATGAAGTTATGGATGGAAGAGA 
AAAGAGAGTTTTTGAAGAATGTAGAAGAGTCGCTAAAGCTGGTACTGTAGAAGGTTCTGTGATGGTTCAT 
AATGATGCACACAGTGAATTTATGATAGAAGTGGCTGAATCTATTGCTTATAATCTTAAAAAAATATATA 
TCGTAATTGTAAAAAATAATGGAATAATTTCAAATTTAGATGATGATGTAATGGTTGAAGTTGCTTCGAT 
AATGACAGCAAATGGACCAAGGCCTCTTTCAGTAGGTAAAATCCCTACATTTTACAAAGGTCTAATTGAA 
TCACAATCAGCTTATGAAAAATTAACAGTAGATGCTTATTTTGAAGGTTCATATGAAAAAGCGTTACAGG 
CATTAACTATGAACAGAACTATCGTATCTGCTAAAAAAGCAAGAGCGGTACTTGATAAATTAATAGAAGC 
CAACAAGGAGTATTGGCCTGAATTTAAATAATAAGATTTAAATAGAATATTGGTATATTAAAAAACAGTA 
CCAATATTCTAATAAAATATGAAATAATTATTATATTAGGAGGAAGAATAAATGACAAATACAAGCTATT 
TCTCTAAATTTCAACAATTAGGAAAAGTATTAATGACCCCAATACTTATATTGCCAATTGCTGGTATATT 
AATGGGAATTGGGTCTGCATTTTTAAGCCCATCTGTAATGAAAACGATGCCTTTTTTGCAAATGCCATTT 
TTCAAGTTGTTTTTTAGTTTGCTTAAATCATCAGGATCAATTGTATTTAATAATTTGCCGGCAATCTTTG 
CAATATCAATAACTATAGGTTATGCAAAAAAAGAGAAAGGTATTGCAGCTTTATCTGCTTTTTTAGGATA 
TATGGTTATGAATGTAACCATGAGCGCCTTACTTATTAATCTTGGTAAAATAAACCCAGATAAACTGCTT 
GTAGGACAATCAAATATACTAGGAGTTCCAACAGTTGATACAGGAGTTTTTGGTGGAATAATAGTAGGAT 
TTTTAATCGTTTATCTACATAATAAATATTATAATATATCTTTACCTCCTGTTTTATCAATATTTAGTGG 
TACAAAATTTGTCCCAATGGTTTCTATTATCGGATCATTAATTTTAGGATTAGCATTGTCTGTAGTATGG 
CCTTTTATTCAAGGTATATTAATTGAATTAAGTATATTAATTAAAAACTCTGGTGCTTATGGATCTATGA 
TATACGGTCTAGCTGAGCGAGCTCTTCTTCCTTTTGGACTTCATCATTTTGTATATCTTCCATTTTTCTT 
TACAAGTCTTGGTGGTAGTATGGAGATAGGTGGAAAAGTAGTTGAAGGTGCTGTTAATATTTATCAGGCT 
CAGTTAGCTACTCCAGGAGAAATGTTTAATATTGATGTCACTAGATTTGCTATGAATGGTAAAGTTATAG 
AATCTATGTTTGGATTGCCAGGGGCAGCTTTGGCTATGTATAAGTGTGCAAAGCCTGAAAGAAAAAAAGT 
TATAGGGGGATTTTTTCTTGCAGCAGTAATTCCAGCCTTCTTTTCTGGAATTACAGAACCAATTGAATTT 
GCATTTTTATTTGTAGCACCAGCATTATATGGAATTCATGCTATATTTGCAGGAACTGCTTATCTTGTAA 
CTTATTTGTTACAAATTAATATACCTGGAAGTGCAGCTTTTGGTGGACCTTTCTTAAGCTTTATATTTAA 
TGGAATTATGCAATCAGATAAAGGTTCTCACTGGATATTTGTTCCTATAGTAGGTGTAATATATTTTTGT 
TTATACTATTTCAGTTTCAAATTTGCAATAAAAAAATGGGATTTAAAAACTCCAGGACGAGAACTTGAAG 
AAGATTCAGAAGAAATTTCAGTAGTTTCATCAAGTAATACAATAATTAATGATATAGTCGATGCACTTGG 
AGGAAAAAATAATATTAAAAGTGTAGATGCCTGCTTTACAAGATTGAGGGTTTCTGTTAATGATATGTCT 
ATGGTTAAAGATGATAATATATGGAAGAAACTTGGTGCTAATGGAGTTGTTAAGGTTAAAGATGGTGTTC 
AGGTCATCTATGGAGCAAAAGCTGATGTTTATAAAACTCAAGTAAGAGATTTACTTGGAATGGAATAGGT 
GATTATATATGTTTAGTAAATTATTTAAGAAAAAAAATGATATTGTAATATATTCTCCGATAAAGGGGAA 
AATTGTTGATATTTCCGAAGTCCCAGATCCAGTGTTTTCTGATAAAATTATGGGTGAAGGTATTGCAGTA 
ATTCCTGAAGATAATATTATATGCTCACCAGTAAATGGTTATGTAGCTCAAATTTTTAAAACTAAGCATG 
CAATTTTACTAAAGAGTAGTGATGATTTAGAAATAATAATTCATATTGGATTAGAAACAGTTAATTTAAA 
TGGTGAAGGTTTTGAAGTGTTAATAAATGAAGGTGACGAAGTAACTACAGGTAAAAAACTTATAAAAGTA 
GACTTTGAGTTCATGAAAAATAAAGGGATTAATACAATAATTCCAGTTGTCATAATTAATCATGCGGATA 
GAAATATTATTAAATATTTTGGAGACAAGCAAACTGGAGCTGAGATAATGAAAATCTCACAATAGCCAAT 
TAATATGGATAATAAAGGGAATAGTGTGCAATTCAAGTCTAATAATAAGATTTGAAATTATAGACCT 
 
 
434fwd primer 
 
446-Digfwdprimer 
447-Digrevprimer 
432fwd primer 
455rev primer 
437glcXfwd primer 
448-Digfwd primer 
508fwd primer 
438glcXrev primer 
449-Digrev primer 
509rev primer 
450-Digfwd primer 
451-Digrevprimer 
433rev primer 
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Figure 5.2: Sequence of the genes cbei 4984, cbei 4983, cbei 4982 and annealing positions of primers 
used in this project. The sequence of the positive strand of   the chromosome is shown.  
    Amplification primers for gene cloning (cbei 4984/ cbei 4983 / cbei 4982) 
    Primers for Dig-labelling of hybridization probes for genes (cbei 4984/ cbei 4983/cbei 4982) 
   Primer 455 reverse primer 281 for gene cbei 4983  
    Primer 508 forward primer for gene cbei 4983  
    Primer 509 reverse primer 181 for gene cbei 4983  
    Primers 437forward primer and 438 reverse primer (glcX ) for gene knockout for (cbei 4983/cbei 
4982)   
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Appendix II.  Protein sequences  
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Sequences of PTS proteins used in construction of phylogenetic tree 
 
phosphotransferase system IICB, N-acetylglucosamine- specific [E. coli] 
 
 LOCUS  WP_000317748 
 
  1 tlimfknafa nlqkvgkslm lpvsvlpiag illgvgsanf swlpavvshv maeaggsvfa  
 61 nmplifaigv algftnndgv salaavvayg imvktmavva plvlhlpaee iaskhladtg 
121 vlggiisgai aaymfnrfyr iklpeylgff agkrfvpiis glaaiftgvv lsfiwppigs 
181 aiqtfsqwaa yqnpvvafgi ygfierclvp fglhhiwnvp fqmqigeytn aagqvfhgdi 
241 prymagdpta gklsggflfk myglpaaaia iwhsakpenr akvggimisa altsfltgit 
301 epiefsfmfv apilyiihai laglafpici llgmrdgtsf shglidfivl sgnssklwlf 
361 pivgigyaiv yytifrvlik aldlktpgre datedakatg tsemapalva afggkenitn 
421 ldacitrlrv svadvskvdq aglkklgaag vvvagsgvqa ifgtksdnlk temdeyirnh 
 
phosphotransferase system EIICBA  glucose-specific [B. subtilis] 
 
  LOCUS  NP_389272  
 
   1 mfkalfgvlq kigralmlpv ailpaagill aignamqnkd miqvlhflsn dnvqlvagvm 
  61 esagqivfdn lpllfavgva iglangdgva giaaiigylv mnvsmsavll angtipsdsv 
 121 erakfftenh payvnmlgip tlatgvfggi ivgvlaallf nrfytielpq ylgffagkrf 
 181 vpivtsisal ilglimlviw ppiqhglnaf stglveanpt laafifgvie rslipfglhh 
 241 ifyspfwyef fsyksaagei irgdqrifma qikdgvqlta gtfmtgkypf mmfglpaaal 
 301 aiyheakpqn kklvagimgs aaltsfltgi teplefsflf vapvlfaihc lfaglsfmvm 
 361 qllnvkigmt fsgglidyfl fgilpnrtaw wlvipvglgl aviyyfgfrf airkfnlktp 
 421 gredaaeeta apgktgeagd lpyeilqamg dqenikhlda citrlrvtvn dqkkvdkdrl 
 481 kqlgasgvle vgnniqaifg prsdglktqm qdiiagrkpr pepktsaqee vgqqveevia 
 541 eplqneigee vfvspitgei hpitdvpdqv fsgkmmgdgf ailpsegivv spvrgkilnv 
 601 fptkhaiglq sdggreilih fgidtvslkg egftsfvseg drvepgqkll evdldavkpn 
 661 vpslmtpivf tnlaegetvs ikasgsvnre qedivkiek 
 
glucose-specific PTS system enzyme II, factor IIA [Staphylococcus carnosus] 
 
  LOCUS  YP_002634092  
 
   1 mwkkffgqlq rigkalmlpv ailpaaglll algnafqgda lqslmpfika egfqnvakmm 
  61 egaggiifdn laiifalgva iglasgdgva aiaafvgfiv lnktmgmflg vtpekaadaa 
 121 tgfanvlgip tlqtgvfggi iigalaawcy nkfynislps ylgffagkrf vpimmatcsf 
 181 ilafpmaiiw psiqgglnaf segllasntg lavflfgfik rllipfglhh ifhapfwfef 
 241 gsyknaagqi ihgdqrifie qirdnvplta gkfmqgefpv mmfglpaaal aiyqtakken 
 301 kkvvaglmls galtsfltgi teplefsflf vapllffiha vldglsflil ylldlhlgyt 
 361 fsggfidffl lgilpnktqw wlvipvglvy aaiyyiifrf livkfnfktp gredkevkss 
 421 nvaaselpfk vldamggkan ikhldacitr lrvevndkak vdvqelkdlg asgvlevgnn 
 481 mqaifgpksd qikhdmqqim dgkitspeet tvteegdket aeiaaagggv vyapikgevv 
 541 disevpdkvf sekmmgdgia ikpetgevva pfdgvvkmvf ptkhaigles kdgiellihf 
 601 gletvklegk gfdilvkend nivlgqplmk vdldyikeha dstitpivvt nlngrtmevl 
 661 qhgevkqgdk vilvk 
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glucose-specific PTS system enzyme II, factor IIB [Staphylococcus carnosus] 
     
  LOCUS  YP_002634093  
  
 1  mknllkkffg qlqrigkalm lpvailpaag illtfgnamh neqilhfapw mqhhyiqlis                                                   
61  qimeasgqvi fdnlpllfam gtalglaggd gvagiaalvg ylimsatmgk iagitiddif 
121 syadgaktlg qsakdpahal vlgiptlqtg vfggiiigal aawcynkfyn iqlpqflgff 
181 agkrfvpiit slvaivtgiv lsfvwppvqd glnnlsnfll gknlalttfi fgiierslip 
241 fglhhifyap fwfefghyvn esgnlvrgdq riwmaqyqdg vpftagaftt gkypfmmfgl 
301 paaafaiyrq akperrkvvg glmlsaalts fltgiteple fsflfvapil yvahvilagt 
361 sflimhllhv qigmtfsggf idyilyglls wdrsnallvi pvgiayaliy yflftflikk 
421 lnlktpgred keveskdvsv selpfevlea mgnkdnikhl dacitrlrve vrdkglvdve 
481 klkqlgasgv levgnnmqai fgpksdqikh dmqqimdgki tspaettvte dgdvetaeiv 
541 aeggaviyap itgeavdlse vpdkvfsakm mgdgiaikpe tgevvapfdg kvkmifptkh 
601 aigleskdgi ellihfglet vkldgegfei lvkendnivl gqplmkvdln yikehaddti 
661 tpiiitnags anievlhtgk veqgeklllv nn 
 
Phosphotransferase system EIICBA  glucosamine-specific[B. subtilis] 
  
 LOCUS  NP_388117  
 
 1  mfkkafqilq qlgralmtpv avlpaaglll rfgdkdllni piikdaggvv fdnlplifav                                                         
61  gvaiglagge gvaglaavig yliltvtldn mgkllglqpp yegaehlidm gvfggiiigl 
121 laaylykrfs sielhpvlgf fsgkrfvpii tsvsslvigv ifsfvwpliq nginaassli 
181 adstvglffy atiyrllipf glhhifytpf yfmmgeytdp stgntvtgdl trffagdpta 
241 grfmmgdfpy mifclpaval aiihtarpek kkmisgvmis aaltsmltgi tepvefsflf 
301 vapvlylins ilagvifvvc dlfhvrhgyt fsgggidyvl nyglstngwv vipvgivfaf 
361 iyyylfrfai lkwnlktpgr etdedgqnee kapvakdqla fhvlqalggq qnianldaci 
421 trlrvtvhqp sqvckdelkr lgavgvlevn nnfqaifgtk sdalkddikt imaggvpata 
481 aaldtvtdkp lkpdsdetfi ypikgetvsl gdvpdqvfse kmmgegfaii psegkvvapa 
541 dgeivsifpt khaigfmsag gteilihvgi dtvklngegf eahvtsgqav kqgellltfd 
601 lnyikqhaas aitpviftnt seedlkhiqm k 
 
phosphotransferase IIABC  transporter subunit [C. acetobutylicum ATCC 824] 
 
LOCUS  NP_347209 
 
 1  mgnkifavlq kigkslmlpv svlpaagill rlgqpdllnm pyvqaagnai fnnlplifav            
61  gvaigfsgge gvaalaavig elileavekt agdtaaaala ktaaashhmt laafqktqey 
121 snivtkttis mgvfggiiig ltaailynkf hdikmpqvlg ffggkrfvpi itsisaliia 
181 tigvniwlpi qaginslaaf attspigpam yaggkrllip lglhhiyypl flyqfghfvs 
241 ngvtyvgdta ryfhgdptag nfmaaeypil mfglpgaala miaaakkekr kemagmmisa 
301 afvafvtgit epiefsfifv apvlfvfhvl aafasglits ylhirlgytf sasfidyvlg 
361 fkyaghplli wlvgigffvl yfvvfyftik amniktpgre dddaegvkki nvkgkakaak 
421 vleaiggkdn ikvldacitr lrlnlndpsl vdkatlkalg aagvmtaeds vqvvfgteae 
481 rikddikaii qnggyvedds dkeeevqedk qiskgahell spadgevvgi esvpdstfae 
541 kmlgdgfavi psgnevhspa dgevsvlfpt khafaitteg glellihvgi dtvalngegf 
601 tahvkqgdkv kkgdliltld tefikskgkn litpvivtnm dvvgnidvkl gnvknsekaa 
661 dvtvk 
 
 
  
122 
 
phosphotransferase  system EIIC  maltose- and glucose-specific [E. coli] 
 
LOCUS  PTOCB_ECOLI  
 
  1 mtaktapkvt lweffqqlgk tfmlpvalls fcgimlgigs slsshdvitl ipvlgnpvlq 
 61 aiftwmskig sfafsflpvm fciaiplgla renkgvaafa gfigyavmnl avnfwltnkg 
121 ilpttdaavl kanniqsilg iqsidtgilg aviagiivwm lherfhnirl pdalaffggt 
181 rfvpiisslv mglvglvipl vwpifamgis glghminsag dfgpmlfgtg erlllpfglh 
241 hilvalirft daggtqevcg qtvsgaltif qaqlscptth gfsesatrfl sqgkmpaflg 
301 glpgaalamy hcarpenrhk ikgllisgli acvvggttep leflflfvap vlyvihallt 
361 glgftvmsvl gvtigntdgn iidfvvfgil hglstkwymv pvvaaiwfvv yyvifrfaitn 
421 rfnlktpgrd sevassieka vagapgksgy nvpailealg gadnivsldn citrlrlsvk 
481 dmslvnvqal kdnraigvvq lnqhnlqvvi gpqvqsvkde maglmhtvqa 
 
phosphotransferase IIABC transporter subunit [E. faecalis] 
 
LOCUS  NP_814695  
 
  1 mkkmfsfefw qkfgkalmvv vavmpaaglm isigkslpli dpnlgllvtt ggvlesigwa 
 61 iignlhllfa laiggswakd raggafaagi sfvlinritg aifgvtneml adeqafthtl 
121 fgtkimvkgf ftsvleapal nmgvfvgiia gfvgamaynk yynyrklpda lsffngkrfv 
181 pfvvilwsti vsialaliwp niqaginnfg lwiaqsqdsa pilapflygt lerlllpfgl 
241 hhmltipiny tqlggtyeil sgaqagtqvf gqdplwlawa tdlvnlkgag dmskyqfvle 
301 nwtparfkvg qmigssgilm gmalamyrnv dadkkakyks myfsaalavf ltgvteplef 
361 mfmfaavply viyaviqgaa famadilplr vhsfgniell trtplaikag lggdlinfvl 
421 mviifgvvty flanflikkf nyatpgrngn ydndnseeia sgaagsgvvd qqiaqivyll 
481 ggkqnikevd acmtrlrvsv kdrekvgsee awkragamgl ivkdngvqav ygpkadvlks 
541 diedllasgv dipepviaes tagvpttnfl gkkkdfvava tgevipmaqv ndpvfsqkmm 
601 gdgfavkple gevvapisgk vlsvfpskha iglqteegie vlvhmgidtv ematpafesf 
661 vkegqslkag tklakmnldv ieqagketti ivaftnsdkv eqvvinqlgt ttagtvigqi 
721 ei 
phosphotransferase system IIABC  glucose-specific transporter [S. mutans] 
  LOCUS  NP_722340  
 
  1 mknykqlfsf efwqkfgkcl mvviavmpaa glmvsignsl alidpkstll vtvaniiaqi 
 61 gwgvinnlhi lfavaiggsw akeraggafa aalafilinl itgnfygisl emiadktsyv 
121 hnifggkmhv adyfinvlgq palnmgvfvg iisgfvgata ynkyynfrkl pdvlsffngk 
181 rfvpfvvivr stivalilsv fwpivqsgin gfgmwiassq htapflapfl ygtlerlllp 
241 fglhhmltip mnytqlggty vvltgaqagk hvlgqdplwl awvqdlihlk gaghmsqyhh 
301 lltsvtparf kvgqmigssg ilmgltlamy rnvdpdkkek ykgmflsaav avfltgvtep 
361 leymfmfaal plylvyavvq glafasadli hlrvhsfgni efltrtpmai kaglamdivn 
421 fivvsvvfgv amyfitnfmi kkfnlatsgr ngnydtgdda sdetasnsna gtanansqiv 
481 kiinllggke nisdvdacmt rlritvtdva kvgdeaawkk agamglivkg ngvqavygpk 
541 advlksdiqd lldsgvdipk tdvtaleedk tadvsfkgvt eeiatvadgq vlpitqvhdp 
601 vfsqkmmgdg favepengni yspvaglvts vfptkhalgl ltddglevlv hvgldtvaln 
661 gapfsakvkd gqrvalgdll lvadleaiks adrettviva ftntaelksv tlektgqqaa 
721 ktvvakvel 
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phosphotransferase  system β-glucoside-specific transporter II [S. mutans] 
  
 LOCUS  NP_721375  
 
  1 makdytelaq divshvggkd nivklvhcvt rlrftlkdes kadddylkqr egivtvvkag                                                      
61  gqyqvvignh vpdvydtvlk vsgitgeggi dvdegdipkg nlfdrfialv sglfqpmlga 
121 lsaagmikgl vailaavgvs ktdgayvvln aagdgffqfl plilaltaak rfkmeqftal 
181 aigfalvypn iaasftvkhp lytlfqgtli espiystffg ipiifpassy lqtvlpivva 
241 iwagskietf fkkiipdvvk vfvvpfftil itvplsflvi gpvmswasdl vgaiftgiyg 
301 fnpviygivl gamwqvlvmf glhwglvpla ilelqkgpgv ilvatiaicf aqagsllnim 
361 mrtkenkvrq lsipafisal fgvtepaiyg itlpmrvpfi mtcvsgaisg aylalfnvkm 
421 qvmggmglfa ipsfidpkns milihfliai amnfvlgfvl tqfikipyly geptstdsdv 
481 ddkeepvkel keikqeiiss pligkvvkle nvpdevfasg amgkgiaidp ddgivvaptk 
541 gevtlvfptk havglrteng aeilihigmd tvslagkgfk sfvkvgdhve agqtllefdv 
601 naikaaglpv itpvivtnsd qfedvlttqe rtveagdyll tavk 
  
PTS system IIABC  sucrose-specific transporter [S. mutans] 
 
    LOCUS  NP_722158   
 
    1 mdyskvasev itavgkdnlv aaahcatrlr lvlkddskvd qkaldknadv kgtfktdgqy 
 61 qviigpgdvn fvydeiikqt gltevstddl kkiaasgkkf npimalikll sdifvpiipa 
121 lvaggllmal nnfltseglf gtkslvqqfp iikgssdmiq lmsaapfwfl pilvgisaak 
181 rfganqflga sigmimvapg aaniiglaan apiskaatig aytgfwnifg lhvtqasyty 
241 qvipvlvavw llsilekffh krlpsavdft ftpllsviit gfltfivigp vmkevsdwlt 
301 ngivwlydtt gflgmgvfga lyspvvmtgl hqsfpaietq lisafqngtg hgdfifvtas 
361 manvaqgaat faiyfltkdk kmkglssssg vsallgitep alfgvnlkyr fpffcaligs 
421 asaaaiagll qvvavslgsa gflgflsika ssipfyvvce lisfaiafav tygygktkav 
481 dvfaaeaave eaieevqeip eeaasaanka qvtdevlaap lageavelts vndpvfssea 
541 mgkgiaikps gntvyapvdg tvqiafdtgh aygiksdnga eilihigidt vsmegkgfeq 
601 kvqadqkikk gdvlgtfdsd kiaeagldnt tmfivtntad yasvetlass gtvavgdsll 
661 evkk 
 
 
 phosphotransferase system IIABC trehalose-specific transporter [S. mutans] 
 
LOCUS  NP_722334  
  
  1 mgkfekdakv lldaiggken vsavthcatr mrfvlndesk advktieaip avkgtftnag 
 61 qfqiiigndv plfyndftav sgiegvsket aksaakshqn piqrvmtlla eiftpiipai 
121 ivgglilgfr nvidqvqwgf ldgqtiaqhs qfwsgissfl wlpgeaifqf lpvgivwsvs 
181 rkmgtsqilg ivlgiclvsp qllnaynvas tpaaeiakkw vwdfgfftvr rigyqgqvip 
241 allaglslsy leifwrkkip evvsmifvpf lslipalila htvlgpigwt igqwistivy 
301 agltgpvkwl fgaifgalya pfvitglhhm tnaidtqlva dtggtglwpm ialsniaqgs 
361 avfayylmnr heereaqvsl patisaylgv tepalfgvni kyvyplvagm igssiagfls 
421 vtfnvtanai gigglpgils ikvkymlpff iimlvaiavp mvltvffrri nfltksedea 
481 hqektetaei sasektnepa vgttfeiksp lkgqvkplse avdpvfaqgv mgqgvlidps 
541 eglltspvng vvsvlfptkh alglvtdqgl ellihigmdt vnlegkgfet yvkqgdtikv 
601 gdklirfdid aihqagytte tpvivtnqnd yqpdvvgslp reiergevll taski 
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phosphotransferase  transmembrane protein [Streptomyces coelicolor] 
 
LOCUS  NP_627133   
 
  1 mstatdtaap akkrgsglfq glqkvgrslq lpiavlpaag imvrlgqddi fgkdglgwdk 
 61 vaavfnnagg altgslpilf cigvaigfak kadgstalaa vvgflvyskv leafpvteav 
121 vqdgadvaat yndpgvlggi imgllaavlw qryhrkklvd wlgffngrrl vpiimafvgi 
181 vvgvffglvw epigdgisnf gewmtglgsg gaalfggvnr alipvgmhqf vntvawfqlg 
241 dftnsagdvv hgditrflag dpsagifqag ffpimmfglp aaalamahta rperrkavlg 
301 mmislaatsf vtgvtepief sfmfiapvly vlhavltais maitwglgvh agfnfsagfi 
361 dyalnwhlat kpwliipigl vfaaiyyvtf rfaivkfnlk tpgrepeeev edltka 
 
protein-N-phosphohistidine sugar phosphotransferase II ABC, N-
acetylglucosamine specific [Ralstonia eutropha] 
 
LOCUS  YP_724831  
    1 mkmdllprvq rlgatlmlpi avlpvaglll rlgqpdvfdi klmaeagnav fanlallfai 
 61 gvavgfardn ngaaalagti gylvlttvlk tidksldmgv lagivagava gglynryrnv 
121 alppylgffs gkrfvpivta lcclllgivl ayawapvqag inaagawltt agsagalvfg 
181 llnrlllvtg lhhlintlaw fvfgnyadpa tgaavsgdlh ryfagdpgag lfmtgffpvm 
241 mfglpaacla myhetpparr alvggmlfsm altsfltgit epiefsfmfl apvlyglhal 
301 mtglsmalch aldirlgftf sagaidyvlg yglssrgwla iplglayalv yyglfrffir 
361 rfnlltpgrd evvpvaaagg aaqpaagsva qqyvealggp anlvvvdact trlrlnvadi 
421 gavseprlka lgvrgvlkrp pnvvqvvigp qaeqvagdir avlqqapqat avvaaapava 
481 tqasvpaaga fdpawwidal ggaaniasvg vvaltrlrvv vrerarvrad hlagsqlmwi 
541 gddtahiafg haadghaaaf eralqampt 
 
 
 phosphotransferase  C2-protein [Streptomyces olivaceoviridis] 
 
LOCUS  CAD_29623 
 
      1 mavlqrigrs lmlpvavlpa aallvrlgna dmlgrpefpa fvtkiagfma aggnaildnm 
  61 allfavgiai gfakksdgst alaavvgylv fknvlatftd knlpqvakav dgkvvmvdap 
 121 vdakvlggvv mglvvallyq rfyrtklpdw agffggrrlv pilsafaglv igivfgyiwp 
 181 vlgtglhnfg ewlvgsgavg agifgvanra lipigmhhll nsfpwfqage yegksgdiar 
 241 flagdptagq fmtgffpimm falpaaclai vhcarperrk vvggmmfsla ltsfvtgvte 
 301 pieftfmfia pvlyaihavl tgvsmaltwa lgmkdgfgfs agavdfflnl giasnpwgla 
 361 lvgvcfaaly yvvfrfaitk fnlptpgres deelaelrka egk 
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fused N-acetyl glucosamine specific Phosphotransferase enzyme: IICBA [E.coli] 
 
LOCUS  NP_415205 
 
      1 mnilgffqrl gralqlpiav lpvaalllrf gqpdllnvaf iaqaggaifd nlalifaigv 
  61 asswskdsag aaalagavgy fvltkamvti npeinmgvla giitglvgga aynrwsdikl 
 121 pdflsffggk rfvpiatgff clvlaaifgy vwppvqhaih aggewivsag algsgifgfi 
 181 nrlliptglh qvlntiawfq igeftnaagt vfhgdinrfy agdgtagmfm sgffpimmfg 
 241 lpgaalamyf aapkerrpmv ggmllsvavt afltgvtepl eflfmflapl lyllhalltg 
 301 islfvatllg ihagfsfsag aidyalmynl paasqnvwml lvmgviffai yfvvfslvir 
 361 mfnlktpgre dkedeivtee ansnteeglt qlatnyiaav ggtdnlkaid acitrlrltv 
 421 adsarvndtm ckrlgasgvv klnkqtiqvi vgakaesigd amkkvvargp vaaasaeatp 
 481 ataapvakpq avpnavsiae lvspitgdvv aldqvpdeaf askavgdgva vkptdkivvs 
 541 paagtivkif ntnhafclet ekgaeivvhm gidtvalegk gfkrlveega qvsagqpile 
 601 mdldylnana rsmispvvcs niddfsglii kaqghivagq tplyeikk 
 
 
phosphotransferase system IIC transporter [C. acetobutylicum] 
 
LOCUS  NP_347981 
 
  1 mgvtnkllaa cqklgkslmt piavlpaagl llrlgqpdll niswmmaagn gifnnlamif 
 61 aigiavgfae enngvaglsa avgyfvltnv atsfnkhidm gvlggiivgi lagnlynkyk 
121 strlpdflgf fggrrlvpil tslcslvlgl isglvwpaiq nvinafgnsv shagvvgsfi 
181 ygllnrllip iglhhvlntl fwfqfgtfks asgkivtgdl hrffaldkta gtymtgffpi 
241 mmfalpaacl amisaakken rkkvsgmllg iaftafltgv tepieflfmf lapvlyvvha 
301 vltglsmait salgiksgft fsagfvdyim nfnistkpil livigilyai iyyflflfti 
361 kkfnlptpgr mddlddlddl ddlddlddld eepentpkik sspsknstle ekavgileai 
421 gnknniqsld acvtrirltv kdgskvdepk lkklgatgim klddknfqiv vgttadiiat 
481 hikeiikk 
 
phosphotransferase  EIICB  N-acetylglucosamine-specific [B. subtilis] 
 
LOCUS  NP_388651 
 
  1 mlsflqklgk sfmlpiavlp avgiilalgr edvfnipfvy qagtavfdhl plifaigiai 
 61 giskdsngaa glsgaisylm ldaatktidk tnnmavfggi iagliagyty nrfkdtklpe 
121 ylgffsgrrl vpiltaiiti ilagifgvvw ppiqscinsf gewmlglggi gagifglfnr 
181 lliplglhhv lnnifwfqfg eyngvtgdla rffakdptag tymtgffpim mfglpaacla 
241 mvvtakpskr katagmmigf altafitgit epiefafmfl spllyavhav ltglslfivn 
301 wlgirsgfsf sagaidyvls ygiaekplll llvgicyaav yfivfyvlik alnlktpgre 
361 dddvdevlde ntvqdvneni mlkglggken lqtidhcatr lrltvkdtal vdeallkkag 
421 akgvvksggq svqviigpnv efaaeelraa vk 
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phosphotransferase IIA,  glucose subfamily [C. beijerinckii NCIMB 8052] 
 
LOCUS  “Cbei_0751”  
 
  1 mkdkvfgvlq rvgrsfmlpi ailpvaglfl gigesftnkt mldtygitgl igpgtfvnal 
 61 lsvmndagni vfenlplifa igvaigmskk erevaalaag iaflimhasi gamikihggt 
121 eallsgaste vlgiislqmg vfggiivglg taalhnryyk ielpqvlsff ggtrfvpiic 
181 sivylivgil mfyiwppvqg aiykvgnivl assyagtwvy glmerllipf glhhvfylpf 
241 wqtavggtaq vgdkviegaq niffaelgtp githfsvsat rfmsgkfplm ifglpgaala 
301 mykcakpekr kavgglllsa altsmltgit epieftflfv apvlygihcv laglaymlmh 
361 mlgvgvgmtf sggfidlflf gilqgnakts wilivivgiv yfvvyyllft flikkldlkt 
421 pgredsgevk lytrsdleak kndqnenade lsamicrglg gknnisdvdc cvtrlrctvh 
481 nselvnegll kqtgasgifh kgvgvqimyg prvtviksnl edylvtapdk edtgyaiikk 
541 esekdtekgi ekkvqgkvis tvilnspltg eakdlsevpd evfasrimgd gavvvpsdgn 
601 viapadgvis fvfpskhalg ltttdglell ihigidtvkl dkkafetyve egdkvqagdk 
661 ilsfdlefik nnapsiaspc ictalnsnqk vrllktgdik agealiavda fe 
 
PTS system IIBC, glucose-like subunint [C. beijerinckii NCIMB 8052] 
 
LOCUS  “Cbei_4983”  
 
   1 mtntsyfskf qqlgkvlmtp ililpiagil mgigsaflsp svmktmpflq mpffklffsl 
  61 lkssgsivfn nlpaifaisi tigyakkekg iaalsaflgy mvmnvtmsal linlgkinpd 
 121 kllvgqsnil gvptvdtgvf ggiivgfliv ylhnkyynis lppvlsifsg tkfvpmvsii 
 181 gslilglals vvwpfiqgil ielsilikns gaygsmiygl aerallpfgl hhfvylpfff 
 241 tslggsmeig gkvvegavni yqaqlatpge mfnidvtrfa mngkviesmf glpgaalamy 
 301 kcakperkkv iggfflaavi paffsgitep iefaflfvap alygihaifa gtaylvtyll 
 361 qinipgsaaf ggpflsfifn gimqsdkgsh wifvpivgvi yfclyyfsfk faikkwdlkt 
 421 pgreleedse eisvvsssnt iindivdalg gknniksvda cftrlrvsvn dmsmvkddni 
 481 wkklgangvv kvkdgvqviy gakadvyktq vrdllgme 
 
 
phosphotransferase  system IIBC,  N-acetylglucosamine [C. beijerinckii NCIMB 
8052] 
 
LOCUS  “Cbei_4532” 
        
      1 mmkylqklgk slmlpvaclp vasilmglgy wldptgwgan niasafmlka gsalidnmgi 
  61 lfaigvgvgm sddndgtagl aglvswlmit tllstgavam fkgidvkeva pafaktqtqf 
 121 igilsgliga acynrfksvk lpdalgffsg krcvaivtaa ysivasivlf fawpliygal 
 181 vafgeaivst gavgsgiyaf fnrllipfgl hhalnsvfwf dvagindlgn fwsgkgtqgv 
 241 tgmymtgffp vmmfglpaga lamyhtakdk kkkavyglll aaaissfftg vteplefafm 
 301 flapglyvlh agltgisafv ctllpvragf nfsagfvdwf lsfkapmaen pimlipiglv 
 361 faviyyvtfr faitkfnlkt pgredddaee lnvklanndy tqvaavilkg vggkenvvsi 
 421 dncvtrlrle ikdqaavdek viksagvsgi irpgktsvqv vvgtqvqfva defkklck 
 
 
 
 Figure 5.3: Sequences of proteins used in alignments comparative in this project. 
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Appendix  III.  DNA molecular weight markers  
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Hyperladder I 
 
 
 
                                           
 
 
 
Figure 5.4: DNA molecular weight markers of Bioline Hyperladder I. 
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Appendix  IV. Restriction map and sequence  
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Figure 5.5: Sequence and restriction map of the pCR 2.1 TOPO vector. 
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(B) 
 
 
Figure 5.6: Sequence and restriction map of  StrataClone PCR cloning vector pSC-A-amp/kan. 
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Figure 5.7: Sequence and restriction map of pJET1.2/blunt 2.1 Cloning Vector.  
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Figure 5.8: Sequence and restriction map of   pUC18 vector. 
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Appnedix   V.  Solutions 
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  1) 20x saline sodium citrate (SSC) stock solution/1000 ml 
 
    - 3 M sodium chloride (NaCl)  
 
    - 300 mM sodium acetate trihydrate (CH3COONa. 3H2O)  
 
    - pH  8.0  
 
  2) 2x saline sodium citrate (SSC) solution/1000 ml  
 
    - 100 ml from 20x SSC stock solution  
 
    - 0.1 % sodium dodecyl sulfate (SDS)   
 
  3) 0.2x saline sodium citrate (SSC) solution/1000 ml  
 
    - 10 ml from 20x SSC stock solution  
 
    - 0.1 % sodium dodecyl sulfate (SDS)  
 
  4) DIG 1 buffer/ 1000 ml 
 
    - 100 mM Tris HCl  
 
    - 1 M sodium chloride (NaCl)  
 
    - 0.2 % Tween 80  
 
    - pH  8.5  
 
  5) DIG 4 buffer/1000 ml   
  
    - 100 mM Tris HCl  
 
    - 1 M sodium chloride (NaCl)  
 
    - 0.2 % Tween 80  
 
    - pH  9.5  
 
  6) Easy hybridization buffer/100  
 
    - 6 M Urea  
 
    - 6x SSC stock solution (30 ml of 20x SSC)  
 
    - 1 % sodium dodecyl sulfate (SDS)  
 
    - 50 mM  Tris HCl    
 
   - pH  7.5   
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  7) Blocking solution/100 ml  
 
    - 100 mM malic acid  
 
    - 1 M sodium chloride (NaCl)  
 
    - pH 8.0 
 
    - 0.3 %  Tween 80  
 
    - 0.5 %  casein 
 
    - 0.1 % (DEPC)     
       
  8) TAE buffer (1x)  
 
    - 40 mM Tris acetate  
 
    - 20 mM glacial acetic acid                              
    - 1 mM EDTA  
  
    - pH 8.0 
 
  9) DEPC- treated water 1000 ml 
 
    - dH2O: 0.1 % DEPC solution  
 
10)   2x YTG/1000 ml  
 
    - Tryptone   16 g  
 
    - Yeast extract 10 g  
 
    - NaCl 5 g  
 
    - 1 %  Carbohydrate  
 
    - pH  7.0  
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